Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_001164508.2(NEB):c.870_873del (p.Ser290fs)	NEB	S290fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001685967	2	152567002 - 152567005	2	151710488 - 151710491	1685967	1677979		NC_000002.12:151710487:CTCACTC:CTC
NM_001164508.2(NEB):c.21417+1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 1, 2021)	criteria provided, single submitter	VCV001679395	2	152389955	2	151533441	1679395	1671318		NC_000002.12:151533440:C:T
NM_001164508.2(NEB):c.17276del (p.Gln5759fs)	NEB	Q4058fs, Q5759fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 2, 2022)	criteria provided, single submitter	VCV001676462					1676462	1667950		
GRCh37/hg19 2q23.3(chr2:150606201-153038451)	ARL5A|CACNB4|NEB|NMI|RBM43|RIF1|RND3|STAM2|TNFAIP6		not specified	Likely pathogenic(Last reviewed: Mar 1, 2022)	criteria provided, single submitter	VCV001526921	2	150606201 - 153038451			1526921	1518410		
GRCh37/hg19 2q22.2-23.3(chr2:143258712-152867819)	ACVR2A|ARHGAP15|ARL5A|CACNB4|EPC2|GTDC1|KYNU|LYPD6|LYPD6B|MBD5|MMADHC|NEB|NMI|ORC4|RBM43|RIF1|RND3|TNFAIP6|ZEB2		not specified	Pathogenic(Last reviewed: Mar 1, 2022)	criteria provided, single submitter	VCV001526906	2	143258712 - 152867819			1526906	1518395		
NM_001164508.2(NEB):c.21418-1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001523428	2	152388411	2	151531897	1523428	1350597		NC_000002.12:151531896:C:T
NM_001164508.2(NEB):c.2524-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001519055	2	152544048	2	151687534	1519055	1343248		NC_000002.12:151687533:T:C
NM_001164508.2(NEB):c.21313-1G>C	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 1, 2021)	criteria provided, single submitter	VCV001515345	2	152390061	2	151533547	1515345	1505210		NC_000002.12:151533546:C:G
NM_001164508.2(NEB):c.12639+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001513661	2	152464016	2	151607502	1513661	1468850		NC_000002.12:151607501:A:G
NM_001164508.2(NEB):c.18366+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 20, 2021)	criteria provided, single submitter	VCV001513590	2	152422013	2	151565499	1513590	1468779		NC_000002.12:151565498:A:G
NM_001164508.2(NEB):c.23650-1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 8, 2021)	criteria provided, single submitter	VCV001510708	2	152362085	2	151505571	1510708	1465385		NC_000002.12:151505570:C:T
NM_001164508.2(NEB):c.6075+2T>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001509970	2	152515577	2	151659063	1509970	1445889		NC_000002.12:151659062:A:C
NM_001164508.2(NEB):c.22375-2A>G	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001508220	2	152380931	2	151524417	1508220	1442871		NC_000002.12:151524416:T:C
NM_001164508.2(NEB):c.21313-2A>T	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 23, 2021)	criteria provided, single submitter	VCV001507077	2	152390062	2	151533548	1507077	1439488		NC_000002.12:151533547:T:A
NM_001164508.2(NEB):c.3988-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001505936	2	152529196	2	151672682	1505936	1339666		NC_000002.12:151672681:T:C
NC_000002.11:g.(?_152541945)_(152544191_?)del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Dec 23, 2020)	criteria provided, single submitter	VCV001505028	2	152541945 - 152544191			1505028	1413897		
NC_000002.11:g.(?_152506680)_(152507409_?)del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 16, 2021)	criteria provided, single submitter	VCV001505001	2	152506680 - 152507409			1505001	1413871		
NM_001164508.2(NEB):c.10675C>G (p.Arg3559Gly)	NEB	R3316G, R3559G	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV001501318	2	152476162	2	151619648	1501318	1402066		NC_000002.12:151619647:G:C
NM_001164508.2(NEB):c.24579+2T>C	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 25, 2021)	criteria provided, single submitter	VCV001500738	2	152350673	2	151494159	1500738	1501661		NC_000002.12:151494158:A:G
NM_001164508.2(NEB):c.295-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001497248	2	152582076	2	151725562	1497248	1475869		NC_000002.12:151725561:T:C
NM_001164508.2(NEB):c.1570-1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001496442	2	152552197	2	151695683	1496442	1359474		NC_000002.12:151695682:C:G
NM_001164508.2(NEB):c.21945+1G>C	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 29, 2021)	criteria provided, single submitter	VCV001494524	2	152383431	2	151526917	1494524	1344667		NC_000002.12:151526916:C:G
NM_001164508.2(NEB):c.22272+2_22272+3del	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001489467	2	152381674 - 152381675	2	151525160 - 151525161	1489467	1495073		NC_000002.12:151525159:TA:
NM_001164508.2(NEB):c.24765+2T>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001487969	2	152349865	2	151493351	1487969	1482001		NC_000002.12:151493350:A:T
NM_001164508.2(NEB):c.18694-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 12, 2021)	criteria provided, single submitter	VCV001485278	2	152419323	2	151562809	1485278	1394004		NC_000002.12:151562808:C:T
NM_001164508.2(NEB):c.5452-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 18, 2021)	criteria provided, single submitter	VCV001484339	2	152520374	2	151663860	1484339	1455269		NC_000002.12:151663859:C:T
NM_001164508.2(NEB):c.21735+1G>C	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001483933	2	152385723	2	151529209	1483933	1458715		NC_000002.12:151529208:C:G
NM_001164508.2(NEB):c.1782+1del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001483660	2	152551035	2	151694521	1483660	1458445		NC_000002.12:151694520:C:
NM_001164508.2(NEB):c.22375-1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001482794	2	152380930	2	151524416	1482794	1464777		NC_000002.12:151524415:C:T
NM_001164508.2(NEB):c.22161+1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 6, 2021)	criteria provided, single submitter	VCV001482691	2	152382471	2	151525957	1482691	1442056		NC_000002.12:151525956:C:T
NM_001164508.2(NEB):c.7432-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 3, 2021)	criteria provided, single submitter	VCV001479910	2	152502749	2	151646235	1479910	1364580		NC_000002.12:151646234:C:T
NM_001164508.2(NEB):c.17535+1G>T	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001477592	2	152425781	2	151569267	1477592	1436471		NC_000002.12:151569266:C:A
NM_001164508.2(NEB):c.24579+1G>T	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001476222	2	152350674	2	151494160	1476222	1423941		NC_000002.12:151494159:C:A
NM_001164508.2(NEB):c.1153-2A>T	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV001475686	2	152554164	2	151697650	1475686	1400717		NC_000002.12:151697649:T:A
NM_001164508.2(NEB):c.12330+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 6, 2021)	criteria provided, single submitter	VCV001471419	2	152466322	2	151609808	1471419	1488490		NC_000002.12:151609807:C:T
NM_001164508.2(NEB):c.6184-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001471221	2	152512979	2	151656465	1471221	1488292		NC_000002.12:151656464:C:T
NM_001164508.2(NEB):c.1470+1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, single submitter	VCV001470657	2	152553661	2	151697147	1470657	1394884		NC_000002.12:151697146:C:G
NM_001164508.2(NEB):c.19945-2A>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 26, 2021)	criteria provided, single submitter	VCV001469480	2	152406256	2	151549742	1469480	1475429		NC_000002.12:151549741:T:G
NM_001164508.2(NEB):c.5031+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001467863	2	152522602	2	151666088	1467863	1462245		NC_000002.12:151666087:A:G
NM_001164508.2(NEB):c.2211+2T>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001466481	2	152548376	2	151691862	1466481	1347840		NC_000002.12:151691861:A:T
NM_001164508.2(NEB):c.23016+1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 4, 2021)	criteria provided, single submitter	VCV001466087	2	152371331	2	151514817	1466087	1448912		NC_000002.12:151514816:C:T
NM_001164508.2(NEB):c.12438del (p.Arg4146fs)	NEB	R4146fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001460342	2	152465083	2	151608569	1460342	1504394		NC_000002.12:151608568:T:
NM_001164508.2(NEB):c.19621del (p.Ser6541fs)	NEB	S6541fs, S4840fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 7, 2021)	criteria provided, single submitter	VCV001460231	2	152410347	2	151553833	1460231	1481587		NC_000002.12:151553832:T:
NM_001164508.2(NEB):c.4132A>T (p.Lys1378Ter)	NEB	K1378*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 7, 2021)	criteria provided, single submitter	VCV001459967	2	152529050	2	151672536	1459967	1481324		NC_000002.12:151672535:T:A
NM_001164508.2(NEB):c.24503dup (p.Asn8168fs)	NEB|RIF1	N6312fs, N8168fs, N8203fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 26, 2021)	criteria provided, single submitter	VCV001459619	2	152350750 - 152350751	2	151494236 - 151494237	1459619	1484807		NC_000002.12:151494236:TTTT:TTTTT
NC_000002.11:g.(?_152380815)_(152384109_?)del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 11, 2021)	criteria provided, single submitter	VCV001459336	2	152380815 - 152384109			1459336	1406463		
NM_001164508.2(NEB):c.25266C>A (p.Tyr8422Ter)	NEB|RIF1	Y8457*, Y6566*, Y8422*	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV001459030	2	152346917	2	151490403	1459030	1406159		NC_000002.12:151490402:G:T
NM_001164508.2(NEB):c.13407_13416del (p.Gly4470fs)	NEB	G4470fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 31, 2021)	criteria provided, single submitter	VCV001458512	2	152458475 - 152458484	2	151601961 - 151601970	1458512	1468223		NC_000002.12:151601960:GTCATAACCAGTCAT:GTCAT
NM_001164508.2(NEB):c.5343+5G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 19, 2021)	criteria provided, single submitter	VCV001458230	2	152521268	2	151664754	1458230	1467945		NC_000002.12:151664753:C:T
NM_001164508.2(NEB):c.24182_24185dup (p.His8062fs)	NEB|RIF1	H8062fs, H8097fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV001458223	2	152354795 - 152354796	2	151498281 - 151498282	1458223	1467938		NC_000002.12:151498281:TGTTTG:TGTTTGTTTG
NM_001164508.2(NEB):c.21751C>T (p.Gln7251Ter)	NEB|RIF1	Q7286*, Q5550*, Q7251*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, single submitter	VCV001457927	2	152384084	2	151527570	1457927	1471494		NC_000002.12:151527569:G:A
NC_000002.11:g.(?_152482028)_(152567072_?)del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001457908	2	152482028 - 152567072			1457908	1471475		
NM_001164508.2(NEB):c.17989A>T (p.Lys5997Ter)	NEB	K4296*, K5997*	Nemaline myopathy 2	Pathogenic(Last reviewed: May 18, 2021)	criteria provided, single submitter	VCV001457395	2	152423849	2	151567335	1457395	1393336		NC_000002.12:151567334:T:A
NM_001164508.2(NEB):c.7335_7338del (p.Lys2445fs)	NEB	K2445fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 21, 2021)	criteria provided, single submitter	VCV001456999	2	152506783 - 152506786	2	151650269 - 151650272	1456999	1477738		NC_000002.12:151650268:TTTCTT:TT
NM_001164508.2(NEB):c.1933_1934del (p.Lys645fs)	NEB	K645fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 2, 2021)	criteria provided, single submitter	VCV001456981	2	152548839 - 152548840	2	151692325 - 151692326	1456981	1477720		NC_000002.12:151692324:TTT:T
NM_001164508.2(NEB):c.7219C>T (p.Gln2407Ter)	NEB	Q2407*	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 19, 2020)	criteria provided, single submitter	VCV001456861	2	152507096	2	151650582	1456861	1454963		NC_000002.12:151650581:G:A
NM_001164508.2(NEB):c.23385T>G (p.Tyr7795Ter)	NEB|RIF1	Y7795*, Y6094*, Y7830*	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 24, 2021)	criteria provided, single submitter	VCV001456494	2	152364585	2	151508071	1456494	1458433		NC_000002.12:151508070:A:C
NM_001164508.2(NEB):c.8269_8270dup (p.Leu2757fs)	NEB	L2757fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 17, 2021)	criteria provided, single submitter	VCV001456397	2	152499190 - 152499191	2	151642676 - 151642677	1456397	1458336		NC_000002.12:151642676:AA:AAAA
NM_001164508.2(NEB):c.23896_23899del (p.Arg7966fs)	NEB|RIF1	R7966fs, R6265fs, R8001fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 20, 2021)	criteria provided, single submitter	VCV001456332	2	152359336 - 152359339	2	151502822 - 151502825	1456332	1458271		NC_000002.12:151502821:CTCTCTC:CTC
NM_001164508.2(NEB):c.20992dup (p.Ser6998fs)	NEB	S6998fs, S5297fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 16, 2021)	criteria provided, single submitter	VCV001456263	2	152394658 - 152394659	2	151538144 - 151538145	1456263	1458203		NC_000002.12:151538144:T:TT
NM_001164508.2(NEB):c.11425G>T (p.Glu3809Ter)	NEB	E3566*, E3809*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 13, 2021)	criteria provided, single submitter	VCV001456050	2	152470966	2	151614452	1456050	1380308		NC_000002.12:151614451:C:A
NM_001164508.2(NEB):c.5309T>A (p.Leu1770Ter)	NEB	L1770*	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 21, 2021)	criteria provided, single submitter	VCV001455883	2	152521307	2	151664793	1455883	1380143		NC_000002.12:151664792:A:T
NM_001164508.2(NEB):c.4740C>A (p.Tyr1580Ter)	NEB	Y1580*	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 26, 2020)	criteria provided, single submitter	VCV001455662	2	152522895	2	151666381	1455662	1379922		NC_000002.12:151666380:G:T
NM_001164508.2(NEB):c.18270T>A (p.Tyr6090Ter)	NEB	Y6090*, Y4389*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV001455302	2	152422111	2	151565597	1455302	1464423		NC_000002.12:151565596:A:T
NM_001164508.2(NEB):c.3400_3401del (p.Lys1134fs)	NEB	K1134fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 29, 2021)	criteria provided, single submitter	VCV001455138	2	152534556 - 152534557	2	151678042 - 151678043	1455138	1441624		NC_000002.12:151678041:TTT:T
NM_001164508.2(NEB):c.10497del (p.Gly3498_Tyr3499insTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV001454998	2	152477496	2	151620982	1454998	1441484		NC_000002.12:151620981:A:
NM_001164508.2(NEB):c.22016del (p.Leu7339fs)	NEB|RIF1	L5638fs, L7339fs, L7374fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001454953	2	152382706	2	151526192	1454953	1441439		NC_000002.12:151526191:A:
NM_001164508.2(NEB):c.10411G>T (p.Glu3471Ter)	NEB	E3471*, E3228*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 2, 2021)	criteria provided, single submitter	VCV001454792	2	152482089	2	151625575	1454792	1445128		NC_000002.12:151625574:C:A
NM_001164508.2(NEB):c.25330C>T (p.Gln8444Ter)	NEB|RIF1	Q6588*, Q8444*, Q8479*	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 14, 2021)	criteria provided, single submitter	VCV001454699	2	152346559	2	151490045	1454699	1445037		NC_000002.12:151490044:G:A
NM_001164508.2(NEB):c.17224C>T (p.Gln5742Ter)	NEB	Q4041*, Q5742*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 3, 2021)	criteria provided, single submitter	VCV001454460	2	152426801	2	151570287	1454460	1444803		NC_000002.12:151570286:G:A
NM_001164508.2(NEB):c.23134_23144del (p.Tyr7712fs)	NEB|RIF1	Y7747fs, Y6011fs, Y7712fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 23, 2021)	criteria provided, single submitter	VCV001454179	2	152370191 - 152370201	2	151513677 - 151513687	1454179	1366785		NC_000002.12:151513676:TCTCGCTTATAT:T
NM_001164508.2(NEB):c.20360_20361insA (p.Ser6788fs)	NEB	S6788fs, S5087fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 3, 2021)	criteria provided, single submitter	VCV001454069	2	152403949 - 152403950	2	151547435 - 151547436	1454069	1366677		NC_000002.12:151547435::T
NM_001164508.2(NEB):c.5587G>T (p.Glu1863Ter)	NEB	E1863*	Nemaline myopathy 2	Pathogenic(Last reviewed: May 7, 2021)	criteria provided, single submitter	VCV001454015	2	152520238	2	151663724	1454015	1366624		NC_000002.12:151663723:C:A
NM_001164508.2(NEB):c.22175del (p.Lys7392fs)	NEB|RIF1	K5691fs, K7427fs, K7392fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 28, 2021)	criteria provided, single submitter	VCV001453846	2	152381774	2	151525260	1453846	1451372		NC_000002.12:151525259:TTTTT:TTTT
NM_001164508.2(NEB):c.3996C>G (p.Tyr1332Ter)	NEB	Y1332*	Nemaline myopathy 2	Pathogenic(Last reviewed: May 25, 2021)	criteria provided, single submitter	VCV001453487	2	152529186	2	151672672	1453487	1428768		NC_000002.12:151672671:G:C
NM_001164508.2(NEB):c.13509del (p.Gly4504fs)	NEB	G4504fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 26, 2021)	criteria provided, single submitter	VCV001453467	2	152457235	2	151600721	1453467	1428749		NC_000002.12:151600720:TTT:TT
NM_001164508.2(NEB):c.13341_13362del (p.Lys4448fs)	NEB	K4448fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV001453430	2	152459107 - 152459128	2	151602593 - 151602614	1453430	1428712		NC_000002.12:151602592:GATCTGCAGGGCATTGATTTTGGAT:GAT
NM_001164508.2(NEB):c.1537C>T (p.Gln513Ter)	NEB	Q513*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 5, 2021)	criteria provided, single submitter	VCV001453423	2	152553183	2	151696669	1453423	1428705		NC_000002.12:151696668:G:A
NM_001164508.2(NEB):c.2675_2678del (p.Ile892fs)	NEB	I892fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 12, 2021)	criteria provided, single submitter	VCV001453328	2	152541449 - 152541452	2	151684935 - 151684938	1453328	1428611		NC_000002.12:151684934:TAGATAG:TAG
NM_001164508.2(NEB):c.23344C>T (p.Gln7782Ter)	NEB|RIF1	Q7817*, Q7782*, Q6081*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 3, 2021)	criteria provided, single submitter	VCV001453113	2	152369249	2	151512735	1453113	1432253		NC_000002.12:151512734:G:A
NM_001164508.2(NEB):c.13157T>A (p.Leu4386Ter)	NEB	L4386*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001452970	2	152460189	2	151603675	1452970	1432110		NC_000002.12:151603674:A:T
NM_001164508.2(NEB):c.2880_2883del (p.Trp961fs)	NEB	W961fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 23, 2020)	criteria provided, single submitter	VCV001452789	2	152539236 - 152539239	2	151682722 - 151682725	1452789	1431933		NC_000002.12:151682721:CCAGCCA:CCA
NM_001164508.2(NEB):c.24672+1del	NEB|RIF1		Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 2, 2021)	criteria provided, single submitter	VCV001452770	2	152350288	2	151493774	1452770	1431914		NC_000002.12:151493773:CC:C
NM_001164508.2(NEB):c.7152C>A (p.Tyr2384Ter)	NEB	Y2384*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 30, 2021)	criteria provided, single submitter	VCV001452684	2	152507163	2	151650649	1452684	1364403		NC_000002.12:151650648:G:T
NM_001164508.2(NEB):c.23939_23942dup (p.Asn7982fs)	NEB|RIF1	N8017fs, N7982fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 19, 2021)	criteria provided, single submitter	VCV001452607	2	152357983 - 152357984	2	151501469 - 151501470	1452607	1364326		NC_000002.12:151501469:TCTTT:TCTTTCTTT
NM_001164508.2(NEB):c.1503del (p.Lys501fs)	NEB	K501fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 19, 2021)	criteria provided, single submitter	VCV001452572	2	152553217	2	151696703	1452572	1364291		NC_000002.12:151696702:TTTT:TTT
NM_001164508.2(NEB):c.13504C>T (p.Gln4502Ter)	NEB	Q4502*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 18, 2021)	criteria provided, single submitter	VCV001452505	2	152457240	2	151600726	1452505	1364225		NC_000002.12:151600725:G:A
NM_001164508.2(NEB):c.22651_22652del (p.Leu7551fs)	NEB|RIF1	L5850fs, L7551fs, L7586fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 18, 2021)	criteria provided, single submitter	VCV001452497	2	152375522 - 152375523	2	151519008 - 151519009	1452497	1364217		NC_000002.12:151519007:AGAGA:AGA
NM_001164508.2(NEB):c.8523del (p.Lys2842fs)	NEB	K2842fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 16, 2021)	criteria provided, single submitter	VCV001452275	2	152497031	2	151640517	1452275	1439032		NC_000002.12:151640516:GG:G
NM_001164508.2(NEB):c.4485dup (p.Asn1496Ter)	NEB	N1496*	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, single submitter	VCV001452217	2	152527557 - 152527558	2	151671043 - 151671044	1452217	1438974		NC_000002.12:151671043:A:AA
NM_001164508.2(NEB):c.20225_20226del (p.Ile6742fs)	NEB	I5041fs, I6742fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 31, 2021)	criteria provided, single submitter	VCV001452150	2	152404184 - 152404185	2	151547670 - 151547671	1452150	1438908		NC_000002.12:151547669:GA:
NM_001164508.2(NEB):c.25426_25429dup (p.Tyr8477Ter)	NEB|RIF1	Y8512*, Y6621*, Y8477*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 4, 2021)	criteria provided, single submitter	VCV001452141	2	152342422 - 152342423	2	151485908 - 151485909	1452141	1438899		NC_000002.12:151485908:AGTCA:AGTCAGTCA
NM_001164508.2(NEB):c.22812del (p.Glu7605fs)	NEB|RIF1	E7605fs, E5904fs, E7640fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 24, 2021)	criteria provided, single submitter	VCV001452035	2	152373066	2	151516552	1452035	1438793		NC_000002.12:151516551:TTT:TT
NM_001164508.2(NEB):c.1526del (p.Pro509fs)	NEB	P509fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 23, 2021)	criteria provided, single submitter	VCV001452031	2	152553194	2	151696680	1452031	1438789		NC_000002.12:151696679:GG:G
NM_001164508.2(NEB):c.4550del (p.Thr1517fs)	NEB	T1517fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 8, 2021)	criteria provided, single submitter	VCV001451969	2	152525602	2	151669088	1451969	1438728		NC_000002.12:151669087:G:
NM_001164508.2(NEB):c.2566_2569del (p.Ile856fs)	NEB	I856fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 19, 2021)	criteria provided, single submitter	VCV001451706	2	152544001 - 152544004	2	151687487 - 151687490	1451706	1426106		NC_000002.12:151687486:CAATCA:CA
NM_001164508.2(NEB):c.24376_24377insCC (p.Gln8126fs)	NEB|RIF1	Q8126fs, Q8161fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 1, 2021)	criteria provided, single submitter	VCV001451650	2	152353471 - 152353472	2	151496957 - 151496958	1451650	1426050		NC_000002.12:151496957:G:GGG
NM_001164508.2(NEB):c.12819del (p.Lys4274fs)	NEB	K4274fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 21, 2021)	criteria provided, single submitter	VCV001451624	2	152461314	2	151604800	1451624	1426024		NC_000002.12:151604799:GGGG:GGG
NM_001164508.2(NEB):c.6103dup (p.Ser2035fs)	NEB	S2035fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 27, 2021)	criteria provided, single submitter	VCV001451595	2	152514576 - 152514577	2	151658062 - 151658063	1451595	1425995		NC_000002.12:151658062:A:AA
NM_001164508.2(NEB):c.20674_20675del (p.Gln6892fs)	NEB	Q5191fs, Q6892fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 9, 2021)	criteria provided, single submitter	VCV001451447	2	152397968 - 152397969	2	151541454 - 151541455	1451447	1425849		NC_000002.12:151541453:TG:
NM_001164508.2(NEB):c.5346del (p.Lys1782fs)	NEB	K1782fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV001451381	2	152521120	2	151664606	1451381	1429635		NC_000002.12:151664605:TTT:TT
NM_001164508.2(NEB):c.25209dup (p.Gly8404fs)	NEB|RIF1	G6548fs, G8404fs, G8439fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 16, 2021)	criteria provided, single submitter	VCV001451265	2	152346973 - 152346974	2	151490459 - 151490460	1451265	1429519		NC_000002.12:151490459:A:AA
NM_001164508.2(NEB):c.11584_11587dup (p.Asp3863delinsValTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV001451228	2	152470803 - 152470804	2	151614289 - 151614290	1451228	1429482		NC_000002.12:151614289:CATA:CATACATA
NM_001164508.2(NEB):c.24617del (p.Thr8206fs)	NEB|RIF1	T8241fs, T6350fs, T8206fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 16, 2021)	criteria provided, single submitter	VCV001451217	2	152350344	2	151493830	1451217	1429471		NC_000002.12:151493829:G:
NM_001164508.2(NEB):c.20934C>A (p.Tyr6978Ter)	NEB	Y6978*, Y5277*	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 10, 2021)	criteria provided, single submitter	VCV001449485	2	152394717	2	151538203	1449485	1416541		NC_000002.12:151538202:G:T
NM_001164508.2(NEB):c.294+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 2, 2021)	criteria provided, single submitter	VCV001445319	2	152584204	2	151727690	1445319	1397645		NC_000002.12:151727689:C:T
NM_001164508.2(NEB):c.445del (p.His149fs)	NEB	H149fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 2, 2021)	criteria provided, single submitter	VCV001445309	2	152581433	2	151724919	1445309	1397635		NC_000002.12:151724918:G:
NM_001164508.2(NEB):c.11610C>A (p.Tyr3870Ter)	NEB	Y3870*, Y3627*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 8, 2021)	criteria provided, single submitter	VCV001445213	2	152468895	2	151612381	1445213	1397539		NC_000002.12:151612380:G:T
NM_001164508.2(NEB):c.5595dup (p.Lys1866fs)	NEB	K1866fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001445125	2	152520229 - 152520230	2	151663715 - 151663716	1445125	1397451		NC_000002.12:151663715:GG:GGG
NM_001164508.2(NEB):c.19653G>A (p.Trp6551Ter)	NEB	W4850*, W6551*	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, single submitter	VCV001436116	2	152409990	2	151553476	1436116	1497232		NC_000002.12:151553475:C:T
NM_001164508.2(NEB):c.13323_13324insGCAATGTGAACGTGCTAATGTGAACGTG (p.Pro4442delinsAlaMetTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001434695	2	152459145 - 152459146	2	151602631 - 151602632	1434695	1506900		NC_000002.12:151602631::CACGTTCACATTAGCACGTTCACATTGC
NM_001164508.2(NEB):c.24175_24178dup (p.Val8060fs)	NEB|RIF1	V8060fs, V8095fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 26, 2021)	criteria provided, single submitter	VCV001433559	2	152354802 - 152354803	2	151498288 - 151498289	1433559	1419232		NC_000002.12:151498288:CTCTCT:CTCTCTCTCT
NM_001164508.2(NEB):c.24089_24092dup (p.His8031fs)	NEB|RIF1	H8031fs, H8066fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV001430704	2	152355833 - 152355834	2	151499319 - 151499320	1430704	1471238		NC_000002.12:151499319:TGTTTG:TGTTTGTTTG
NM_001164508.2(NEB):c.5557C>T (p.Gln1853Ter)	NEB	Q1853*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 3, 2021)	criteria provided, single submitter	VCV001429156	2	152520268	2	151663754	1429156	1454273		NC_000002.12:151663753:G:A
NM_001164508.2(NEB):c.22966del (p.Val7656fs)	NEB|RIF1	V7691fs, V7656fs, V5955fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 31, 2021)	criteria provided, single submitter	VCV001427957	2	152371382	2	151514868	1427957	1464112		NC_000002.12:151514867:CC:C
NM_001164508.2(NEB):c.25181C>A (p.Ser8394Ter)	NEB|RIF1	S8394*, S6538*, S8429*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 5, 2021)	criteria provided, single submitter	VCV001421987	2	152347002	2	151490488	1421987	1337601		NC_000002.12:151490487:G:T
NM_001164508.2(NEB):c.25333C>T (p.Gln8445Ter)	NEB|RIF1	Q8480*, Q8445*, Q6589*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 15, 2021)	criteria provided, single submitter	VCV001421316	2	152346556	2	151490042	1421316	1422732		NC_000002.12:151490041:G:A
NM_001164508.2(NEB):c.1184_1185dup (p.Ala396fs)	NEB	A396fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 24, 2021)	criteria provided, single submitter	VCV001420704	2	152554129 - 152554130	2	151697615 - 151697616	1420704	1403310		NC_000002.12:151697615:TTTT:TTTTTT
NM_001164508.2(NEB):c.934del (p.Tyr312fs)	NEB	Y312fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 16, 2020)	criteria provided, single submitter	VCV001420415	2	152566271	2	151709757	1420415	1503194		NC_000002.12:151709756:A:
NM_001164508.2(NEB):c.24271_24274dup (p.Lys8092fs)	NEB|RIF1	K8092fs, K8127fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 2, 2021)	criteria provided, single submitter	VCV001417880	2	152354165 - 152354166	2	151497651 - 151497652	1417880	1396935		NC_000002.12:151497651:TGACT:TGACTGACT
NM_001164508.2(NEB):c.12865del (p.Glu4289fs)	NEB	E4289fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001417581	2	152461268	2	151604754	1417581	1374068		NC_000002.12:151604753:C:
NM_001164508.2(NEB):c.18714T>G (p.Tyr6238Ter)	NEB	Y6238*, Y4537*	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 26, 2020)	criteria provided, single submitter	VCV001415346	2	152419302	2	151562788	1415346	1374853		NC_000002.12:151562787:A:C
NM_001164508.2(NEB):c.16803_16804del (p.Phe5601fs)	NEB	F5601fs, F3900fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 25, 2021)	criteria provided, single submitter	VCV001414700	2	152432769 - 152432770	2	151576255 - 151576256	1414700	1369902		NC_000002.12:151576254:AAAA:AA
NM_001164508.2(NEB):c.13389G>A (p.Trp4463Ter)	NEB	W4463*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001412093	2	152458502	2	151601988	1412093	1349232		NC_000002.12:151601987:C:T
NM_001164508.2(NEB):c.17845-1G>C	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 7, 2021)	criteria provided, single submitter	VCV001410922	2	152423994	2	151567480	1410922	1510359		NC_000002.12:151567479:C:G
NM_001164508.2(NEB):c.13085G>A (p.Trp4362Ter)	NEB	W4362*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001408902	2	152460261	2	151603747	1408902	1496691		NC_000002.12:151603746:C:T
NM_001164508.2(NEB):c.5523_5527del (p.Lys1842fs)	NEB	K1842fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001406304	2	152520298 - 152520302	2	151663784 - 151663788	1406304	1408325		NC_000002.12:151663783:GCTTGG:G
NM_001164508.2(NEB):c.4347G>A (p.Trp1449Ter)	NEB	W1449*	Nemaline myopathy 2	Pathogenic(Last reviewed: May 9, 2021)	criteria provided, single submitter	VCV001406062	2	152527696	2	151671182	1406062	1493324		NC_000002.12:151671181:C:T
NM_001164508.2(NEB):c.10809G>A (p.Trp3603Ter)	NEB	W3603*, W3360*	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 9, 2021)	criteria provided, single submitter	VCV001404461	2	152476028	2	151619514	1404461	1480157		NC_000002.12:151619513:C:T
NM_001164508.2(NEB):c.4842C>G (p.Tyr1614Ter)	NEB	Y1614*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 25, 2021)	criteria provided, single submitter	VCV001402055	2	152522793	2	151666279	1402055	1453865		NC_000002.12:151666278:G:C
NM_001164508.2(NEB):c.19294C>T (p.Gln6432Ter)	NEB	Q4731*, Q6432*	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 30, 2021)	criteria provided, single submitter	VCV001401769	2	152417126	2	151560612	1401769	1457428		NC_000002.12:151560611:G:A
NM_001164508.2(NEB):c.13142del (p.Asn4381fs)	NEB	N4381fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 9, 2021)	criteria provided, single submitter	VCV001399682	2	152460204	2	151603690	1399682	1366039		NC_000002.12:151603689:TT:T
NM_001164508.2(NEB):c.12394G>T (p.Glu4132Ter)	NEB	E4132*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV001397664	2	152465127	2	151608613	1397664	1352864		NC_000002.12:151608612:C:A
NM_001164508.2(NEB):c.5493_5494del (p.Ile1832fs)	NEB	I1832fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 8, 2021)	criteria provided, single submitter	VCV001397061	2	152520331 - 152520332	2	151663817 - 151663818	1397061	1414935		NC_000002.12:151663816:TGTGT:TGT
NM_001164508.2(NEB):c.11473del (p.Val3825fs)	NEB	V3582fs, V3825fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 29, 2021)	criteria provided, single submitter	VCV001396147	2	152470918	2	151614404	1396147	1350926		NC_000002.12:151614403:CC:C
NM_001164508.2(NEB):c.13599C>G (p.Tyr4533Ter)	NEB	Y4533*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001396044	2	152457145	2	151600631	1396044	1350823		NC_000002.12:151600630:G:C
NM_001164508.2(NEB):c.23746_23747dup (p.Met7916fs)	NEB|RIF1	M7916fs, M6215fs, M7951fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 2, 2021)	criteria provided, single submitter	VCV001395587	2	152359950 - 152359951	2	151503436 - 151503437	1395587	1424986		NC_000002.12:151503436:ATA:ATATA
NM_001164508.2(NEB):c.732del (p.Gly245fs)	NEB	G245fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 18, 2021)	criteria provided, single submitter	VCV001395149	2	152574020	2	151717506	1395149	1412163		NC_000002.12:151717505:TTTTTT:TTTTT
NM_001164508.2(NEB):c.12356G>A (p.Trp4119Ter)	NEB	W4119*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001391730	2	152465165	2	151608651	1391730	1386528		NC_000002.12:151608650:C:T
NM_001164508.2(NEB):c.19635C>G (p.Tyr6545Ter)	NEB	Y4844*, Y6545*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 10, 2021)	criteria provided, single submitter	VCV001391632	2	152410008	2	151553494	1391632	1386431		NC_000002.12:151553493:G:C
NM_001164508.2(NEB):c.2778C>A (p.Tyr926Ter)	NEB	Y926*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 17, 2021)	criteria provided, single submitter	VCV001391512	2	152541349	2	151684835	1391512	1390192		NC_000002.12:151684834:G:T
NM_001164508.2(NEB):c.24575dup (p.Ser8192fs)	NEB|RIF1	S8227fs, S6336fs, S8192fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 17, 2021)	criteria provided, single submitter	VCV001391390	2	152350678 - 152350679	2	151494164 - 151494165	1391390	1390070		NC_000002.12:151494164:C:CC
NM_001164508.2(NEB):c.5225_5226del (p.Leu1742fs)	NEB	L1742fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 13, 2021)	criteria provided, single submitter	VCV001390265	2	152521859 - 152521860	2	151665345 - 151665346	1390265	1373864		NC_000002.12:151665344:CA:
NM_001164508.2(NEB):c.13103G>A (p.Trp4368Ter)	NEB	W4368*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 6, 2021)	criteria provided, single submitter	VCV001389849	2	152460243	2	151603729	1389849	1377329		NC_000002.12:151603728:C:T
NM_001164508.2(NEB):c.19635C>A (p.Tyr6545Ter)	NEB	Y4844*, Y6545*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 6, 2021)	criteria provided, single submitter	VCV001386453	2	152410008	2	151553494	1386453	1357580		NC_000002.12:151553493:G:T
NM_001164508.2(NEB):c.5458_5459del (p.Tyr1820fs)	NEB	Y1820fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 8, 2021)	criteria provided, single submitter	VCV001386300	2	152520366 - 152520367	2	151663852 - 151663853	1386300	1361308		NC_000002.12:151663851:TAT:T
NM_001164508.2(NEB):c.23998_24001del (p.Leu8000fs)	NEB|RIF1	L8000fs, L8035fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 2, 2021)	criteria provided, single submitter	VCV001385740	2	152357925 - 152357928	2	151501411 - 151501414	1385740	1460888		NC_000002.12:151501410:TGAGT:T
NM_001164508.2(NEB):c.6242_6243del (p.Leu2081fs)	NEB	L2081fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 25, 2021)	criteria provided, single submitter	VCV001384146	2	152512919 - 152512920	2	151656405 - 151656406	1384146	1447742		NC_000002.12:151656404:GAGA:GA
NM_001164508.2(NEB):c.21313-680C>T	RIF1|NEB	Q5435*, Q7136*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 26, 2021)	criteria provided, single submitter	VCV001382666	2	152390740	2	151534226	1382666	1513140		NC_000002.12:151534225:G:A
NM_001164508.2(NEB):c.24337del (p.Leu8113fs)	NEB|RIF1	L8113fs, L8148fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 17, 2020)	criteria provided, single submitter	VCV001380379	2	152353511	2	151496997	1380379	1421201		NC_000002.12:151496996:G:
NM_001164508.2(NEB):c.23786dup (p.Thr7930fs)	NEB|RIF1	T6229fs, T7930fs, T7965fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 17, 2021)	criteria provided, single submitter	VCV001378986	2	152359911 - 152359912	2	151503397 - 151503398	1378986	1408177		NC_000002.12:151503397:A:AA
NM_001164508.2(NEB):c.18828G>A (p.Trp6276Ter)	NEB	W4575*, W6276*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 10, 2021)	criteria provided, single submitter	VCV001378946	2	152419188	2	151562674	1378946	1408137		NC_000002.12:151562673:C:T
NM_001164508.2(NEB):c.24245T>A (p.Leu8082Ter)	NEB|RIF1	L8117*, L8082*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV001374182	2	152354195	2	151497681	1374182	1456999		NC_000002.12:151497680:A:T
NM_001164508.2(NEB):c.13220del (p.Pro4407fs)	NEB	P4407fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001372386	2	152460126	2	151603612	1372386	1443631		NC_000002.12:151603611:GGGG:GGG
NM_001164508.2(NEB):c.617del (p.Leu206fs)	NEB	L206fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 24, 2021)	criteria provided, single submitter	VCV001370565	2	152579996	2	151723482	1370565	1430633		NC_000002.12:151723481:A:
NM_001164508.2(NEB):c.6204T>G (p.Tyr2068Ter)	NEB	Y2068*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 22, 2021)	criteria provided, single submitter	VCV001370327	2	152512958	2	151656444	1370327	1352666		NC_000002.12:151656443:A:C
NM_001164508.2(NEB):c.13593del (p.Arg4531fs)	NEB	R4531fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 29, 2021)	criteria provided, single submitter	VCV001368566	2	152457151	2	151600637	1368566	1340158		NC_000002.12:151600636:CC:C
NM_001164508.2(NEB):c.660del (p.Tyr221fs)	NEB	Y221fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 6, 2021)	criteria provided, single submitter	VCV001368540	2	152579953	2	151723439	1368540	1340133		NC_000002.12:151723438:GGGG:GGG
NM_001164508.2(NEB):c.12782delinsTAACCTTCCACCAAC (p.Gly4261fs)	NEB	G4261fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 14, 2021)	criteria provided, single submitter	VCV001366908	2	152461351	2	151604837	1366908	1338073		NC_000002.12:151604836:C:GTTGGTGGAAGGTTA
NM_001164508.2(NEB):c.5258G>A (p.Trp1753Ter)	NEB	W1753*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 25, 2021)	criteria provided, single submitter	VCV001365940	2	152521358	2	151664844	1365940	1398930		NC_000002.12:151664843:C:T
NM_001164508.2(NEB):c.9580C>T (p.Gln3194Ter)	NEB	Q3194*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 21, 2020)	criteria provided, single submitter	VCV001365254	2	152487695	2	151631181	1365254	1019460	rs2098659971	NC_000002.12:151631180:G:A
NM_001164508.2(NEB):c.9600del (p.Asn3200fs)	NEB	N3200fs, N2957fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 11, 2021)	criteria provided, single submitter	VCV001364239	2	152487675	2	151631161	1364239	1386178		NC_000002.12:151631160:A:
NM_001164508.2(NEB):c.13328del (p.Leu4443fs)	NEB	L4443fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001360156	2	152459141	2	151602627	1360156	1363602		NC_000002.12:151602626:A:
NM_001164508.2(NEB):c.1157del (p.Leu386fs)	NEB	L386fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 7, 2021)	criteria provided, single submitter	VCV001356979	2	152554158	2	151697644	1356979	1348410		NC_000002.12:151697643:A:
NM_001164508.2(NEB):c.25129C>T (p.Arg8377Ter)	NEB|RIF1	R8412*, R6521*, R8377*	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV001356561	2	152348218	2	151491704	1356561	1447310		NC_000002.12:151491703:G:A
NM_001164508.2(NEB):c.23998_24001dup (p.Asn8001fs)	NEB|RIF1	N8001fs, N8036fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV001356551	2	152357924 - 152357925	2	151501410 - 151501411	1356551	1447300		NC_000002.12:151501410:TGAGT:TGAGTGAGT
NM_001164508.2(NEB):c.10598_10610del (p.His3533fs)	NEB	H3290fs, H3533fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 13, 2021)	criteria provided, single submitter	VCV001355873	2	152476227 - 152476239	2	151619713 - 151619725	1355873	1354170		NC_000002.12:151619712:GCGCCAATGTGGTG:G
NM_001164508.2(NEB):c.19897del (p.Thr6633fs)	NEB	T4932fs, T6633fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 11, 2021)	criteria provided, single submitter	VCV001355816	2	152408299	2	151551785	1355816	1354113		NC_000002.12:151551784:TTTT:TTT
NM_001164508.2(NEB):c.12331-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 12, 2021)	criteria provided, single submitter	VCV001347600	2	152465191	2	151608677	1347600	1466030		NC_000002.12:151608676:C:T
NM_001164508.2(NEB):c.8373+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 14, 2021)	criteria provided, single submitter	VCV001346401	2	152499087	2	151642573	1346401	1456363		NC_000002.12:151642572:C:T
NM_001164508.2(NEB):c.5763+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 26, 2021)	criteria provided, single submitter	VCV001345880	2	152520061	2	151663547	1345880	1452747		NC_000002.12:151663546:C:T
GRCh37/hg19 2q22.2-23.3(chr2:142409401-152680804)x3	ACVR2A|ARHGAP15|ARL5A|EPC2|GTDC1|KYNU|LRP1B|LYPD6|LYPD6B|MBD5|MMADHC|NEB|NMI|ORC4|RBM43|RIF1|RND3|TNFAIP6|ZEB2		not provided	Pathogenic(Last reviewed: Feb 1, 2021)	no assertion criteria provided	VCV001341063	2	142409401 - 152680804			1341063	1332271		
NM_001164508.2(NEB):c.23628_23631del (p.Gln7876fs)	NEB|RIF1	Q6175fs, Q7876fs, Q7911fs	Nemaline myopathy 2|Nemaline myopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV001339685	2	152362698 - 152362701	2	151506184 - 151506187	1339685	1330896		NC_000002.12:151506183:TGTTTGTTT:TGTTT
NM_001164508.2(NEB):c.20975_20976del (p.Lys6992fs)	NEB	K5291fs, K6992fs	Nemaline myopathy	Likely pathogenic(Last reviewed: Jan 9, 2022)	criteria provided, single submitter	VCV001339664	2	152394675 - 152394676	2	151538161 - 151538162	1339664	1330875		NC_000002.12:151538160:TTT:T
NM_001164508.2(NEB):c.7345C>T (p.Gln2449Ter)	NEB	Q2449*	Nemaline myopathy 2	Likely pathogenic	criteria provided, single submitter	VCV001339130	2	152506776	2	151650262	1339130	1330173		NC_000002.12:151650261:G:A
NM_001164508.2(NEB):c.23836-2A>G	NEB|RIF1		not provided	Likely pathogenic(Last reviewed: Jul 19, 2019)	criteria provided, single submitter	VCV001335963	2	152359401	2	151502887	1335963	1326976		NC_000002.12:151502886:T:C
NM_001164508.2(NEB):c.2772C>A (p.Tyr924Ter)	NEB	Y924*	not provided	Likely pathogenic(Last reviewed: Nov 11, 2021)	no assertion criteria provided	VCV001324795	2	152541355	2	151684841	1324795	1315061		NC_000002.12:151684840:G:T
NM_001164508.2(NEB):c.24527dup (p.Val8177fs)	NEB|RIF1	V6321fs, V8177fs, V8212fs	not provided	Likely pathogenic(Last reviewed: Oct 8, 2021)	no assertion criteria provided	VCV001324794	2	152350726 - 152350727	2	151494212 - 151494213	1324794	1315060		NC_000002.12:151494212:GGGG:GGGGG
NM_001164508.2(NEB):c.22091del (p.Gly7364fs)	NEB|RIF1	G5663fs, G7364fs, G7399fs	not provided	Likely pathogenic(Last reviewed: May 12, 2021)	no assertion criteria provided	VCV001324793	2	152382542	2	151526028	1324793	1315059		NC_000002.12:151526027:CCC:CC
NM_001164508.2(NEB):c.6775C>T (p.Gln2259Ter)	NEB	Q2259*	not provided	Likely pathogenic(Last reviewed: Feb 9, 2021)	no assertion criteria provided	VCV001324792	2	152511816	2	151655302	1324792	1315058		NC_000002.12:151655301:G:A
NM_001164508.2(NEB):c.5075del (p.Gly1692fs)	NEB	G1692fs	not provided	Likely pathogenic(Last reviewed: Feb 9, 2021)	no assertion criteria provided	VCV001324791	2	152522010	2	151665496	1324791	1315057		NC_000002.12:151665495:CC:C
NM_001164508.2(NEB):c.18366+1del	NEB		not provided	Likely pathogenic(Last reviewed: Sep 20, 2021)	no assertion criteria provided	VCV001324790	2	152422014	2	151565500	1324790	1315056		NC_000002.12:151565499:C:
NM_001164508.2(NEB):c.23795del (p.Glu7932fs)	NEB|RIF1	E6231fs, E7932fs, E7967fs	not provided	Likely pathogenic(Last reviewed: Apr 27, 2021)	no assertion criteria provided	VCV001324789	2	152359903	2	151503389	1324789	1315055		NC_000002.12:151503388:T:
NM_001164508.2(NEB):c.19836+1G>A	NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2022)	criteria provided, multiple submitters, no conflicts	VCV001324788	2	152409185	2	151552671	1324788	1315054		NC_000002.12:151552670:C:T
NM_001164508.2(NEB):c.739del (p.Ala247fs)	NEB	A247fs	not provided	Pathogenic(Last reviewed: Oct 14, 2020)	no assertion criteria provided	VCV001323354	2	152574013	2	151717499	1323354	1313639		NC_000002.12:151717498:C:
NM_001164508.2(NEB):c.5768del (p.Gln1923fs)	NEB	Q1923fs	not provided	Pathogenic(Last reviewed: Dec 11, 2019)	no assertion criteria provided	VCV001323353	2	152518851	2	151662337	1323353	1313638		NC_000002.12:151662336:T:
NM_001164508.2(NEB):c.1998+1G>A	NEB		not provided	Pathogenic(Last reviewed: Dec 17, 2020)	no assertion criteria provided	VCV001323352	2	152548774	2	151692260	1323352	1313637		NC_000002.12:151692259:C:T
NM_001164508.2(NEB):c.12262G>T (p.Glu4088Ter)	NEB	E3845*, E4088*	not provided	Pathogenic(Last reviewed: Aug 20, 2020)	no assertion criteria provided	VCV001323351	2	152466391	2	151609877	1323351	1313636		NC_000002.12:151609876:C:A
NM_001164508.2(NEB):c.14747_14748del (p.Lys4916fs)	NEB	K4916fs	not provided	Pathogenic(Last reviewed: Apr 16, 2020)	no assertion criteria provided	VCV001323348	2	152448626 - 152448627	2	151592112 - 151592113	1323348	1313633		NC_000002.12:151592111:TTT:T
NM_001164508.2(NEB):c.19078C>T (p.Gln6360Ter)	NEB	Q4659*, Q6360*	not provided	Pathogenic(Last reviewed: Jun 25, 2019)	no assertion criteria provided	VCV001323347	2	152417745	2	151561231	1323347	1313632		NC_000002.12:151561230:G:A
NM_001164508.2(NEB):c.4602del (p.Asn1534fs)	NEB	N1534fs	not provided	Pathogenic(Last reviewed: Jun 4, 2019)	no assertion criteria provided	VCV001323346	2	152525550	2	151669036	1323346	1313631		NC_000002.12:151669035:G:
NM_001164508.2(NEB):c.612+1G>A	NEB		not provided	Pathogenic(Last reviewed: Dec 7, 2020)	no assertion criteria provided	VCV001323345	2	152580773	2	151724259	1323345	1313630		NC_000002.12:151724258:C:T
NM_001164508.2(NEB):c.19094_19097dup (p.Glu6367fs)	NEB	E4666fs, E6367fs	not provided	Pathogenic(Last reviewed: Dec 3, 2019)	no assertion criteria provided	VCV001323344	2	152417725 - 152417726	2	151561211 - 151561212	1323344	1313629		NC_000002.12:151561211:CTGGC:CTGGCTGGC
NM_001164508.2(NEB):c.13170del (p.Tyr4391fs)	NEB	Y4391fs	not provided	Pathogenic(Last reviewed: Jul 3, 2019)	no assertion criteria provided	VCV001323343	2	152460176	2	151603662	1323343	1313628		NC_000002.12:151603661:C:
NM_001164508.2(NEB):c.24946C>T (p.Arg8316Ter)	NEB|RIF1	R6460*, R8316*, R8351*	Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: Nov 18, 2021)	criteria provided, single submitter	VCV001323342	2	152348723	2	151492209	1323342	1313627		NC_000002.12:151492208:G:A
NM_001164508.2(NEB):c.4549_4553del (p.Tyr1516_Thr1517insTer)	NEB		not provided	Pathogenic(Last reviewed: Aug 18, 2020)	no assertion criteria provided	VCV001323341	2	152525599 - 152525603	2	151669085 - 151669089	1323341	1313626		NC_000002.12:151669084:ATAGTATA:ATA
NM_001164508.2(NEB):c.21829C>T (p.Gln7277Ter)	NEB|RIF1	Q5576*, Q7277*, Q7312*	not provided	Pathogenic(Last reviewed: Feb 14, 2019)	no assertion criteria provided	VCV001323339	2	152384006	2	151527492	1323339	1313624		NC_000002.12:151527491:G:A
NM_001164508.2(NEB):c.9505G>T (p.Glu3169Ter)	NEB	E3169*	not provided	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, single submitter	VCV001298827	2	152487770	2	151631256	1298827	1288689		NC_000002.12:151631255:C:A
NM_001164508.2(NEB):c.1266T>A (p.Tyr422Ter)	NEB	Y422*	not provided	Pathogenic	no assertion criteria provided	VCV001285142	2	152553963	2	151697449	1285142	1274989		NC_000002.12:151697448:A:T
NM_001164508.2(NEB):c.16909-1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 29, 2021)	no assertion criteria provided	VCV001252068	2	152432314	2	151575800	1252068	1242016		NC_000002.12:151575799:C:T
NM_001164508.2(NEB):c.20976del (p.Val6993fs)	NEB	V5292fs, V6993fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 29, 2021)	no assertion criteria provided	VCV001252067	2	152394675	2	151538161	1252067	1242015		NC_000002.12:151538160:TTT:TT
NM_001164508.2(NEB):c.8425C>T (p.Arg2809Ter)	NEB	R2809*	not provided	Likely pathogenic(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV001213189	2	152497129	2	151640615	1213189	1203183		NC_000002.12:151640614:G:A
NM_001164508.2(NEB):c.520C>T (p.Gln174Ter)	NEB	Q174*	not provided	Likely pathogenic(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV001193977	2	152580866	2	151724352	1193977	1183008		NC_000002.12:151724351:G:A
NM_001164508.2(NEB):c.3726dup (p.Ser1243fs)	NEB	S1243fs	not provided	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, single submitter	VCV001184896	2	152534126 - 152534127	2	151677612 - 151677613	1184896	1174786		NC_000002.12:151677612:G:GG
NM_001164508.2(NEB):c.3084C>G (p.Tyr1028Ter)	NEB	Y1028*	not provided	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, single submitter	VCV001184895	2	152536495	2	151679981	1184895	1174787		NC_000002.12:151679980:G:C
NM_001164508.2(NEB):c.1015del (p.Ala339fs)	NEB	A339fs	Arthrogryposis multiplex congenita 6	Pathogenic(Last reviewed: Jan 4, 2021)	criteria provided, single submitter	VCV001177402	2	152566190	2	151709676	1177402	1166694		NC_000002.12:151709675:C:
NM_001164508.2(NEB):c.11719C>T (p.Gln3907Ter)	NEB	Q3664*, Q3907*	not provided	Likely pathogenic(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001163217	2	152468786	2	151612272	1163217	1151954		NC_000002.12:151612271:G:A
NM_001164508.2(NEB):c.19102-1G>T	NEB		Arthrogryposis multiplex congenita 6	Pathogenic(Last reviewed: May 28, 2021)	no assertion criteria provided	VCV001120191	2	152417623	2	151561109	1120191	1109009		NC_000002.12:151561108:C:A
NM_001164508.2(NEB):c.18786C>G (p.Tyr6262Ter)	NEB	Y6262*, Y4561*	Arthrogryposis multiplex congenita 6	Pathogenic(Last reviewed: May 27, 2021)	no assertion criteria provided	VCV001120189	2	152419230	2	151562716	1120189	1109007		NC_000002.12:151562715:G:C
NM_001164508.2(NEB):c.12048_12049del (p.Lys4017fs)	NEB	K3774fs, K4017fs	Arthrogryposis multiplex congenita 6	Pathogenic(Last reviewed: May 28, 2021)	no assertion criteria provided	VCV001120188	2	152466604 - 152466605	2	151610090 - 151610091	1120188	1109006		NC_000002.12:151610089:TCT:T
NM_001164508.2(NEB):c.12523C>T (p.Gln4175Ter)	NEB	Q4175*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001076740	2	152464998	2	151608484	1076740	1058970		NC_000002.12:151608483:G:A
NM_001164508.2(NEB):c.22813G>T (p.Glu7605Ter)	RIF1|NEB	E5904*, E7605*, E7640*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001076720	2	152373065	2	151516551	1076720	1058943		NC_000002.12:151516550:C:A
NM_001164508.2(NEB):c.20644_20645dup (p.Leu6883fs)	NEB	L5182fs, L6883fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 4, 2020)	criteria provided, single submitter	VCV001076712	2	152397997 - 152397998	2	151541483 - 151541484	1076712	1058949		NC_000002.12:151541483:AGA:AGAGA
NM_001164508.2(NEB):c.7527_7531del (p.Asn2509fs)	NEB	N2509fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV001076665	2	152502649 - 152502653	2	151646135 - 151646139	1076665	1058982		NC_000002.12:151646134:TTGTGTTG:TTG
NM_001164508.2(NEB):c.24517_24518dup (p.Ala8174fs)	NEB|RIF1	A6318fs, A8174fs, A8209fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001076430	2	152350735 - 152350736	2	151494221 - 151494222	1076430	1058933		NC_000002.12:151494221:GTG:GTGTG
NM_001164508.2(NEB):c.11024dup (p.Asp3676fs)	NEB	D3433fs, D3676fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 10, 2021)	criteria provided, single submitter	VCV001076427	2	152474840 - 152474841	2	151618326 - 151618327	1076427	1058976		NC_000002.12:151618326:G:GG
NM_001164508.2(NEB):c.12441_12442del (p.Leu4147_Tyr4148insTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001076283	2	152465079 - 152465080	2	151608565 - 151608566	1076283	1058971		NC_000002.12:151608564:AGAG:AG
NM_001164508.2(NEB):c.18504_18517del (p.Lys6168fs)	NEB	K4467fs, K6168fs	not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 17, 2020)	criteria provided, single submitter	VCV001076255	2	152420399 - 152420412	2	151563885 - 151563898	1076255	1058955		NC_000002.12:151563884:TGTAGCCATAGGCCT:T
NM_001164508.2(NEB):c.17233C>T (p.Arg5745Ter)	NEB	R4044*, R5745*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001076163	2	152426792	2	151570278	1076163	1058959		NC_000002.12:151570277:G:A
NM_001164508.2(NEB):c.17654G>A (p.Trp5885Ter)	NEB	W4184*, W5885*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001076162	2	152424912	2	151568398	1076162	1058957		NC_000002.12:151568397:C:T
NM_001164508.2(NEB):c.10687A>T (p.Lys3563Ter)	NEB	K3320*, K3563*	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001076123	2	152476150	2	151619636	1076123	1058977		NC_000002.12:151619635:T:A
NM_001164508.2(NEB):c.3601A>T (p.Lys1201Ter)	NEB	K1201*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 5, 2021)	criteria provided, single submitter	VCV001076082	2	152534252	2	151677738	1076082	1058991		NC_000002.12:151677737:T:A
NM_001164508.2(NEB):c.9532C>T (p.Gln3178Ter)	NEB	Q3178*	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 5, 2021)	criteria provided, single submitter	VCV001075968	2	152487743	2	151631229	1075968	1058979		NC_000002.12:151631228:G:A
NM_001164508.2(NEB):c.2212-1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001075799	2	152547340	2	151690826	1075799	1058994		NC_000002.12:151690825:C:T
NM_001164508.2(NEB):c.22905+1del	NEB|RIF1		Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV001075629	2	152372972	2	151516458	1075629	1058942		NC_000002.12:151516457:CCCC:CCC
NM_001164508.2(NEB):c.12374G>A (p.Trp4125Ter)	NEB	W4125*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001075595	2	152465147	2	151608633	1075595	1058973		NC_000002.12:151608632:C:T
NM_001164508.2(NEB):c.7163G>A (p.Trp2388Ter)	NEB	W2388*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001075478	2	152507152	2	151650638	1075478	1058983		NC_000002.12:151650637:C:T
NM_001164508.2(NEB):c.4843A>T (p.Lys1615Ter)	NEB	K1615*	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV001075448	2	152522792	2	151666278	1075448	1058988		NC_000002.12:151666277:T:A
NM_001164508.2(NEB):c.12402_12403del (p.Asn4134fs)	NEB	N4134fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001075201	2	152465118 - 152465119	2	151608604 - 151608605	1075201	1058972		NC_000002.12:151608603:TGT:T
NM_001164508.2(NEB):c.20326del (p.Gln6776fs)	NEB	Q5075fs, Q6776fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001075191	2	152403984	2	151547470	1075191	1058951		NC_000002.12:151547469:GGGG:GGG
NM_001164508.2(NEB):c.24291_24294dup (p.Ser8099delinsTyrTer)	NEB|RIF1		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001075183	2	152354145 - 152354146	2	151497631 - 151497632	1075183	1058935		NC_000002.12:151497631:AATA:AATAAATA
NM_001164508.2(NEB):c.20995A>T (p.Lys6999Ter)	NEB	K5298*, K6999*	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001075153	2	152394656	2	151538142	1075153	1058948		NC_000002.12:151538141:T:A
NM_001164508.2(NEB):c.13347del (p.Asn4450fs)	NEB	N4450fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 4, 2021)	criteria provided, single submitter	VCV001075109	2	152459122	2	151602608	1075109	1058964		NC_000002.12:151602607:G:
NM_001164508.2(NEB):c.21405dup (p.Met7136fs)	NEB|RIF1	M7136fs, M7171fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001074852	2	152389967 - 152389968	2	151533453 - 151533454	1074852	1058947		NC_000002.12:151533453:A:AA
NM_001164508.2(NEB):c.8803C>T (p.Gln2935Ter)	NEB	Q2935*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001074607	2	152496457	2	151639943	1074607	1058980		NC_000002.12:151639942:G:A
NM_001164508.2(NEB):c.13751_13752dup (p.Ile4585Ter)	NEB	I4585*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001074517	2	152456991 - 152456992	2	151600477 - 151600478	1074517	1058961		NC_000002.12:151600477:CACA:CACACA
NM_001164508.2(NEB):c.24816T>G (p.Tyr8272Ter)	NEB|RIF1	Y6416*, Y8272*, Y8307*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 27, 2020)	criteria provided, single submitter	VCV001074400	2	152348958	2	151492444	1074400	1058932		NC_000002.12:151492443:A:C
NM_001164508.2(NEB):c.24461_24464dup (p.His8155fs)	NEB|RIF1	H6299fs, H8155fs, H8190fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 1, 2021)	criteria provided, single submitter	VCV001074359	2	152352811 - 152352812	2	151496297 - 151496298	1074359	1058934		NC_000002.12:151496297:TGTTTG:TGTTTGTTTG
NM_001164508.2(NEB):c.18981C>A (p.Tyr6327Ter)	NEB	Y4626*, Y6327*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001074050	2	152418639	2	151562125	1074050	1058954		NC_000002.12:151562124:G:T
NM_001164508.2(NEB):c.5959dup (p.Ile1987fs)	NEB	I1987fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV001073910	2	152518659 - 152518660	2	151662145 - 151662146	1073910	1058986		NC_000002.12:151662145:TTTTT:TTTTTT
NM_001164508.2(NEB):c.12659G>A (p.Trp4220Ter)	NEB	W4220*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV001073868	2	152463208	2	151606694	1073868	1058969		NC_000002.12:151606693:C:T
NM_001164508.2(NEB):c.12996G>A (p.Trp4332Ter)	NEB	W4332*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV001073754	2	152461137	2	151604623	1073754	1058967		NC_000002.12:151604622:C:T
NM_001164508.2(NEB):c.13631_13634dup (p.Ile4546fs)	NEB	I4546fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, single submitter	VCV001073729	2	152457109 - 152457110	2	151600595 - 151600596	1073729	1058962		NC_000002.12:151600595:GAGA:GAGAGAGA
NM_001164508.2(NEB):c.6562del (p.Glu2188fs)	NEB	E2188fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 20, 2020)	criteria provided, single submitter	VCV001073671	2	152512471	2	151655957	1073671	1058985		NC_000002.12:151655956:CC:C
NM_001164508.2(NEB):c.24176_24179dup (p.Lys8061fs)	RIF1|NEB	K8061fs, K8096fs	not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001073581	2	152354801 - 152354802	2	151498287 - 151498288	1073581	1058936		NC_000002.12:151498287:ACTC:ACTCACTC
NM_001164508.2(NEB):c.3562_3563del (p.Gln1187_Ser1188insTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV001073501	2	152534394 - 152534395	2	151677880 - 151677881	1073501	1058992		NC_000002.12:151677879:CTCT:CT
NM_001164508.2(NEB):c.23998_24002dup (p.Gln8002fs)	NEB|RIF1	Q8002fs, Q8037fs	not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV001073497	2	152357923 - 152357924	2	151501409 - 151501410	1073497	1058939		NC_000002.12:151501409:TTGAGTT:TTGAGTTGAGTT
NM_001164508.2(NEB):c.20446dup (p.Arg6816fs)	NEB	R5115fs, R6816fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001073398	2	152402878 - 152402879	2	151546364 - 151546365	1073398	1058950		NC_000002.12:151546364:GGG:GGGG
NM_001164508.2(NEB):c.3083dup (p.Tyr1028Ter)	NEB	Y1028*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV001073390	2	152536495 - 152536496	2	151679981 - 151679982	1073390	1058993		NC_000002.12:151679981:T:TT
NM_001164508.2(NEB):c.16707_16710dup (p.Tyr5571fs)	NEB	Y3870fs, Y5571fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 12, 2020)	criteria provided, single submitter	VCV001073258	2	152432862 - 152432863	2	151576348 - 151576349	1073258	1058960		NC_000002.12:151576348:GAGGG:GAGGGAGGG
NM_001164508.2(NEB):c.3731del (p.Pro1244fs)	NEB	P1244fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001073161	2	152534122	2	151677608	1073161	1058990		NC_000002.12:151677607:GGGG:GGG
NM_001164508.2(NEB):c.133_146del (p.Ser45fs)	NEB	S45fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 27, 2021)	criteria provided, single submitter	VCV001072759	2	152584353 - 152584366	2	151727839 - 151727852	1072759	1059000		NC_000002.12:151727838:TTGGAAGTTTCTGATTG:TTG
NM_001164508.2(NEB):c.21628_21630+2del	NEB|RIF1		Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV001072753	2	152387506 - 152387510	2	151530992 - 151530996	1072753	1058946		NC_000002.12:151530991:ACATCAC:AC
NM_001164508.2(NEB):c.23805_23806del (p.Arg7935fs)	NEB|RIF1	R6234fs, R7935fs, R7970fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, single submitter	VCV001072267	2	152359892 - 152359893	2	151503378 - 151503379	1072267	1058940		NC_000002.12:151503377:CTCTCTC:CTCTC
NM_001164508.2(NEB):c.18040C>T (p.Gln6014Ter)	NEB	Q4313*, Q6014*	Nemaline myopathy 2	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001072057	2	152423798	2	151567284	1072057	1058956		NC_000002.12:151567283:G:A
NM_001164508.2(NEB):c.23505del (p.Asp7836fs)	NEB|RIF1	D6135fs, D7836fs, D7871fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001072056	2	152363474	2	151506960	1072056	1058941		NC_000002.12:151506959:TT:T
NM_001164508.2(NEB):c.13417del (p.Leu4473fs)	NEB	L4473fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001071929	2	152458474	2	151601960	1071929	1058963		NC_000002.12:151601959:GG:G
NM_001164508.2(NEB):c.24077_24084del (p.Met8026fs)	NEB|RIF1	M8026fs, M8061fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001071818	2	152355842 - 152355849	2	151499328 - 151499335	1071818	1058937		NC_000002.12:151499327:TCTCTCCATCTCT:TCTCT
NM_001164508.2(NEB):c.9840C>G (p.Tyr3280Ter)	NEB	Y3037*, Y3280*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV001071773	2	152484340	2	151627826	1071773	1058978		NC_000002.12:151627825:G:C
NM_001164508.2(NEB):c.175C>T (p.Gln59Ter)	NEB	Q59*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001071473	2	152584324	2	151727810	1071473	1058999		NC_000002.12:151727809:G:A
NM_001164508.2(NEB):c.19915del (p.Ala6639fs)	NEB	A4938fs, A6639fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001071472	2	152408281	2	151551767	1071472	1058952		NC_000002.12:151551766:CCC:CC
NM_001164508.2(NEB):c.1083T>A (p.Tyr361Ter)	NEB	Y361*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001071349	2	152563464	2	151706950	1071349	1058996		NC_000002.12:151706949:A:T
NM_001164508.2(NEB):c.288del (p.Phe96fs)	NEB	F96fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV001071337	2	152584211	2	151727697	1071337	1058998		NC_000002.12:151727696:AAAAA:AAAA
NM_001164508.2(NEB):c.13099G>T (p.Gly4367Ter)	NEB	G4367*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV001071192	2	152460247	2	151603733	1071192	1058966		NC_000002.12:151603732:C:A
NM_001164508.2(NEB):c.12736del (p.Ile4246fs)	NEB	I4246fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV001071142	2	152463131	2	151606617	1071142	1058968		NC_000002.12:151606616:TTT:TT
NM_001164508.2(NEB):c.6639del (p.Phe2213fs)	NEB	F2213fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001071130	2	152512394	2	151655880	1071130	1058984		NC_000002.12:151655879:AAA:AA
NM_001164508.2(NEB):c.63del (p.Glu22fs)	NEB	E22fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 10, 2020)	criteria provided, single submitter	VCV001071128	2	152586144	2	151729630	1071128	1059001		NC_000002.12:151729629:TT:T
NM_001164508.2(NEB):c.19156G>T (p.Glu6386Ter)	NEB	E4685*, E6386*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 2, 2021)	criteria provided, single submitter	VCV001071068	2	152417568	2	151561054	1071068	1058953		NC_000002.12:151561053:C:A
NM_001164508.2(NEB):c.5229dup (p.Met1744fs)	NEB	M1744fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV001070917	2	152521855 - 152521856	2	151665341 - 151665342	1070917	1058987		NC_000002.12:151665341:G:GG
NM_001164508.2(NEB):c.611del (p.Lys204fs)	NEB	K204fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001070706	2	152580775	2	151724261	1070706	1058997		NC_000002.12:151724260:TT:T
NM_001164508.2(NEB):c.17373C>A (p.Cys5791Ter)	NEB	C4090*, C5791*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001070695	2	152426652	2	151570138	1070695	1058958		NC_000002.12:151570137:G:T
NM_001164508.2(NEB):c.2075_2076del (p.His692fs)	NEB	H692fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 27, 2020)	criteria provided, single submitter	VCV001070630	2	152548603 - 152548604	2	151692089 - 151692090	1070630	1058995		NC_000002.12:151692088:GTGTGTGTG:GTGTGTG
NM_001164508.2(NEB):c.13173T>A (p.Tyr4391Ter)	NEB	Y4391*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 17, 2021)	criteria provided, single submitter	VCV001069703	2	152460173	2	151603659	1069703	1058965		NC_000002.12:151603658:A:T
NC_000002.11:g.(?_152417188)_152418728del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV001069478					1069478	1056910		
NC_000002.11:g.(?_152524298)_(152525665_?)del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	VCV001069477	2	152524298 - 152525665			1069477	1056911		
NM_001164508.2(NEB):c.25003A>T (p.Lys8335Ter)	NEB|RIF1	K6479*, K8335*, K8370*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001069433	2	152348666	2	151492152	1069433	1058931		NC_000002.12:151492151:T:A
NM_001164508.2(NEB):c.3843del (p.Leu1282fs)	NEB	L1282fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001069319	2	152531837	2	151675323	1069319	1058989		NC_000002.12:151675322:AAA:AA
NM_001164508.2(NEB):c.8386del (p.Glu2796fs)	NEB	E2796fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001069231	2	152497168	2	151640654	1069231	1058981		NC_000002.12:151640653:C:
NM_001164508.2(NEB):c.22044_22045del (p.Val7348_Ser7349insTer)	NEB|RIF1		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001068855	2	152382677 - 152382678	2	151526163 - 151526164	1068855	1058945		NC_000002.12:151526162:ACAC:AC
NM_001164508.2(NEB):c.12074del (p.Ser4025fs)	NEB	S3782fs, S4025fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001068585	2	152466579	2	151610065	1068585	1058974		NC_000002.12:151610064:C:
NM_001164508.2(NEB):c.24003_24006dup (p.Glu8003fs)	NEB|RIF1	E8003fs, E8038fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 18, 2021)	criteria provided, single submitter	VCV001068470	2	152357919 - 152357920	2	151501405 - 151501406	1068470	1058938		NC_000002.12:151501405:TTGATTGA:TTGATTGATTGA
NM_001164508.2(NEB):c.13477-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV001068350	2	152457269	2	151600755	1068350	1054915		NC_000002.12:151600754:T:C
NC_000002.11:g.(?_152511637)_152512693del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001068090					1068090	1054276		
NC_000002.11:g.(?_152541945)_152544192del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV001068089					1068089	1054277		
NC_000002.11:g.(?_152420500)_152423885del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV001068088					1068088	1054275		
NM_001164508.2(NEB):c.12748-1_12761del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001068062	2	152461372 - 152461386	2	151604858 - 151604872	1068062	1054917		NC_000002.12:151604857:TCTTTGTATTTGTACT:T
NM_001164508.2(NEB):c.2836-2A>G	NEB		not provided|Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 21, 2021)	criteria provided, single submitter	VCV001068018	2	152539285	2	151682771	1068018	1054926		NC_000002.12:151682770:T:C
NM_001164508.2(NEB):c.928-1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 4, 2021)	criteria provided, single submitter	VCV001068014	2	152566278	2	151709764	1068014	1054929		NC_000002.12:151709763:C:T
NM_001164508.2(NEB):c.1257+2T>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV001067822	2	152554056	2	151697542	1067822	1054928		NC_000002.12:151697541:A:C
NM_001164508.2(NEB):c.24115-2A>G	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV001067706	2	152354868	2	151498354	1067706	1054910		NC_000002.12:151498353:T:C
NM_001164508.2(NEB):c.12330+5G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 29, 2021)	criteria provided, single submitter	VCV001067580	2	152466318	2	151609804	1067580	1054919		NC_000002.12:151609803:C:T
NM_001164508.2(NEB):c.613-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 22, 2020)	criteria provided, single submitter	VCV001067309	2	152580001	2	151723487	1067309	1054930		NC_000002.12:151723486:C:T
NM_001164508.2(NEB):c.23556+1G>T	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001067004	2	152363422	2	151506908	1067004	1054912		NC_000002.12:151506907:C:A
NM_001164508.2(NEB):c.1570-2del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV001066812	2	152552198	2	151695684	1066812	1054927		NC_000002.12:151695683:T:
NM_001164508.2(NEB):c.23929-1G>C	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV001066809	2	152357998	2	151501484	1066809	1054911		NC_000002.12:151501483:C:G
NM_001164508.2(NEB):c.18472-1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 9, 2021)	criteria provided, single submitter	VCV001066715	2	152420445	2	151563931	1066715	1054914		NC_000002.12:151563930:C:G
NM_001164508.2(NEB):c.12640-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV001066714	2	152463228	2	151606714	1066714	1054918		NC_000002.12:151606713:C:T
NM_001164508.2(NEB):c.4507-2A>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001066689	2	152525647	2	151669133	1066689	1054925		NC_000002.12:151669132:T:G
NM_001164508.2(NEB):c.4507-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV001066590	2	152525646	2	151669132	1066590	1054924		NC_000002.12:151669131:C:T
NM_001164508.2(NEB):c.20262+2T>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 29, 2021)	criteria provided, single submitter	VCV001066514	2	152404146	2	151547632	1066514	1054913		NC_000002.12:151547631:A:C
NM_001164508.2(NEB):c.9723+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001066261	2	152487228	2	151630714	1066261	1054921		NC_000002.12:151630713:C:T
NM_001164508.2(NEB):c.10144-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 12, 2021)	criteria provided, single submitter	VCV001066180	2	152483721	2	151627207	1066180	1054920		NC_000002.12:151627206:T:C
NM_001164508.2(NEB):c.8994+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 9, 2020)	criteria provided, single submitter	VCV001066080	2	152495793	2	151639279	1066080	1054922		NC_000002.12:151639278:C:T
NM_001164508.2(NEB):c.24765+1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 15, 2021)	criteria provided, single submitter	VCV001066037	2	152349866	2	151493352	1066037	1054909		NC_000002.12:151493351:C:T
NM_001164508.2(NEB):c.4611+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV001065998	2	152525540	2	151669026	1065998	1054923		NC_000002.12:151669025:C:T
GRCh37/hg19 2q21.3-23.3(chr2:136473383-152727396)	ACVR2A|ARHGAP15|ARL5A|CACNB4|CXCR4|DARS1|EPC2|GTDC1|HNMT|KYNU|LCT|LRP1B|LYPD6|LYPD6B|MBD5|MCM6|MMADHC|NEB|NMI|NXPH2|ORC4|R3HDM1|RBM43|RIF1|RND3|SPOPL|THSD7B|TNFAIP6|UBXN4|ZEB2		Global developmental delay|Strabismus|Short stature	Pathogenic(Last reviewed: Mar 15, 2021)	criteria provided, single submitter	VCV001047890	2	136473383 - 152727396			1047890	1035690		
NM_001164508.2(NEB):c.5388T>A (p.Tyr1796Ter)	NEB	Y1796*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV001031200	2	152521078	2	151664564	1031200	1015855	rs2099187757	NC_000002.12:151664563:A:T
NM_001164508.2(NEB):c.13285G>T (p.Glu4429Ter)	NEB	E4429*	Nemaline myopathy 2	Pathogenic(Last reviewed: May 5, 2020)	criteria provided, single submitter	VCV001030244	2	152459184	2	151602670	1030244	1015851	rs2097550591	NC_000002.12:151602669:C:A
NM_001164508.2(NEB):c.24766-1G>C	NEB|RIF1		Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 10, 2021)	no assertion criteria provided	VCV001027398	2	152349009	2	151492495	1027398	1015126		NC_000002.12:151492494:C:G
NM_001164508.2(NEB):c.7956+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000986361	2	152500331	2	151643817	986361	974480	rs2098919015	NC_000002.12:151643816:C:T
NM_001164508.2(NEB):c.10872+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000986357	2	152475964	2	151619450	986357	974479	rs1336053002	NC_000002.12:151619449:C:T
NM_001164508.2(NEB):c.20157+2T>A	NEB		Nemaline myopathy 2	Pathogenic	criteria provided, single submitter	VCV000982036	2	152404820	2	151548306	982036	970146	rs1553717306	NC_000002.12:151548305:A:T
NM_001164508.2(NEB):c.1152+1G>T	NEB		Nemaline myopathy 2|Nemaline myopathy	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV000974957	2	152563394	2	151706880	974957	963250	rs398124167	NC_000002.12:151706879:C:A
NM_001164508.2(NEB):c.3264_3265del (p.Tyr1088_Lys1089delinsTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV000972358	2	152534692 - 152534693	2	151678178 - 151678179	972358	952725	rs2099386637	NC_000002.12:151678177:TGT:T
NM_001164508.2(NEB):c.736del (p.Leu246fs)	NEB	L246fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000971176	2	152574016	2	151717502	971176	952733	rs2099762296	NC_000002.12:151717501:G:
NM_001164508.2(NEB):c.4535_4536del (p.Leu1512fs)	NEB	L1512fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000970388	2	152525616 - 152525617	2	151669102 - 151669103	970388	952721	rs2099254893	NC_000002.12:151669101:CA:
NM_001164508.2(NEB):c.22645G>T (p.Glu7549Ter)	RIF1|NEB	E5848*, E7584*, E7549*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000968758	2	152375529	2	151519015	968758	952654	rs2080077889	NC_000002.12:151519014:C:A
NM_001164508.2(NEB):c.13441C>T (p.Gln4481Ter)	NEB	Q4481*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000968326	2	152458450	2	151601936	968326	952676	rs2097548467	NC_000002.12:151601935:G:A
NM_001164508.2(NEB):c.2523+2T>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000967912	2	152544138	2	151687624	967912	960449	rs2099513404	NC_000002.12:151687623:A:T
NM_001164508.2(NEB):c.19851T>A (p.Tyr6617Ter)	NEB	Y6617*, Y4916*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 6, 2021)	criteria provided, single submitter	VCV000966571	2	152408345	2	151551831	966571	952665	rs2095359371	NC_000002.12:151551830:A:T
NM_001164508.2(NEB):c.13369-6_13372delinsGGCATT	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000965759	2	152458519 - 152458528	2	151602005 - 151602014	965759	960445	rs2097548810	NC_000002.12:151602004:GTTTCTGCAA:AATGCC
NM_001164508.2(NEB):c.580C>T (p.Gln194Ter)	NEB	Q194*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000961628	2	152580806	2	151724292	961628	942293	rs1032240985	NC_000002.12:151724291:G:A
NM_001164508.2(NEB):c.20281_20282dup (p.Phe6762fs)	NEB	F6762fs, F5061fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000961303	2	152404027 - 152404028	2	151547513 - 151547514	961303	942261	rs2094863263	NC_000002.12:151547513:AA:AAAA
NM_001164508.2(NEB):c.12433G>T (p.Glu4145Ter)	NEB	E4145*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV000961052	2	152465088	2	151608574	961052	942274	rs2097773972	NC_000002.12:151608573:C:A
NM_001164508.2(NEB):c.18211del (p.Asp6071fs)	NEB	D4370fs, D6071fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000959919	2	152422280	2	151565766	959919	942268	rs997878946	NC_000002.12:151565765:CC:C
NM_001164508.2(NEB):c.6824del (p.Gly2275fs)	NEB	G2275fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000959465	2	152510597	2	151654083	959465	942284	rs2099060040	NC_000002.12:151654082:CC:C
NM_001164508.2(NEB):c.12733G>T (p.Glu4245Ter)	NEB	E4245*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000959226	2	152463134	2	151606620	959226	942273	rs2097711830	NC_000002.12:151606619:C:A
NM_001164508.2(NEB):c.1152+1G>C	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV000959213	2	152563394	2	151706880	959213	959582	rs398124167	NC_000002.12:151706879:C:G
NM_001164508.2(NEB):c.17734del (p.Gln5912fs)	NEB	Q4211fs, Q5912fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000956902	2	152424832	2	151568318	956902	942270	rs2096501278	NC_000002.12:151568317:GG:G
NM_001164508.2(NEB):c.11010dup (p.Phe3671fs)	NEB	F3671fs, F3428fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 17, 2019)	criteria provided, single submitter	VCV000955019	2	152474854 - 152474855	2	151618340 - 151618341	955019	942276	rs2098273867	NC_000002.12:151618340:TTT:TTTT
NM_001164508.2(NEB):c.7997del (p.Gly2666fs)	NEB	G2666fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000953681	2	152499827	2	151643313	953681	942282	rs2098909937	NC_000002.12:151643312:CC:C
NM_001164508.2(NEB):c.23967dup (p.Pro7990fs)	NEB|RIF1	P7990fs, P8025fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 12, 2021)	criteria provided, single submitter	VCV000953147	2	152357958 - 152357959	2	151501444 - 151501445	953147	942254	rs2064466448	NC_000002.12:151501444:T:TT
NM_001164508.2(NEB):c.633G>A (p.Trp211Ter)	NEB	W211*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000952491	2	152579980	2	151723466	952491	922296	rs2099780461	NC_000002.12:151723465:C:T
NM_001164508.2(NEB):c.822+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000950916	2	152573929	2	151717415	950916	940659	rs2099762097	NC_000002.12:151717414:C:T
NM_001164508.2(NEB):c.9775C>T (p.Arg3259Ter)	NEB	R3016*, R3259*	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 2, 2021)	criteria provided, single submitter	VCV000950734	2	152486109	2	151629595	950734	922276	rs1301228529	NC_000002.12:151629594:G:A
NM_001164508.2(NEB):c.3270del (p.Asp1091fs)	NEB	D1091fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000950665	2	152534687	2	151678173	950665	922289	rs2099386610	NC_000002.12:151678172:TTTTTT:TTTTT
NM_001164508.2(NEB):c.25259C>A (p.Ser8420Ter)	NEB|RIF1	S8420*, S6564*, S8455*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 23, 2021)	criteria provided, single submitter	VCV000950614	2	152346924	2	151490410	950614	922257	rs949111967	NC_000002.12:151490409:G:T
NM_001164508.2(NEB):c.12738del (p.Ile4246fs)	NEB	I4246fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV000950613	2	152463129	2	151606615	950613	922274	rs2097711696	NC_000002.12:151606614:AA:A
NM_001164508.2(NEB):c.20633del (p.Asp6878fs)	NEB	D6878fs, D5177fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000950597	2	152398010	2	151541496	950597	922265	rs2094062438	NC_000002.12:151541495:T:
NM_001164508.2(NEB):c.21318del (p.Lys7106fs)	NEB|RIF1	K7141fs, K7106fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000950169	2	152390055	2	151533541	950169	922262	rs2092318339	NC_000002.12:151533540:TTTT:TTT
NM_001164508.2(NEB):c.4417C>T (p.Arg1473Ter)	NEB	R1473*	Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: Aug 29, 2021)	criteria provided, single submitter	VCV000948322	2	152527626	2	151671112	948322	922286	rs2099279723	NC_000002.12:151671111:G:A
NM_001164508.2(NEB):c.3384del (p.Asp1129fs)	NEB	D1129fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV000946170	2	152534573	2	151678059	946170	922288	rs2099386045	NC_000002.12:151678058:TTTTTT:TTTTT
NM_001164508.2(NEB):c.12457G>T (p.Glu4153Ter)	NEB	E4153*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV000943866	2	152465064	2	151608550	943866	930840	rs2097773424	NC_000002.12:151608549:C:A
NM_001164508.2(NEB):c.3042+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV000943795	2	152537243	2	151680729	943795	939850	rs2099408391	NC_000002.12:151680728:C:T
NM_001164508.2(NEB):c.1529_1533del (p.Val510fs)	NEB	V510fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 18, 2019)	criteria provided, single submitter	VCV000943455	2	152553187 - 152553191	2	151696673 - 151696677	943455	930860	rs2099599008	NC_000002.12:151696672:CAGAACAG:CAG
NM_001164508.2(NEB):c.2200C>T (p.Gln734Ter)	NEB	Q734*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 18, 2021)	criteria provided, single submitter	VCV000942743	2	152548389	2	151691875	942743	930859	rs780299519	NC_000002.12:151691874:G:A
NM_001164508.2(NEB):c.3473_3488del (p.Asn1158fs)	NEB	N1158fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000942659	2	152534469 - 152534484	2	151677955 - 151677970	942659	930856	rs1463906422	NC_000002.12:151677954:TGCTTATAGTTGACATTGCT:TGCT
NM_001164508.2(NEB):c.24402C>G (p.Tyr8134Ter)	NEB|RIF1	Y6278*, Y8169*, Y8134*	Nemaline myopathy 2|Abnormality of the musculature	Pathogenic(Last reviewed: Jul 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000942342	2	152352874	2	151496360	942342	930822	rs758277406	NC_000002.12:151496359:G:C
NM_001164508.2(NEB):c.13525del (p.Cys4509fs)	NEB	C4509fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000941884	2	152457219	2	151600705	941884	930839	rs2097453337	NC_000002.12:151600704:A:
NM_001164508.2(NEB):c.17695dup (p.Leu5899fs)	NEB	L5899fs, L4198fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV000941032	2	152424870 - 152424871	2	151568356 - 151568357	941032	930837	rs2096502530	NC_000002.12:151568356:GGGGGG:GGGGGGG
NM_001164508.2(NEB):c.6710del (p.Tyr2237fs)	NEB	Y2237fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, single submitter	VCV000940652	2	152511881	2	151655367	940652	930850	rs2099076260	NC_000002.12:151655366:T:
NM_001164508.2(NEB):c.11533G>T (p.Glu3845Ter)	NEB	E3845*, E3602*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV000939973	2	152470858	2	151614344	939973	930842	rs755390933	NC_000002.12:151614343:C:A
NM_001164508.2(NEB):c.1006_1018del (p.Asn336fs)	NEB	N336fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, single submitter	VCV000939766	2	152566187 - 152566199	2	151709673 - 151709685	939766	930862	rs2099738446	NC_000002.12:151709672:CAGCTTTTTTATTCA:CA
NM_001164508.2(NEB):c.22511del (p.Lys7504fs)	RIF1|NEB	K5803fs, K7504fs, K7539fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000937167	2	152376251	2	151519737	937167	930827	rs2080623161	NC_000002.12:151519736:TTTT:TTT
NM_001164508.2(NEB):c.19929C>G (p.Tyr6643Ter)	NEB	Y6643*, Y4942*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000936937	2	152408267	2	151551753	936937	930831	rs1440532058	NC_000002.12:151551752:G:C
NM_001164508.2(NEB):c.21426C>A (p.Tyr7142Ter)	NEB|RIF1	Y5441*, Y7177*, Y7142*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV000936044	2	152388402	2	151531888	936044	930830	rs2091275452	NC_000002.12:151531887:G:T
NM_001164508.2(NEB):c.13788+1G>C	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, single submitter	VCV000935753	2	152456955	2	151600441	935753	939846	rs1553862061	NC_000002.12:151600440:C:G
NM_001164508.2(NEB):c.2647C>T (p.Arg883Ter)	NEB	R883*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 27, 2019)	criteria provided, single submitter	VCV000933332	2	152541480	2	151684966	933332	930858	rs1333519240	NC_000002.12:151684965:G:A
NM_001164508.2(NEB):c.21141del (p.Ile7047fs)	NEB	I5346fs, I7047fs	Nemaline myopathy	Likely pathogenic(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000929152	2	152393712	2	151537198	929152	916831	rs2093339890	NC_000002.12:151537197:AA:A
NM_001164508.2(NEB):c.18918G>A (p.Trp6306Ter)	NEB	W4605*, W6306*	Nemaline myopathy	Likely pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000928637	2	152418702	2	151562188	928637	916832	rs1559952676	NC_000002.12:151562187:C:T
NM_001164508.2(NEB):c.22831C>T (p.Arg7611Ter)	NEB|RIF1	R5910*, R7646*, R7611*	Nemaline myopathy 2|Nemaline myopathy|not provided	Pathogenic(Last reviewed: Nov 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000918157	2	152373047	2	151516533	918157	915016	rs555582398	NC_000002.12:151516532:G:A
NM_001164508.2(NEB):c.18024_18027del (p.Val6009fs)	NEB	V4308fs, V6009fs	Nemaline myopathy|Nemaline myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000917562	2	152423811 - 152423814	2	151567297 - 151567300	917562	905884	rs748358450	NC_000002.12:151567296:GACTGAC:GAC
NM_001164508.2(NEB):c.18157-2A>G	NEB		not provided	Pathogenic(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000871821	2	152422336	2	151565822	871821	859006	rs925947627	NC_000002.12:151565821:T:C
NM_001164508.2(NEB):c.22479G>C (p.Gln7493His)	NEB|RIF1	Q5792H, Q7493H, Q7528H	not provided	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000871820	2	152380825	2	151524311	871820	859005	rs1474341248	NC_000002.12:151524310:C:G
NM_001164508.2(NEB):c.6734dup (p.Thr2246fs)	NEB	T2246fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 11, 2020)	criteria provided, single submitter	VCV000870615	2	152511856 - 152511857	2	151655342 - 151655343	870615	858776	rs2099076059	NC_000002.12:151655342:TT:TTT
NM_001271208.2(NEB):c.18696_18697insSVAelement	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000870236	2	152419319 - 152419320	2	151562805 - 151562806	870236	858399		
NM_001164508.2(NEB):c.12991C>T (p.Gln4331Ter)	NEB	Q4331*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000864424	2	152461142	2	151604628	864424	824880	rs1326513178	NC_000002.12:151604627:G:A
NM_001164508.2(NEB):c.1558C>T (p.Gln520Ter)	NEB	Q520*	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV000863778	2	152553162	2	151696648	863778	824962	rs757999917	NC_000002.12:151696647:G:A
NM_001164508.2(NEB):c.17653_17654del (p.Trp5885fs)	NEB	W4184fs, W5885fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 6, 2019)	criteria provided, single submitter	VCV000862121	2	152424912 - 152424913	2	151568398 - 151568399	862121	824871	rs2096504394	NC_000002.12:151568397:CA:
NM_001164508.2(NEB):c.7892G>A (p.Trp2631Ter)	NEB	W2631*	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 7, 2021)	criteria provided, single submitter	VCV000861741	2	152500396	2	151643882	861741	824920	rs2098919758	NC_000002.12:151643881:C:T
NM_001164508.2(NEB):c.5977dup (p.Tyr1993fs)	NEB	Y1993fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000861713	2	152515676 - 152515677	2	151659162 - 151659163	861713	824935	rs2099118606	NC_000002.12:151659162:A:AA
NM_001164508.2(NEB):c.11613del (p.Lys3871fs)	NEB	K3628fs, K3871fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000860942	2	152468892	2	151612378	860942	824892	rs2098013713	NC_000002.12:151612377:TTT:TT
NM_001164508.2(NEB):c.21198_21199del (p.Tyr7067fs)	NEB	Y5366fs, Y7067fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 6, 2019)	criteria provided, single submitter	VCV000860448	2	152393654 - 152393655	2	151537140 - 151537141	860448	824852	rs2093334853	NC_000002.12:151537139:AGAGAG:AGAG
NM_001164508.2(NEB):c.12648C>G (p.Tyr4216Ter)	NEB	Y4216*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, single submitter	VCV000859915	2	152463219	2	151606705	859915	824881	rs2097713802	NC_000002.12:151606704:G:C
NM_001164508.2(NEB):c.22312_22315dup (p.Thr7439fs)	NEB|RIF1	T7474fs, T7439fs, T5738fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV000859754	2	152381087 - 152381088	2	151524573 - 151524574	859754	824843	rs2084217268	NC_000002.12:151524573:TGGT:TGGTTGGT
NM_001164508.2(NEB):c.13420C>T (p.Arg4474Ter)	NEB	R4474*	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 3, 2021)	criteria provided, single submitter	VCV000856764	2	152458471	2	151601957	856764	824879	rs1578869371	NC_000002.12:151601956:G:A
NM_001164508.2(NEB):c.9954T>G (p.Tyr3318Ter)	NEB	Y3318*, Y3075*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV000856292	2	152484226	2	151627712	856292	824904	rs763541152	NC_000002.12:151627711:A:C
NM_001164508.2(NEB):c.6542G>A (p.Trp2181Ter)	NEB	W2181*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000856160	2	152512491	2	151655977	856160	824932	rs2099082250	NC_000002.12:151655976:C:T
NM_001164508.2(NEB):c.24397_24398dup (p.Leu8133fs)	NEB|RIF1	L6277fs, L8133fs, L8168fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000855559	2	152352877 - 152352878	2	151496363 - 151496364	855559	824824	rs1553545126	NC_000002.12:151496363:AA:AAAA
NM_001164508.2(NEB):c.13060-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV000855389	2	152460288	2	151603774	855389	850834	rs2097571378	NC_000002.12:151603773:T:C
NM_001164508.2(NEB):c.6753del (p.Met2251fs)	NEB	M2251fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000854267	2	152511838	2	151655324	854267	824929	rs2099075936	NC_000002.12:151655323:C:
NM_001164508.2(NEB):c.493C>T (p.Gln165Ter)	NEB	Q165*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 12, 2019)	criteria provided, single submitter	VCV000854027	2	152581385	2	151724871	854027	824969	rs2099785680	NC_000002.12:151724870:G:A
NM_001164508.2(NEB):c.36+1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000852793	2	152589634	2	151733120	852793	851087	rs1553711195	NC_000002.12:151733119:C:G
NM_001164508.2(NEB):c.17781del (p.Gly5926_Tyr5927insTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000852024	2	152424648	2	151568134	852024	824870	rs2096491549	NC_000002.12:151568133:G:
NM_001164508.2(NEB):c.12182del (p.Pro4061fs)	NEB	P3818fs, P4061fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 23, 2021)	criteria provided, single submitter	VCV000851515	2	152466471	2	151609957	851515	824884	rs2097886912	NC_000002.12:151609956:GGG:GG
NM_001164508.2(NEB):c.2472_2638-455del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000847953	2	152541944 - 152544191	2	151685430 - 151687677	847953	850795		
NM_001164508.2(NEB):c.17845-2A>T	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV000847448	2	152423995	2	151567481	847448	850793	rs1177405905	NC_000002.12:151567480:T:A
NM_001164508.2(NEB):c.5245_5254del (p.Tyr1749fs)	NEB	Y1749fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000846712	2	152521362 - 152521371	2	151664848 - 151664857	846712	824939	rs2099191297	NC_000002.12:151664847:TTTCAGTGTA:
NM_001164508.2(NEB):c.12639+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV000845691	2	152464017	2	151607503	845691	851085	rs2097758221	NC_000002.12:151607502:C:T
NM_001164508.2(NEB):c.3879+2T>C	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV000845647	2	152531799	2	151675285	845647	850836	rs2099350888	NC_000002.12:151675284:A:G
NM_001164508.2(NEB):c.22776dup (p.Glu7593fs)	NEB|RIF1	E5892fs, E7593fs, E7628fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV000844887	2	152374855 - 152374856	2	151518341 - 151518342	844887	824838	rs2079459982	NC_000002.12:151518341:TTTT:TTTTT
NM_001164508.2(NEB):c.6993del (p.Val2332fs)	NEB	V2332fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000843176	2	152507322	2	151650808	843176	824927	rs2099021112	NC_000002.12:151650807:AA:A
NM_001164508.2(NEB):c.17118+1G>A	NEB		Nemaline myopathy|not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000841709	2	152427010	2	151570496	841709	851338	rs747946275	NC_000002.12:151570495:C:T
NM_001164508.2(NEB):c.13537A>T (p.Lys4513Ter)	NEB	K4513*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000840725	2	152457207	2	151600693	840725	824878	rs2097452910	NC_000002.12:151600692:T:A
NM_001164508.2(NEB):c.7984del (p.Trp2661_Leu2662insTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000840577	2	152499840	2	151643326	840577	824917	rs2098910159	NC_000002.12:151643325:G:
NM_001164508.2(NEB):c.13780C>T (p.Gln4594Ter)	NEB	Q4594*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000836763	2	152456964	2	151600450	836763	824877	rs2097449114	NC_000002.12:151600449:G:A
NM_001164508.2(NEB):c.22418dup (p.Leu7473fs)	NEB|RIF1	L5772fs, L7473fs, L7508fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000835709	2	152380885 - 152380886	2	151524371 - 151524372	835709	824842	rs2084059565	NC_000002.12:151524371:AA:AAA
NM_001164508.2(NEB):c.12555del (p.Ala4184_Trp4185insTer)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000835568	2	152464102	2	151607588	835568	824882	rs2097759896	NC_000002.12:151607587:CC:C
NC_000002.12:g.(?_151485750)_(151957616_?)del	CACNB4|NEB|ARL5A		Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000833295	2	152342264 - 152814130			833295	819053		
NC_000002.12:g.(?_151614266)_(151697658_?)del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000831138	2	152470780 - 152554172			831138	819055		
NM_001164508.2(NEB):c.4299+4A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 3, 2019)	no assertion criteria provided	VCV000827800	2	152528879	2	151672365	827800	816023	rs781754253	NC_000002.12:151672364:T:C
NM_001164508.2(NEB):c.12330+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 3, 2019)	no assertion criteria provided	VCV000827799	2	152466321	2	151609807	827799	816022	rs1374971806	NC_000002.12:151609806:A:G
NM_001164508.2(NEB):c.15781G>T (p.Glu5261Ter)	NEB	E5261*	not provided	Pathogenic(Last reviewed: Feb 28, 2019)	criteria provided, single submitter	VCV000817518	2	152440163	2	151583649	817518	805244	rs1391372707	NC_000002.12:151583648:C:A
NM_001164508.2(NEB):c.17235dup (p.Glu5746fs)	NEB	E4045fs, E5746fs	not provided	Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000817135	2	152426789 - 152426790	2	151570275 - 151570276	817135	805243	rs1578009926	NC_000002.12:151570275:T:TT
NM_001164508.2(NEB):c.7966A>T (p.Lys2656Ter)	NEB	K2656*	not provided	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000816962	2	152499858	2	151643344	816962	805245	rs745420110	NC_000002.12:151643343:T:A
NM_001164508.2(NEB):c.24988C>T (p.Arg8330Ter)	NEB|RIF1	R6474*, R8365*, R8330*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000816837	2	152348681	2	151492167	816837	804985	rs767709270	NC_000002.12:151492166:G:A
GRCh37/hg19 2q22.3-24.1(chr2:147173792-158346266)x1	RND3|EPC2|ARL6IP6|MBD5|RBM43|NR4A2|ARL5A|KCNJ3|CYTIP|FMNL2|GALNT5|MMADHC|TNFAIP6|PRPF40A|GPD2|RPRM|STAM2|CACNB4|GALNT13|LYPD6B|RIF1|ACVR2A|NMI|ERMN|LYPD6|ORC4|NEB		not provided	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000814314	2	147173792 - 158346266			814314	802527		
NM_001164508.2(NEB):c.13130_13131del (p.Met4377fs)	NEB	M4377fs	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000814016	2	152460215 - 152460216	2	151603701 - 151603702	814016	802245	rs1490309743	NC_000002.12:151603700:CA:
NM_001164508.2(NEB):c.13147C>T (p.Gln4383Ter)	NEB	Q4383*	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000813958	2	152460199	2	151603685	813958	802126	rs1212374733	NC_000002.12:151603684:G:A
GRCh37/hg19 2q23.3(chr2:152502644-152502748)	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000813318	2	152502644 - 152502748			813318	801567		
NM_001164508.2(NEB):c.4507-2A>G	NEB		not provided|Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000808827	2	152525647	2	151669133	808827	794794	rs1575668113	NC_000002.12:151669132:T:C
NM_001164508.2(NEB):c.19800C>G (p.Tyr6600Ter)	NEB	Y4899*, Y6600*	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000807448	2	152409222	2	151552708	807448	798485	rs552379239	NC_000002.12:151552707:G:C
NM_001164508.2(NEB):c.20808T>A (p.Tyr6936Ter)	NEB	Y5235*, Y6936*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000807447	2	152396942	2	151540428	807447	798484	rs753417634	NC_000002.12:151540427:A:T
NM_001164508.2(NEB):c.6184-2A>G	NEB		not provided	Pathogenic(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000805081	2	152512980	2	151656466	805081	794003	rs1575300582	NC_000002.12:151656465:T:C
NM_001164508.2(NEB):c.10612C>T (p.Arg3538Ter)	NEB	R3295*, R3538*	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000801770	2	152476225	2	151619711	801770	790063	rs779909544	NC_000002.12:151619710:G:A
NM_001164508.2(NEB):c.19102-10_19102-4del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801769	2	152417626 - 152417632	2	151561112 - 151561118	801769	790062	rs1577576425	NC_000002.12:151561111:TAGACAA:
NM_001164508.2(NEB):c.20467-2A>C	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801768	2	152402514	2	151546000	801768	790061	rs1392500142	NC_000002.12:151545999:T:G
NM_001164508.2(NEB):c.22327C>T (p.Arg7443Ter)	NEB|RIF1	R5742*, R7478*, R7443*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000801766	2	152381076	2	151524562	801766	790059	rs1576203853	NC_000002.12:151524561:G:A
NM_001164508.2(NEB):c.22748C>G (p.Pro7583Arg)	RIF1|NEB	P7583R, P7618R, P5882R	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801765	2	152374884	2	151518370	801765	790058	rs1575897069	NC_000002.12:151518369:G:C
NM_001164508.2(NEB):c.23140C>T (p.Arg7714Ter)	NEB|RIF1	R7714*, R6013*, R7749*	Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000801764	2	152370195	2	151513681	801764	790057	rs1575714905	NC_000002.12:151513680:G:A
NM_001164508.2(NEB):c.23847del (p.Glu7950fs)	NEB|RIF1	E7950fs, E6249fs, E7985fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801763	2	152359388	2	151502874	801763	790056	rs1575305566	NC_000002.12:151502873:TTT:TT
NM_001164508.2(NEB):c.24304_24305dup (p.Leu8102fs)	RIF1|NEB	L8102fs, L8137fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801762	2	152353542 - 152353543	2	151497028 - 151497029	801762	790055	rs1559207733	NC_000002.12:151497028:AA:AAAA
NM_001164508.2(NEB):c.937C>T (p.Gln313Ter)	NEB	Q313*	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000692009	2	152566268	2	151709754	692009	679740	rs1577253760	NC_000002.12:151709753:G:A
NM_001164508.2(NEB):c.24238dup (p.Thr8080fs)	NEB|RIF1	T8080fs, T8115fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, single submitter	VCV000692008	2	152354201 - 152354202	2	151497687 - 151497688	692008	679739	rs1575024425	NC_000002.12:151497687:TT:TTT
NM_001164508.2(NEB):c.19626+1G>A	NEB		Nemaline myopathy 2|Nemaline myopathy	Likely pathogenic(Last reviewed: Nov 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000691986	2	152410341	2	151553827	691986	679820	rs756352186	NC_000002.12:151553826:C:T
NM_001164508.2(NEB):c.20401G>T (p.Gly6801Ter)	NEB	G5100*, G6801*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000690395	2	152402924	2	151546410	690395	678059	rs1405498595	NC_000002.12:151546409:C:A
GRCh37/hg19 2q23.3(chr2:152434811-152466339)x1	NEB		not provided	Pathogenic(Last reviewed: Aug 23, 2017)	no assertion criteria provided	VCV000688549	2	152434811 - 152466339			688549	676141		
NC_000002.12:g.(?_151646110)_(151646254_?)del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000665633	2	152502624 - 152502768	2	151646110 - 151646254	665633	650713		
NM_001164508.2(NEB):c.11054dup (p.Asn3685fs)	NEB	N3442fs, N3685fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000665171	2	152474810 - 152474811	2	151618296 - 151618297	665171	628584	rs1560499498	NC_000002.12:151618296:TTTTTT:TTTTTTT
NM_001164508.2(NEB):c.20682+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 18, 2021)	criteria provided, single submitter	VCV000664360	2	152397960	2	151541446	664360	650831	rs1576819152	NC_000002.12:151541445:C:T
NM_001164508.2(NEB):c.9217_9218del (p.Arg3073fs)	NEB	R3073fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000662889	2	152490364 - 152490365	2	151633850 - 151633851	662889	628601	rs1574526903	NC_000002.12:151633849:CT:
NM_001164508.2(NEB):c.17986del (p.Thr5996fs)	NEB	T4295fs, T5996fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 10, 2021)	criteria provided, single submitter	VCV000662876	2	152423852	2	151567338	662876	628551	rs1577890764	NC_000002.12:151567337:TTTT:TTT
NM_001164508.2(NEB):c.20503C>T (p.Arg6835Ter)	NEB	R6835*, R5134*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 22, 2021)	criteria provided, single submitter	VCV000662526	2	152402476	2	151545962	662526	628530	rs370098540	NC_000002.12:151545961:G:A
NM_001164508.2(NEB):c.17953_18472-56del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV000660893	2	152420500 - 152423885	2	151563986 - 151567371	660893	650874		
NM_001164508.2(NEB):c.24580-1G>C	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000660317	2	152350382	2	151493868	660317	650829	rs1574772311	NC_000002.12:151493867:C:G
NM_001164508.2(NEB):c.19711_19714del (p.Ala6571fs)	NEB	A6571fs, A4870fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 4, 2018)	criteria provided, single submitter	VCV000660184	2	152409929 - 152409932	2	151553415 - 151553418	660184	628535	rs1577244250	NC_000002.12:151553414:AAGCA:A
NM_001164508.2(NEB):c.1676del (p.Asn559fs)	NEB	N559fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV000660081	2	152551142	2	151694628	660081	628661	rs1576600442	NC_000002.12:151694627:TT:T
NM_001164508.2(NEB):c.24329_24332dup (p.Pro8112fs)	NEB|RIF1	P8112fs, P8147fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV000658330	2	152353515 - 152353516	2	151497001 - 151497002	658330	628506	rs1574981296	NC_000002.12:151497001:GTTC:GTTCGTTC
NM_001164508.2(NEB):c.21052del (p.Asp7018fs)	NEB	D5317fs, D7018fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, single submitter	VCV000658225	2	152394436	2	151537922	658225	628524	rs1576695735	NC_000002.12:151537921:C:
NM_001164508.2(NEB):c.1333del (p.His445fs)	NEB	H445fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV000657235	2	152553896	2	151697382	657235	628665	rs1576704575	NC_000002.12:151697381:G:
NM_001164508.2(NEB):c.7253G>A (p.Trp2418Ter)	NEB	W2418*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 16, 2021)	criteria provided, single submitter	VCV000656677	2	152506868	2	151650354	656677	628618	rs1575122070	NC_000002.12:151650353:C:T
NM_001164508.2(NEB):c.13773C>A (p.Tyr4591Ter)	NEB	Y4591*	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 1, 2021)	criteria provided, single submitter	VCV000656253	2	152456971	2	151600457	656253	628569	rs1553862114	NC_000002.12:151600456:G:T
NM_001164508.2(NEB):c.2065dup (p.Tyr689fs)	NEB	Y689fs	not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 23, 2021)	criteria provided, single submitter	VCV000653699	2	152548613 - 152548614	2	151692099 - 151692100	653699	628657	rs1576517390	NC_000002.12:151692099:A:AA
NM_001164508.2(NEB):c.18124C>T (p.Gln6042Ter)	NEB	Q6042*, Q4341*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000652416	2	152423714	2	151567200	652416	628550	rs1577886635	NC_000002.12:151567199:G:A
NC_000002.12:g.(?_151646120)_(151646244_?)del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000652395	2	152502634 - 152502758	2	151646120 - 151646244	652395	650770		
NC_000002.12:g.(?_151645758)_(151648259_?)del	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000652384	2	152502272 - 152504773	2	151645758 - 151648259	652384	650711		
NM_001164508.2(NEB):c.1674+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000651953	2	152552091	2	151695577	651953	650855	rs750585238	NC_000002.12:151695576:C:T
NM_001164508.2(NEB):c.24710_24731del (p.Thr8237fs)	NEB|RIF1	T8237fs, T8272fs, T6381fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 30, 2021)	criteria provided, single submitter	VCV000651749	2	152349901 - 152349922	2	151493387 - 151493408	651749	628499	rs761067911	NC_000002.12:151493386:TCCATCTCTGGAGTAACAGGTGTC:TC
NM_001164508.2(NEB):c.17196_17200del (p.Ile5732fs)	NEB	I4031fs, I5732fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 9, 2021)	criteria provided, single submitter	VCV000651742	2	152426825 - 152426829	2	151570311 - 151570315	651742	628560	rs1578011278	NC_000002.12:151570310:AGCGGA:A
NM_001164508.2(NEB):c.18996+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000650419	2	152418622	2	151562108	650419	650873	rs1577636079	NC_000002.12:151562107:A:G
NM_001164508.2(NEB):c.724del (p.Tyr242fs)	NEB	Y242fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000648486	2	152574028	2	151717514	648486	628670	rs1577548638	NC_000002.12:151717513:A:
NM_001164508.2(NEB):c.496_499del (p.Gln166fs)	NEB	Q166fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000647587	2	152581379 - 152581382	2	151724865 - 151724868	647587	628671	rs1340063197	NC_000002.12:151724864:CTTGCT:CT
NM_001164508.2(NEB):c.22792C>T (p.Gln7598Ter)	NEB|RIF1	Q7598*, Q5897*, Q7633*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000646620	2	152374840	2	151518326	646620	628515	rs752267876	NC_000002.12:151518325:G:A
NM_001164508.2(NEB):c.23626C>T (p.Gln7876Ter)	NEB|RIF1	Q7876*, Q6175*, Q7911*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 19, 2018)	criteria provided, single submitter	VCV000646106	2	152362703	2	151506189	646106	628511	rs537560378	NC_000002.12:151506188:G:A
NM_001164508.2(NEB):c.6112_6115del (p.Lys2038fs)	NEB	K2038fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 4, 2018)	criteria provided, single submitter	VCV000645659	2	152514565 - 152514568	2	151658051 - 151658054	645659	628628	rs1575358650	NC_000002.12:151658050:CTTTCTTT:CTTT
NM_001164508.2(NEB):c.10493del (p.Gly3498fs)	NEB	G3498fs, G3255fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000645208	2	152477500	2	151620986	645208	628590	rs1574014358	NC_000002.12:151620985:CC:C
NM_001164508.2(NEB):c.17415C>A (p.Tyr5805Ter)	NEB	Y4104*, Y5805*	Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000644721	2	152426610	2	151570096	644721	628556	rs555516831	NC_000002.12:151570095:G:T
NM_001164508.2(NEB):c.8458_8459del (p.Ser2820fs)	NEB	S2820fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, single submitter	VCV000644503	2	152497095 - 152497096	2	151640581 - 151640582	644503	628608	rs776982138	NC_000002.12:151640580:GA:
NM_001164508.2(NEB):c.8425del (p.Arg2809fs)	NEB	R2809fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000644459	2	152497129	2	151640615	644459	628609	rs1574820458	NC_000002.12:151640614:GGG:GG
NM_001164508.2(NEB):c.24673-1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000642413	2	152349960	2	151493446	642413	650893	rs1574741105	NC_000002.12:151493445:C:T
NM_001164508.2(NEB):c.24172C>T (p.Gln8058Ter)	NEB|RIF1	Q8058*, Q8093*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 3, 2021)	criteria provided, single submitter	VCV000642100	2	152354809	2	151498295	642100	628508	rs1323364980	NC_000002.12:151498294:G:A
NM_001164508.2(NEB):c.13476+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, single submitter	VCV000642008	2	152458414	2	151601900	642008	650878	rs1578868550	NC_000002.12:151601899:C:T
NM_001164508.2(NEB):c.11077-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, single submitter	VCV000641029	2	152473983	2	151617469	641029	650837	rs1458096844	NC_000002.12:151617468:C:T
NM_001164508.2(NEB):c.6343_6344dup (p.Ala2117fs)	NEB	A2117fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000640888	2	152512817 - 152512818	2	151656303 - 151656304	640888	628625	rs1575295628	NC_000002.12:151656303:GTGTG:GTGTGTG
NM_001164508.2(NEB):c.717+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000640592	2	152579895	2	151723381	640592	650849	rs1577833924	NC_000002.12:151723380:C:T
NM_001164508.2(NEB):c.12160del (p.Trp4054fs)	NEB	W3811fs, W4054fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000639479	2	152466493	2	151609979	639479	628576	rs1319778592	NC_000002.12:151609978:A:
NM_001164508.2(NEB):c.25136T>G (p.Leu8379Ter)	NEB|RIF1	L8414*, L8379*, L6523*	Nemaline myopathy|Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000633334	2	152348211	2	151491697	633334	621094	rs760200697	NC_000002.12:151491696:A:C
NM_001164508.2(NEB):c.24302_24305dup (p.Leu8102fs)	NEB|RIF1	L8102fs, L8137fs	Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000633333	2	152353542 - 152353543	2	151497028 - 151497029	633333	621095	rs1344099907	NC_000002.12:151497028:AACA:AACAAACA
NM_001164508.2(NEB):c.734del (p.Gly245fs)	NEB	G245fs	Nemaline myopathy	Likely pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000632924	2	152574018	2	151717504	632924	621099	rs1559573882	NC_000002.12:151717503:CC:C
NM_001164508.2(NEB):c.3252_3255+3del	NEB		Nemaline myopathy	Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000632922	2	152536232 - 152536238	2	151679718 - 151679724	632922	621711	rs1559168230	NC_000002.12:151679717:TACGTCA:
NM_001164508.2(NEB):c.21793C>T (p.Arg7265Ter)	NEB|RIF1	R7300*, R5564*, R7265*	Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000632921	2	152384042	2	151527528	632921	621096	rs750900690	NC_000002.12:151527527:G:A
NM_001164508.2(NEB):c.20554G>T (p.Glu6852Ter)	NEB	E6852*, E5151*	not provided|Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000632920	2	152402425	2	151545911	632920	621097	rs777819332	NC_000002.12:151545910:C:A
NM_001164508.2(NEB):c.24206C>A (p.Ser8069Ter)	NEB|RIF1	S8104*, S8069*	Nemaline myopathy 2	Pathogenic	no assertion criteria provided	VCV000626280	2	152354775	2	151498261	626280	614596	rs1037388276	NC_000002.12:151498260:G:T
NM_001164508.2(NEB):c.23351dup (p.Tyr7785fs)	RIF1|NEB	Y6084fs, Y7785fs, Y7820fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623342	2	152364618 - 152364619	2	151508104 - 151508105	623342	612348	rs1559360386	NC_000002.12:151508104:TTTTT:TTTTTT
GRCh37/hg19 2p25.3-q37.3(chr2:15672-243101834)x3	CCDC148|SPEG|ETAA1|EIF2AK2|MTX2|TNS1|INPP1|EPB41L5|PPP1R21|ELMOD3|ALLC|WDR12|IL36RN|LIMS1|PTMA|STON1-GTF2A1L|LYPD6|UBR3|ORMDL1|ITPRID2|STON1|STK17B|SLC4A5|STAT1|MIR128-1|FLACC1|CCDC150|MAP2|MYO3B|ABI2|ANKZF1|TTC32|ALKAL2|GIGYF2|COX7A2L|BIN1|CRYGC|CACNB4|KLHL23|SCRN3|FAM124B|NYAP2|ZNF513|TRABD2A|MAP3K2|HOXD13|MARCO|STK39|PPP1CB|DIRC3|SRBD1|AMMECR1L|DTYMK|TMEM182|TTC27|DNER|PCBP1|MCM6|CHPF|DLX2|CDK15|CDRT15P3|PNO1|SEMA4C|LNPK|COPS9|TET3|FAM161A|METTL21A|EML4|BIRC6|UGT1A9|ROCK2|GPBAR1|NEU2|CHRNG|COPS8|EHD3|MAT2A|USP40|UGT1A8|RNU4ATAC|VAMP5|MITD1|ASNSD1|REEP1|GCG|GALNT3|PELI1|LPIN1|MTHFD2|CCNT2|ARID5A|LGALSL|RPL37A|HOXD1|LTBP1|FBXO11|PRR21|DNAJC27|TMEM17|TNP1|MPP4|ALPP|ANKRD53|TMEM87B|RGPD3|LCT|SAG|INHA|IL1R1|GYPC|SPTBN1|FAHD2B|POLR1A|IGFBP2|PHOSPHO2|VPS54|FAM117B|CFC1|SLC3A1|SPRED2|AGXT|PSMD14|KIF3C|XIRP2|PJVK|CD207|SLC39A10|LAPTM4A|TMSB10|SLC23A3|CRYGB|TMEM37|DNAAF10|COL6A3|MATN3|TMEM185B|DYNC2LI1|ERBB4|GPATCH11|C2orf74|CGREF1|SP140|MIR10B|TDRD15|RAB6C|HOXD8|UGT1A5|PRKAG3|COMMD1|TMEM247|ACSL3|HOXD3|DRC1|DNPEP|TWIST2|ITPRIPL1|ADGRF3|SCN7A|CCDC85A|FBXO41|RAD51AP2|HOXD12|PTPRN|RNF144A|NBAS|SFXN5|NAT8|ZNF385B|IL1RL1|APLF|VAMP8|SFT2D3|DIRC1|HEATR5B|NBEAL1|CATIP|ACTG2|UCN|DLX1|ALPI|C2orf68|ARHGAP25|FOXN2|CHAC2|INO80D|PROM2|SLC66A3|CYS1|AGBL5|OXER1|FRZB|MTIF2|ARHGEF33|FARSB|PCARE|UPP2|NDUFAF7|TCF7L1|CDKL4|CRYBA2|MRPL30|EN1|CIB4|RPS27A|UNC50|FMNL2|NEMP2|CKAP2L|TCF23|SLC1A4|RESP18|FBXO48|C2orf48|PID1|LIMS2|CENPA|SLC11A1|HAT1|IFIH1|SOWAHC|ANKRD36C|SPOPL|FAHD2A|SPP2|HADHB|FKBP1B|NTSR2|MOGS|THSD7B|CEBPZ|PNKD|TRMT61B|ABCG8|CNRIP1|HNMT|NCKAP5|MERTK|CHRNA1|RNF25|PCYOX1|GPR45|MTERF4|DNAJC5G|HECW2|ERFE|PKDCC|SLC5A6|UGT1A10|IL18R1|TRIM54|STEAP3|NABP1|ANTXR1|UNC80|CRYGA|TMEM127|STPG4|RPE|PDE6D|MBOAT2|NT5C1B-RDH14|TMEM178A|CFLAR|POTEF|ESPNL|IL36G|FABP1|SANBR|RGPD5|BUB1|IKZF2|WIPF1|TANC1|DNAJB3|PUS10|LRRFIP1|RNF103|SF3B1|ACVR2A|NGEF|RGPD6|SCTR|RND3|TTC30A|GNLY|PNPT1|MORN2|COL3A1|LOXL3|MOB1A|MFSD2B|SLC20A1|NR4A2|TTLL4|UGGT1|FAM126B|CALCRL|PLEK|PLEKHH2|DDX1|TEKT4|CTNNA2|ANXA4|GPR75|NPPC|DNMT3A|OTOF|RAMP1|TLK1|CCDC88A|RETSAT|ZRANB3|CCNYL1|NEUROD1|HS1BP3|C2orf83|GPC1|ICOS|ECRG4|EFEMP1|RAB11FIP5|CPS1|WNT6|MOGAT1|ITGA6|DHRS9|LANCL1|MTA3|RBKS|VIL1|PGAP1|CMPK2|CNNM3|TMEM150A|COPS7B|UGT1A6|KCNJ13|TTC7A|GTDC1|OSR1|CALM2|C2orf76|GCKR|ANKAR|ATG16L1|CCDC93|ANKRD39|SNX17|NAB1|IHH|FASTKD2|TRIM43|ATRAID|NLRC4|NOL10|AP1S3|PTPN4|SLC25A12|RBMS1|FAM110C|TEX261|DAW1|CYP27A1|DYSF|PRLH|IL18RAP|COL5A2|ATP6V1B1|LY75-CD302|PAPOLG|ANKRD36B|ALPG|RNASEH1|HJURP|LBH|RTP5|TRAPPC12|EVX2|DYTN|ITSN2|SP140L|CWC22|BOLA3|CCDC74B|ASXL2|COL4A4|POLR2D|BCL2L11|CAPG|AFTPH|RDH14|CFC1B|SPATA3|ZNF806|LIMS4|EEF1B2|TP53I3|PCGEM1|PXDN|MARCHF4|DDX18|EVA1A|SP3|GAL3ST2|LRPPRC|SULT6B1|RRM2|ACTR2|SNRPG|STRN|GLI2|MRPL35|KCNF1|CRIM1|LCLAT1|DGUOK|IL1R2|SAP130|EPCAM|ACTR1B|MYO1B|SATB2|GORASP2|FOXI3|PRSS56|PREB|HSPD1|YIPF4|STK11IP|GLB1L|ATF2|APOB|AFF3|GRHL1|C2orf16|ATP6V1E2|DCDC2C|SF3B6|SEMA4F|IFT172|SRD5A2|PLEKHM3|OST4|MSGN1|MFSD6|RANBP2|CCDC142|CREG2|WDFY1|PKP4|LYPD6B|GEMIN6|IQCA1|WDR43|SH3YL1|TTN|SPDYA|TRPM8|OSGEPL1|SULT1C2|EIPR1|KLHL41|RNPEPL1|DGKD|PRR30|B3GALT1|COL4A3|RBM44|ADCY3|SCN9A|GALNT14|MFSD9|SP100|ZSWIM2|CPSF3|SNRNP200|ABCG5|FHL2|IL36A|CENPO|B3GNT7|SULT1C3|NFE2L2|STK16|KLHL30|FNDC4|CAPN13|ZEB2|OR6B3|KCNK3|MEMO1|LHCGR|MSH2-OT1|STK25|TMEM237|POTEJ|RPRM|CCDC121|GPR39|ADI1|POMC|NOTO|KCNIP3|NEB|MIR216A|MAB21L4|SGO2|DNAH7|USP39|TFPI|PPM1G|CLASP1|LINC02898|FER1L5|SOX11|KYNU|MYL1|FARP2|DOCK10|MLPH|NOP58|PDE11A|HS6ST1|IL1RN|RGPD1|HOXD10|CFAP65|MIR217|SLC38A11|ATAD2B|RHBDD1|VWC2L|DOK1|CNOT11|SP110|CNTNAP5|KANSL3|BBS5|STAT4|PARD3B|RAB1A|MALL|IL1A|CBWD2|ERMN|MAL|MARS2|PDIA6|COBLL1|IAH1|FTCDNL1|UXS1|PASK|TPO|ASPRV1|ZNF804A|SPR|OTOS|RPS7|CCDC140|FEZ2|HDAC4|PECR|DHX57|NPHP1|CUL3|FAM168B|ALK|GPN1|CYBRD1|C2orf72|XRCC5|WDCP|KCTD18|NIFK|HDLBP|NDUFS1|ACYP2|POLR1B|CASP8|NCOA1|RUFY4|PIGF|TMEM214|CXCR1|ARL6IP6|PSD4|NCKAP1|GPD2|CD302|MIR375|FEV|PUM2|DUSP11|RNF181|GPAT2|IMP4|ACVR1|MAIP1|GAD1|ASTL|NCAPH|TSN|PIKFYVE|MAP3K20|LDAH|CAPN10|DES|PPIL3|TM4SF20|KLF11|TTC21B|MYT1L|MIR149|RAPGEF4|FAM98A|SELENOI|PLA2R1|NXPH2|RALB|CCT7|ABCB11|TTL|PRKCE|LRATD1|CERS6|OBSL1|SMC6|PROC|ABHD1|B3GNT2|GALNT13|GDF7|BCYRN1|GRB14|ARL5A|ING5|GCC2|ID2|MAP4K4|CCDC138|TUBA3D|ACOXL|WDR54|SESTD1|TMEM18|TBR1|ANKRD44|METTL5|GPR155|PPIG|PAX8|DYNC1I2|RASGRP3|UGT1A3|AUP1|TRIM43B|RAB17|GBX2|MARCHF7|OSBPL6|ANAPC1|ATG9A|CYTIP|ZFAND2B|DNAJB2|NDUFB3|SLC9A2|C2orf27A|KRTCAP3|CYRIA|QPCT|PRADC1|ZNF514|ECEL1|ZNF142|IRS1|NCK2|MMADHC|GPR55|SUCLG1|ILKAP|NMUR1|FSIP2|TYW5|TNFAIP6|GALM|CHST10|MSTN|VSNL1|TGFA|GALNT5|CFAP36|SH3BP4|CRYGD|PPP3R1|CAPN14|INO80B|FASTKD1|SMYD5|COQ10B|MXD1|EDAR|ADAM23|NAGK|TMEM131|RTN4|TMEM198|CNGA3|HTR2B|MAP4K3|ALS2|PREPL|NIF3L1|PMS1|CD8B|CTLA4|DNAJC10|REG1B|EIF2AK3|MCEE|TRIB2|TIGD1|FBXO36|FSHR|CMKLR2|PLEKHA3|ITGA4|SDC1|PLEKHB2|CDC42EP3|ACMSD|CEP68|SLC35F5|LBX2|ZDBF2|CDK5R2|FIGN|PAX3|STAM2|ACKR3|SP9|BMP10|R3HDM1|PLCD4|NT5C1B|SRSF7|FAM228A|KANSL1L|CHN1|UBE2F|INHBB|TRIP12|RHOQ|RFTN2|HADHA|SULT1C4|DCAF17|SCLY|C2orf69|PRPF40A|D2HGDH|ZC3H15|C2orf15|TTC31|SNORD82|GCA|CNPPD1|MSH6|SLC40A1|SIX3|TMBIM1|CAB39|SUMO1|ST3GAL5|SPAST|FN1|INPP4A|CCDC74A|SPATS2L|TFCP2L1|TGFBRAP1|RNF103-CHMP3|SOS1-IT1|RAB3GAP1|MRPS5|NUP35|MAP3K19|DARS1|ATIC|POLE4|HAAO|AGAP1|SLC35F6|TACR1|MIR26B|THAP4|SPC25|SGPP2|HPCAL1|GKN1|MSH2|RMDN2|IL36B|AOX1|C2orf66|TEX44|PPP1R7|ZFP36L2|FOXD4L1|ANKMY1|SLC8A1|CAMKMT|RGPD8|C2orf73|ZAP70|SLC5A7|CYP26B1|GCFC2|CCDC141|C2orf50|FAM178B|XPO1|CREB1|CLIP4|CNOT9|STK36|IL37|KCNK12|CAD|SNRNP27|PCGF1|FIGLA|NMI|REV1|ANO7|INSIG2|NRBP1|RGPD4|USP37|BZW1|SLC4A3|CHRND|MGAT4A|WDPCP|STAMBP|GGCX|CLK1|HK2|GPR17|EPC2|EFR3B|SNORD20|C2orf42|COA5|DPY30|CASP10|ASIC4|PRKRA|EFHD1|HES6|GPR35|TOGARAM2|SMPD4|GULP1|CCL20|PRKD3|IL1B|HIBCH|RNF149|LMAN2L|MDH1B|GFPT1|LYPD1|LRRTM4|RGPD2|PEX13|KCNJ3|CHCHD5|PROKR1|C1QL2|ABCB6|RETREG2|NOSTRIN|RSAD2|LINC01873|ZC3H6|MRPL33|SLC19A3|EML6|CYP1B1|KCNS3|CERKL|TUBA4A|ARHGEF4|ORC4|RABL2A|ARHGAP15|SLC16A14|RBM43|DCTN1|NPAS2|RIF1|ZNF2|GLS|KIF1A|C1D|TANK|SERTAD2|MBD5|ARL4C|NRP2|PSME4|RPL31|KCMF1|WDR35|EHBP1|MDH1|M1AP|ASB1|PDE1A|CCT4|SP5|C2CD6|UGT1A7|YPEL5|COLEC11|MRPS9|ARMC9|OTX1|BABAM2|ATG4B|GAREM2|THNSL2|MAPRE3|DUSP2|VAX2|ERLEC1|DBI|CD28|USP34|SPHKAP|EMILIN1|CRIPT|LINC00570|MROH2A|ATOH8|CD8A|FAP|ASAP2|IDH1|LIMS3|WDR33|MZT2A|RAB10|PLGLB1|KCNG3|PFN4|AQP12B|MZT2B|HOXD11|AGPS|ITM2C|SPAG16|UGT1A1|AMER3|SOS1|ANKRD23|TMEM163|GREB1|ACP1|BCL11A|KLF7|EIF2B4|CIAO1|SIX2|ATP6V1C2|MCFD2|BMPR2|POU3F3|SFTPB|C2orf49|CHMP3|KRCC1|HOXD4|TUBA3E|NFU1|BOK|SCN2A|THUMPD2|TIA1|MOB4|CFAP210|DNAH6|IMMT|NCL|PPP4R3B|REG1A|C2orf81|PLCL1|WNT10A|CNNM4|DPYSL5|CSRNP3|C2orf78|ACTR3|YWHAQ|MREG|SLC30A6|WBP1|LRRTM1|PTRHD1|CAVIN2|TBC1D8|SNORC|SOCS5|IL1RL2|BAZ2B|EXOC6B|POTEI|SCN3A|ST6GAL2|WDSUB1|ZC3H8|GKN2|FAM228B|BCS1L|VRK2|KCNH7|ACADL|FZD5|DQX1|RHOB|GTF3C3|EIF5B|SSB|STARD7|TMEM177|AAMP|UBXN2A|TMEM169|THADA|CARF|ABCA12|FAM171B|REG3A|PLB1|KIDINS220|CLHC1|ADAM17|SCG2|ADRA2B|C2orf80|SMYD1|MYCN|TRAK2|AQP12A|CYP20A1|PER2|ANKRD36|GEN1|MPV17|PPP1R1C|CTDSP1|FAM166C|TEX37|SH2D6|NMS|VWA3B|CXCR4|WDR75|OLA1|FAM136A|RAPH1|FBLN7|MYCNOS|DIS3L2|ERCC3|SLC4A10|PPM1B|DTNB|IGFBP5|EIF4E2|MFF|RPIA|MYO7B|LRP2|LIPT1|TRAF3IP1|COX5B|ASB18|METAP1D|ACVR1C|SLC4A1AP|NDUFA10|GTF2A1L|KCNE4|REG3G|ICA1L|DPP4|TXNDC9|FANCL|GMPPA|KDM3A|TMEFF2|BARD1|DUSP19|KHK|CXCR2|METTL8|EPAS1|ARPC2|UGT1A4|DUSP28|PTCD3|FOSL2|CIR1|SLC30A3|G6PC2|ORC2|ALMS1|DAPL1|HOXD9|ITGAV|SUPT7L|TGOLN2|PTH2R|MIR1258|E2F6|ERICH2|GPR75-ASB3|NAT8B|CLEC4F|NHEJ1|MRPL19|PDCD1|BOLL|CPO|NRXN1|MEIS1|ZNF638|UBXN4|C2orf88|ASB3|MPHOSPH10|HSPE1|EMX1|MGAT5|AGFG1|UGP2|SCN1A|DPP10|RTKN|LY75|LOC100128563|GTF3C2|ITGB6|NEU4|RBM45|CDCA7|SLC9A4|SNTG2|UBE2E3|LYG1|LYG2|EGR4|SEPTIN10|ADD2|SEPTIN2|IGKC|ITGB1BP1|LRP1B|LONRF2|POTEE|TSGA10|PAIP2B|MRPL44|RMND5A|TLX2|SMARCAL1|IL1F10|ODC1|KLHL29|NT5DC4|VIT|GPR148|HNRNPLL|IWS1|XDH|EPHA4|MRPL53|SNED1|TPRKB|PDCL3|TAF1B|PSMD1|HNRNPA3|FZD7|AAK1|HTRA2|CYP27C1|ZNF512|FKBP7|SERPINE2|GMCL1|STRADB|RFX8|TTC30B|OR6B2|CRACDL|ATP5MC3|TSPYL6|REL|PDK1|PTPN18|CCDC115|ATL2		not provided	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000616168	2	15672 - 243101834			616168	607504		
GRCh37/hg19 2p25.3-q37.3(chr2:14238-243048760)x3	POTEF|C2orf27A|UGP2|SFTPB|NOSTRIN|SNORD20|SCG2|DPYSL5|DPP4|EFEMP1|MFSD9|SPOPL|NPAS2|REV1|DIRC3|PELI1|FOXD4L1|PDCL3|RAB1A|TRIM43B|PDIA6|SP100|ATP6V1B1|ELMOD3|COBLL1|IL36B|FAM98A|SLC16A14|TRAK2|LY75-CD302|HOXD13|TTC7A|VAMP8|TBC1D8|NBEAL1|EIF2AK2|LRRFIP1|POLR1B|PLEKHH2|NAB1|MGAT4A|KHK|SOS1|MRPS5|CNTNAP5|FKBP1B|GPR17|HSPD1|HIBCH|TMEM214|CDKL4|STON1-GTF2A1L|PHOSPHO2|MYO1B|AGPS|STON1|PNO1|TAF1B|RGPD5|HDAC4|GPBAR1|LANCL1|GCG|NFU1|GPR55|NEMP2|SOS1-IT1|CCNYL1|PUS10|RIF1|TANK|BIN1|PLEKHB2|PTCD3|PREPL|ASTL|EIF5B|CRYBA2|MCEE|HPCAL1|GMPPA|SULT1C2|EIF2B4|GORASP2|TMEFF2|REG1A|INPP4A|ORC4|GFPT1|DNAJC5G|AGAP1|MFSD2B|IRS1|ERICH2|KLF7|CTLA4|SIX3|BIRC6|NABP1|CDK5R2|CCDC74A|GPR75|MORN2|TEX44|KDM3A|TET3|RGPD4|ATIC|FEZ2|TPRKB|NCL|CEP68|PFN4|DUSP28|C2orf66|B3GALT1|SP110|TNFAIP6|MRPL30|LDAH|CAPN14|QPCT|NAT8B|EIF4E2|ZDBF2|TWIST2|PDE1A|PGAP1|HNRNPA3|DIRC1|MOGS|TEX37|ALMS1|WDR43|AGXT|STAMBP|LONRF2|SPAST|CALCRL|INO80B|RTP5|FBXO41|USP39|UGT1A4|SANBR|RAB10|ZC3H8|GNLY|GCFC2|SEMA4F|TMEM163|SRD5A2|INPP1|PCGF1|POLE4|NCAPH|REEP1|SLC4A10|TUBA3D|RAB6C|NBAS|POTEE|CNNM3|CD8B|CYS1|IAH1|CGREF1|PNPT1|ARHGEF4|ACTG2|TMEM247|ASB18|UGT1A3|TP53I3|FBXO36|LIMS1|CYP1B1|LGALSL|SPEG|CYBRD1|SRSF7|MAP3K20|GGCX|HAAO|RESP18|SPTBN1|ANKRD36B|SNRNP27|SLC4A3|KCTD18|TCF23|SNX17|DOCK10|BCS1L|DDX1|PLEK|APLF|MTX2|RHOB|ALPP|MERTK|SGPP2|B3GNT7|GLS|RAD51AP2|CAPN10|USP34|COLEC11|ATOH8|MTIF2|CHST10|BCYRN1|CIAO1|CCDC85A|GMCL1|MIR149|FAHD2B|PDE11A|SPHKAP|NPHP1|ZAP70|MDH1B|SLC5A6|ZNF2|PROC|PROM2|CHRND|RPL37A|RGPD3|CYP26B1|MYCN|PLA2R1|PRKRA|DNAJC10|GCKR|ZNF385B|UPP2|CHAC2|FOSL2|ANKAR|HOXD10|PLEKHA3|CASP10|MZT2B|ZEB2|ST3GAL5|PPP4R3B|DBI|ABCG5|SLC38A11|TTN|RAB17|MAP3K2|RAPGEF4|NOL10|BMP10|SPR|NT5C1B-RDH14|DPP10|VIL1|UGT1A5|EML6|ANKRD39|TIGD1|AQP12A|UNC80|STRN|ATG4B|NYAP2|SOX11|C2orf88|SCN7A|TTC32|LIMS4|MAL|RNF144A|KCNJ13|THUMPD2|FBXO11|ID2|TMBIM1|ADI1|SRBD1|RGPD8|TEKT4|DUSP2|RETSAT|PTPN18|PPM1G|SP9|FAM166C|CARF|NPPC|NMUR1|LHCGR|FOXN2|MAIP1|CRYGB|DQX1|TTLL4|NLRC4|SERTAD2|COX7A2L|DCTN1|TFCP2L1|NAT8|NCK2|RASGRP3|IGFBP5|CNPPD1|XDH|CCT7|KLHL30|SLC35F5|IL1F10|FEV|RNF181|SSB|KCNF1|CCDC140|GPR35|SPRED2|CHRNG|ACTR1B|EPCAM|PLEKHM3|HSPE1|MYO3B|UBE2F|TXNDC9|ALS2|IMMT|CRYGA|ALLC|CENPO|ITM2C|POU3F3|CCDC121|GALNT5|CATIP|ZNF513|SLC9A4|SCTR|SEPTIN2|SERPINE2|TDRD15|CAPN13|ALPG|TSN|KIF3C|PUM2|HOXD4|RNF103-CHMP3|TMEM177|WDPCP|CCDC115|FN1|PCBP1|TMEM131|PRKCE|TMSB10|GEN1|GPAT2|IWS1|MAP2|MYO7B|DPY30|GPD2|MTA3|SATB2|GTF3C2|GTF3C3|CAB39|EXOC6B|EVX2|UGT1A8|GAD1|NHEJ1|SNRPG|GEMIN6|GRHL1|LNPK|CUL3|CNOT11|SLC30A6|KCNS3|REG1B|SP140|SCN9A|IL1R2|VWC2L|TUBA3E|C2orf80|ABCG8|HK2|VRK2|TSPYL6|EPB41L5|SAG|CD207|UCN|HECW2|CCNT2|BBS5|STK25|SH2D6|ANKZF1|SLC4A1AP|KCNG3|ZNF638|LOC100128563|EFR3B|FBLN7|LRRTM1|CXCR2|BUB1|RDH14|VIT|UGGT1|TRIP12|SH3YL1|RGPD1|RTN4|TFPI|PCARE|NEUROD1|HTR2B|RBM45|PRPF40A|SLC11A1|INSIG2|ZC3H6|HOXD1|MOB1A|MPP4|PPP1R1C|TMEM127|CRACDL|MIR216A|RANBP2|PRLH|SPATA3|GIGYF2|CDCA7|ST6GAL2|MZT2A|CFLAR|CPO|MIR375|RGPD2|SCN3A|C2orf16|PKP4|RPS27A|GPR39|FAM178B|PRR30|C2orf83|OSGEPL1|COPS7B|ASB3|FAM171B|R3HDM1|TMEM37|RRM2|ABHD1|SPATS2L|OLA1|VSNL1|STARD7|CXCR1|TLX2|FAM124B|MCM6|TGFBRAP1|AP1S3|KCMF1|WDR33|STK39|NTSR2|RUFY4|UBE2E3|RMDN2|MTHFD2|AFF3|TMEM185B|RETREG2|FER1L5|FHL2|FMNL2|HADHA|CCT4|GRB14|MAB21L4|FSIP2|VPS54|SCRN3|MSH6|HJURP|LINC02898|OBSL1|INHBB|PPP1CB|C1QL2|HDLBP|NRBP1|STK11IP|SP140L|HS6ST1|INHA|TM4SF20|LINC00570|MTERF4|FASTKD1|SLC23A3|YWHAQ|PPM1B|POTEI|RSAD2|CSRNP3|RALB|GBX2|VWA3B|TMEM237|MSH2-OT1|KYNU|FIGN|IL36RN|PLGLB1|CHN1|CFAP210|POMC|CDRT15P3|HOXD8|SLC9A2|TNS1|LPIN1|PRADC1|OXER1|XPO1|AGFG1|ZFAND2B|EPHA4|EPC2|LYPD6|EPAS1|RNU4ATAC|CREG2|APOB|FAHD2A|TGFA|ORC2|ASB1|MIR10B|STK36|NEU4|DNAH7|MAPRE3|MFF|ASPRV1|CTNNA2|IL37|TYW5|ACSL3|ANAPC1|ABCA12|KLF11|PAX8|FANCL|SEMA4C|STAT1|WDCP|RABL2A|REG3A|PECR|UGT1A9|MBOAT2|ALK|DCAF17|MCFD2|HOXD9|RNF149|SH3BP4|PAX3|KCNK12|PTMA|KRCC1|WDR75|ICA1L|NOP58|LTBP1|TOGARAM2|KCNE4|TTC21B|ACADL|IMP4|NRP2|CYP27A1|NR4A2|BABAM2|DUSP19|GKN2|C2orf42|ANKRD53|TMEM150A|SF3B6|PIGF|PSMD1|SPC25|NUP35|EIF2AK3|CD302|DLX1|SLC30A3|USP37|SESTD1|DUSP11|KLHL23|MRPL53|RNF103|CYTIP|MRPL44|NXPH2|PPP1R7|FZD5|PAIP2B|PKDCC|SUMO1|CALM2|GCC2|MFSD6|DNAJC27|THNSL2|MYT1L|CACNB4|CRIPT|RPE|PPP1R21|TRIB2|MPV17|STPG4|COPS8|IL1RN|CCDC138|IL1RL1|STAT4|TANC1|CD8A|RAMP1|SMC6|COL3A1|LIMS2|ASAP2|NMI|CLEC4F|MYCNOS|ILKAP|B3GNT2|RHOQ|SNED1|ING5|IKZF2|WDFY1|SPDYA|NOTO|ZNF514|MITD1|ARL5A|METTL8|ECRG4|SELENOI|ANKRD36C|RPS7|GDF7|AMER3|GREB1|BOLA3|SLC3A1|CLASP1|SP3|KCNK3|NMS|EMX1|FAM126B|TTC27|ARHGAP15|CAMKMT|SLC39A10|IGFBP2|TRPM8|KANSL3|METAP1D|GPATCH11|TUBA4A|PTH2R|SLC20A1|CHPF|EVA1A|COQ10B|MOGAT1|SPP2|ACVR1|ARHGEF33|MDH1|SLC8A1|ACVR1C|CLHC1|WIPF1|LOXL3|DNAJB3|SLC19A3|DNPEP|CRYGC|SMYD1|MSGN1|KIDINS220|MLPH|FAM110C|ARMC9|HOXD3|TRIM43|ATP5MC3|UGT1A1|GCA|C2orf50|TMEM198|CPSF3|IL1RL2|ACTR2|STK16|BCL2L11|TTC30A|ARHGAP25|DDX18|PIKFYVE|CKAP2L|CYP20A1|SLC4A5|RPL31|CREB1|CASP8|ANXA4|CAD|RAB3GAP1|CERS6|CPS1|UGT1A7|KCNIP3|SEPTIN10|ERCC3|BAZ2B|MBD5|ACP1|LCLAT1|ERLEC1|SMYD5|OST4|VAX2|CCDC93|COX5B|THSD7B|PDE6D|FIGLA|POLR2D|ITGB1BP1|BOLL|TRAPPC12|COL4A3|CMKLR2|COL4A4|GPR155|E2F6|METTL5|POLR1A|RHBDD1|YPEL5|ATRAID|DNAAF10|ERBB4|ABCB6|LRP2|MSTN|ADAM23|TEX261|ERFE|KLHL29|EGR4|CIR1|BZW1|IQCA1|CYRIA|PLB1|OTOF|UBXN2A|UXS1|TMEM182|AUP1|CERKL|ATAD2B|CCDC88A|C2orf73|ATP6V1E2|PREB|STEAP3|ATL2|GALNT14|ZNF512|PRR21|STAM2|COA5|HAT1|ZFP36L2|PASK|ITGAV|NDUFS1|MAT2A|FOXI3|IL18RAP|DNAH6|SOWAHC|EHBP1|C2orf15|GYPC|GPR75-ASB3|FTCDNL1|ASNSD1|LYPD1|CFC1|RMND5A|MARCO|SMPD4|XIRP2|IL1A|NIF3L1|RBMS1|UGT1A6|WBP1|NGEF|ORMDL1|FNDC4|KCNH7|CEBPZ|ANKRD23|FAM117B|IL1B|CFC1B|DYNC1I2|NRXN1|MAP4K4|SLC1A4|TRAF3IP1|CCDC141|DTYMK|CFAP36|HNRNPLL|CLK1|GAL3ST2|ADAM17|MIR26B|EMILIN1|REL|SULT6B1|PSD4|PDCD1|TSGA10|NT5DC4|FARSB|FKBP7|TTC30B|ALKAL2|TNP1|CAVIN2|REG3G|NDUFB3|PCYOX1|SCLY|SF3B1|CNNM4|IL18R1|NCKAP1|ANTXR1|ABI2|OSBPL6|CBWD2|ZNF806|GKN1|USP40|TRABD2A|RFX8|BOK|PNKD|SFT2D3|GLB1L|LRP1B|SLC66A3|MAP4K3|GALM|SIX2|ZC3H15|SCN2A|TBR1|ACYP2|AFTPH|CIB4|DLX2|ARID5A|INO80D|FBXO48|DNAJB2|C2orf76|C2CD6|TLK1|MREG|GAREM2|WDSUB1|UGT1A10|ZNF142|ECEL1|PXDN|DHX57|SNORC|GPC1|GALNT13|OSR1|IDH1|KIF1A|LIMS3|PPIL3|OTX1|DHRS9|NEU2|ADRA2B|LRATD1|PSME4|ZNF804A|PRKD3|NCOA1|NT5C1B|EEF1B2|GULP1|CENPA|PARD3B|RPRM|DOK1|SLC35F6|SMARCAL1|C1D|RBM43|CCL20|MSH2|SUPT7L|AAK1|MIR128-1|KANSL1L|LRPPRC|MALL|C2orf81|FSHR|CHCHD5|NIFK|ZSWIM2|PROKR1|LMAN2L|PPP3R1|CHRNA1|WDR12|HNMT|TIA1|PER2|EFHD1|ZRANB3|SULT1C3|SGO2|LYG1|CAPG|PSMD14|ALPI|PCGEM1|ESPNL|LY75|SDC1|MEIS1|ODC1|CCDC74B|LYPD6B|MXD1|DYSF|ACTR3|PAPOLG|FLACC1|ACVR2A|AQP12B|ITPRID2|DCDC2C|ARPC2|C2orf69|RND3|ABCB11|GPN1|C2orf78|TMEM169|EDAR|ATG16L1|TRIM54|PTPRN|SULT1C4|ATG9A|LYG2|AAMP|NDUFAF7|PLCD4|SPAG16|WNT6|DTNB|PTRHD1|AOX1|TMEM17|DYNC2LI1|LIPT1|MEMO1|BMPR2|MIR1258|M1AP|TRMT61B|MARCHF4|GALNT3|PJVK|FAM228B|DARS1|ARL4C|EHD3|ITGA4|RBKS|METTL21A|CCDC148|IFIH1|SLC25A12|YIPF4|PRKAG3|FAP|NAGK|ASXL2|OR6B2|C2orf68|FZD7|COMMD1|NCKAP5|MOB4|TMEM178A|CDK15|PEX13|C2orf49|SP5|HADHB|ETAA1|EIPR1|ANKRD44|CRIM1|HOXD11|GLI2|AMMECR1L|TMEM87B|ANKMY1|LBH|WDR54|SLC40A1|PRSS56|SCN1A|ITGB6|WDR35|VAMP5|IL36G|POTEJ|CHMP3|IHH|RTKN|MATN3|ATF2|CTDSP1|DYTN|FRZB|TGOLN2|RNASEH1|CNGA3|CNOT9|TTC31|CD28|D2HGDH|SNTG2|TTL|FAM168B|C2orf72|EML4|CNRIP1|LRRTM4|MRPL19|NDUFA10|LBX2|SNRNP200|MROH2A|MRPS9|UBXN4|FARP2|RPIA|THADA|FAM161A|GPR45|STRADB|MARCHF7|OR6B3|MAP3K19|TPO|FAM228A|DNER|ACOXL|COPS9|HS1BP3|CRYGD|MIR217|CLIP4|ADGRF3|THAP4|IL1R1|HOXD12|C2orf74|PPIG|NFE2L2|RAPH1|LINC01873|ITPRIPL1|SFXN5|ACKR3|ARL6IP6|CWC22|GPR148|PLCL1|KCNJ3|BCL11A|RGPD6|DGUOK|UBR3|LCT|C2orf48|KLHL41|IFT172|TCF7L1|LAPTM4A|TMEM18|MARS2|MRPL33|BARD1|STK17B|PID1|SAP130|FABP1|MPHOSPH10|HES6|DES|CXCR4|IL36A|ROCK2|SOCS5|MMADHC|SUCLG1|ASIC4|ADD2|ITGA6|HEATR5B|PMS1|DNMT3A|CCDC142|DGKD|WNT10A|COL6A3|ACMSD|CCDC150|XRCC5|SNORD82|CDC42EP3|SLC5A7|DIS3L2|ITSN2|RBM44|ERMN|CMPK2|HTRA2|UNC50|PDK1|FAM136A|MGAT5|ANKRD36|NEB|EN1|CYP27C1|ICOS|GTDC1|ANO7|KRTCAP3|DAPL1|ATP6V1C2|TACR1|MYL1|AGBL5|GTF2A1L|IGKC|CFAP65|G6PC2|RFTN2|DAW1|DRC1|ADCY3|COL5A2|MRPL35|RNF25|FASTKD2|RNPEPL1|RAB11FIP5|PTPN4|OTOS		not provided	Pathogenic(Last reviewed: Jan 5, 2017)	no assertion criteria provided	VCV000616166	2	14238 - 243048760			616166	607502		
GRCh37/hg19 2q23.3-31.2(chr2:152409978-179325736)x3	CCDC148|GPD2|CFAP210|SCN3A|STAM2|PHOSPHO2|ITGB6|NEB|METTL8|CYBRD1|SPC25|ARL5A|DHRS9|EVX2|ATP5MC3|PSMD14|GCA|BBS5|FASTKD1|HOXD10|CERS6|COBLL1|ATF2|NR4A2|FIGN|DCAF17|PRKRA|SCN2A|ABCB11|TTC21B|ITGA6|UPP2|NFE2L2|TTC30A|TBR1|GPR155|SLC38A11|SP9|ERICH2|HNRNPA3|GAD1|CIR1|TANC1|CD302|ERMN|KLHL41|PDE11A|HOXD8|HOXD3|WDSUB1|ACVR1|CDCA7|XIRP2|LY75|STK39|DYNC1I2|OLA1|LY75-CD302|HOXD9|ARL6IP6|OSBPL6|METTL5|CACNB4|RPRM|HAT1|FAP|SSB|PPIG|LNPK|PKP4|SCN1A|SLC4A10|RAPGEF4|RBM45|GORASP2|GRB14|SP3|PDK1|PLA2R1|CHN1|IFIH1|BAZ2B|METAP1D|GALNT5|UBR3|HOXD12|RBMS1|SCRN3|WIPF1|TANK|GALNT13|DAPL1|ACVR1C|G6PC2|SCN9A|PRPF40A|KCNJ3|DPP4|GCG|SLC25A12|MYO3B|DLX1|CSRNP3|HOXD4|SCN7A|MTX2|KLHL23|HOXD11|KCNH7|MAP3K20|TTC30B|MARCHF7|PJVK|LRP2|FMNL2|CHRNA1|GALNT3|HOXD1|DLX2|HOXD13|SP5|B3GALT1|NOSTRIN|CYTIP|AGPS|MIR10B|TLK1		not provided	Pathogenic(Last reviewed: Nov 18, 2014)	no assertion criteria provided	VCV000604018	2	152409978 - 179325736			604018	595354		
NM_001164508.2(NEB):c.23496_23499del (p.Val7833fs)	NEB|RIF1	V7868fs, V6132fs, V7833fs	Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000594174	2	152363480 - 152363483	2	151506966 - 151506969	594174	585237	rs762780413	NC_000002.12:151506965:AACT:
NM_001164508.2(NEB):c.1161C>G (p.Tyr387Ter)	NEB	Y387*	not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000586164	2	152554154	2	151697640	586164	576568	rs1259297878	NC_000002.12:151697639:G:C
NM_001164508.2(NEB):c.4623del (p.Ala1542fs)	NEB	A1542fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 4, 2021)	criteria provided, single submitter	VCV000582645	2	152524414	2	151667900	582645	558797	rs1559039815	NC_000002.12:151667899:TTT:TT
NM_001164508.2(NEB):c.17828del (p.Asn5943fs)	NEB	N4242fs, N5943fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000581901	2	152424601	2	151568087	581901	557603	rs1560031341	NC_000002.12:151568086:TT:T
NM_001164508.2(NEB):c.10899G>A (p.Trp3633Ter)	NEB	W3633*, W3390*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000581881	2	152474966	2	151618452	581881	559254	rs780343350	NC_000002.12:151618451:C:T
NM_001164508.2(NEB):c.5364G>A (p.Trp1788Ter)	NEB	W1788*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jun 26, 2021)	criteria provided, single submitter	VCV000580393	2	152521102	2	151664588	580393	558791	rs201636991	NC_000002.12:151664587:C:T
NM_001164508.2(NEB):c.22170C>G (p.Tyr7390Ter)	NEB|RIF1	Y7425*, Y5689*, Y7390*	Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000578209	2	152381779	2	151525265	578209	559236	rs748922882	NC_000002.12:151525264:G:C
NM_001164508.2(NEB):c.1623del (p.Asp542fs)	NEB	D542fs	Nemaline myopathy 2|Nemaline myopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000575054	2	152552143	2	151695629	575054	559286	rs772366030	NC_000002.12:151695628:A:
NM_001164508.2(NEB):c.13756C>T (p.Gln4586Ter)	NEB	Q4586*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, single submitter	VCV000574810	2	152456988	2	151600474	574810	557558	rs1560283028	NC_000002.12:151600473:G:A
NM_001164508.2(NEB):c.23848_23851dup (p.Asn7951fs)	NEB|RIF1	N6250fs, N7951fs, N7986fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 25, 2021)	criteria provided, single submitter	VCV000574224	2	152359383 - 152359384	2	151502869 - 151502870	574224	558749	rs1559296376	NC_000002.12:151502869:TTTCTTT:TTTCTTTCTTT
NM_001164508.2(NEB):c.21711_21712dup (p.Asp7238fs)	NEB|RIF1	D5537fs, D7238fs, D7273fs	Nemaline myopathy 2	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000568050	2	152385746 - 152385747	2	151529232 - 151529233	568050	557589	rs1559580467	NC_000002.12:151529232:CC:CCCC
NM_001164508.2(NEB):c.18261+1G>T	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000567515	2	152422229	2	151565715	567515	559250	rs112544116	NC_000002.12:151565714:C:A
NM_001164508.2(NEB):c.22256_22257delinsG (p.Ala7419fs)	NEB|RIF1	A7454fs, A5718fs, A7419fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000567422	2	152381692 - 152381693	2	151525178 - 151525179	567422	559234	rs1559534672	NC_000002.12:151525177:GG:C
NM_001164508.2(NEB):c.6076-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000565328	2	152514606	2	151658092	565328	557621	rs1553469514	NC_000002.12:151658091:T:C
GRCh37/hg19 2q23.2-23.3(chr2:150134077-154848282)x1	MMADHC|NEB|STAM2|CACNB4|RIF1|RPRM|PRPF40A|NMI|ARL6IP6|TNFAIP6|RBM43|FMNL2|GALNT13|LYPD6|RND3|ARL5A		not provided	Likely pathogenic(Last reviewed: Dec 6, 2017)	no assertion criteria provided	VCV000562665	2	150134077 - 154848282			562665	553849		
NM_001164508.2(NEB):c.3567+1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000558713	2	152534389	2	151677875	558713	541717	rs587780399	NC_000002.12:151677874:C:G
NM_001164508.2(NEB):c.22696-1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000558699	2	152374937	2	151518423	558699	541570	rs745511810	NC_000002.12:151518422:C:T
NM_001164508.2(NEB):c.23451+1G>T	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000558659	2	152364518	2	151508004	558659	541535	rs1011425121	NC_000002.12:151508003:C:A
NM_001164508.2(NEB):c.8994+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, single submitter	VCV000558655	2	152495792	2	151639278	558655	541690	rs1553962493	NC_000002.12:151639277:A:G
NM_001164508.2(NEB):c.18471+1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000558560	2	152421557	2	151565043	558560	541642	rs1553769576	NC_000002.12:151565042:C:G
NM_001164508.2(NEB):c.25151-1G>T	RIF1|NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000558523	2	152347033	2	151490519	558523	541493	rs1553520609	NC_000002.12:151490518:C:A
NM_001164508.2(NEB):c.22138del (p.Glu7380fs)	NEB|RIF1	E7415fs, E5679fs, E7380fs	Nemaline myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000558429	2	152382495	2	151525981	558429	541591	rs1235589246	NC_000002.12:151525980:CC:C
NM_001164508.2(NEB):c.613-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000558373	2	152580002	2	151723488	558373	541789	rs752893483	NC_000002.12:151723487:T:C
NM_001164508.2(NEB):c.19126_19151del (p.Gln6376fs)	NEB	Q4675fs, Q6376fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000558370	2	152417573 - 152417598	2	151561059 - 151561084	558370	541585	rs1553757097	NC_000002.12:151561058:ACTGTTGTGTATTTGTCCTTAATCTGA:A
NM_001164508.2(NEB):c.5451+2_5451+11del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000558368	2	152521004 - 152521013	2	151664490 - 151664499	558368	541643	rs1553487838	NC_000002.12:151664489:CAAGCACTTACA:CA
NM_001164508.2(NEB):c.1570-2A>G	NEB		Nemaline myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000558305	2	152552198	2	151695684	558305	541707	rs1553603958	NC_000002.12:151695683:T:C
NM_001164508.2(NEB):c.3774+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000558277	2	152534077	2	151677563	558277	541740	rs1553531049	NC_000002.12:151677562:A:G
NM_001164508.2(NEB):c.24275_24278dup (p.His8093fs)	NEB|RIF1	H8093fs, H8128fs	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000558158	2	152354161 - 152354162	2	151497647 - 151497648	558158	541543	rs1553551748	NC_000002.12:151497647:TGTTTG:TGTTTGTTTG
NM_001164508.2(NEB):c.24039del (p.Asn8013fs)	RIF1|NEB	N8048fs, N8013fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 29, 2018)	criteria provided, single submitter	VCV000558119	2	152355887	2	151499373	558119	541533	rs1553561525	NC_000002.12:151499372:G:
NM_001164508.2(NEB):c.11289+1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000558099	2	152472515	2	151616001	558099	541669	rs1553901249	NC_000002.12:151616000:C:G
NM_001164508.2(NEB):c.24363_24364del (p.Arg8121fs)	NEB|RIF1	R8121fs, R8156fs	not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000558081	2	152353484 - 152353485	2	151496970 - 151496971	558081	541414	rs752582527	NC_000002.12:151496969:CTCTCTC:CTCTC
NM_001164508.2(NEB):c.24267_24270dup (p.Val8091fs)	NEB|RIF1	V8126fs, V8091fs	Nemaline myopathy 2|Nemaline myopathy	Pathogenic(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000558069	2	152354169 - 152354170	2	151497655 - 151497656	558069	541518	rs747564597	NC_000002.12:151497655:TCTTTC:TCTTTCTTTC
NM_001164508.2(NEB):c.23834C>A (p.Ser7945Ter)	NEB|RIF1	S7980*, S6244*, S7945*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000558061	2	152359864	2	151503350	558061	541563	rs755970391	NC_000002.12:151503349:G:T
NM_001164508.2(NEB):c.20390_20412del (p.Gln6797fs)	NEB	Q6797fs, Q5096fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000558050	2	152402913 - 152402935	2	151546399 - 151546421	558050	541574	rs1553710982	NC_000002.12:151546398:GCAGCCAAATCCCTTCAGGACCTGCA:GCA
NM_001164508.2(NEB):c.24207+2T>C	RIF1|NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000557898	2	152354772	2	151498258	557898	541521	rs1553555768	NC_000002.12:151498257:A:G
NM_001164508.2(NEB):c.20659C>T (p.Arg6887Ter)	NEB	R6887*, R5186*	Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000557888	2	152397984	2	151541470	557888	541648	rs749452641	NC_000002.12:151541469:G:A
NM_001164508.2(NEB):c.24766-9_24767del	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000557882	2	152349007 - 152349017	2	151492493 - 151492503	557882	541510	rs1553530144	NC_000002.12:151492492:ACCTGATGCAG:
NM_001164508.2(NEB):c.24301_24305dup (p.Tyr8103fs)	NEB|RIF1	Y8103fs, Y8138fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000557837	2	152353542 - 152353543	2	151497028 - 151497029	557837	541494	rs1553548771	NC_000002.12:151497028:AACAC:AACACAACAC
NM_001164508.2(NEB):c.295-1G>T	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	VCV000557807	2	152582075	2	151725561	557807	541653	rs111300270	NC_000002.12:151725560:C:A
NM_001164508.2(NEB):c.2659G>T (p.Glu887Ter)	NEB	E887*	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000557804	2	152541468	2	151684954	557804	541743	rs1553558398	NC_000002.12:151684953:C:A
NM_001164508.2(NEB):c.24554_24555dup (p.Arg8186fs)	NEB|RIF1	R6330fs, R8221fs, R8186fs	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557774	2	152350698 - 152350699	2	151494184 - 151494185	557774	541505	rs1553537512	NC_000002.12:151494184:TTT:TTTTT
NM_001164508.2(NEB):c.18676C>T (p.Gln6226Ter)	NEB	Q6226*, Q4525*	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000557505	2	152420137	2	151563623	557505	541640	rs1475648900	NC_000002.12:151563622:G:A
NM_001164508.2(NEB):c.24394-1G>A	RIF1|NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 24, 2018)	criteria provided, single submitter	VCV000557406	2	152352883	2	151496369	557406	541404	rs1421095081	NC_000002.12:151496368:C:T
NM_001164508.2(NEB):c.6183+1del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 24, 2018)	criteria provided, single submitter	VCV000557404	2	152514496	2	151657982	557404	541589	rs1553468960	NC_000002.12:151657981:C:
NM_001164508.2(NEB):c.6183+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000557392	2	152514496	2	151657982	557392	541587	rs557870969	NC_000002.12:151657981:C:T
NM_001164508.2(NEB):c.11181+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000557386	2	152473876	2	151617362	557386	541651	rs1553904694	NC_000002.12:151617361:A:G
NM_001164508.2(NEB):c.23451+1G>C	RIF1|NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000557373	2	152364518	2	151508004	557373	541536	rs1011425121	NC_000002.12:151508003:C:G
NM_001271208.1(NEB):c.21103delG (p.Val7035Terfs)	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2021)	criteria provided, multiple submitters, no conflicts	VCV000557353	2	152393750	2	151537236	557353	541622	rs1553686994	NC_000002.12:151537235:CC:C
NM_001164508.2(NEB):c.18981C>G (p.Tyr6327Ter)	NEB	Y6327*, Y4626*	Arthrogryposis multiplex congenita 6|Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000557321	2	152418639	2	151562125	557321	541590	rs761964375	NC_000002.12:151562124:G:C
NM_001164508.2(NEB):c.20787+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000557313	2	152397209	2	151540695	557313	541479	rs1337287633	NC_000002.12:151540694:A:G
NM_001164508.2(NEB):c.1366-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	VCV000557102	2	152553768	2	151697254	557102	541710	rs1553607505	NC_000002.12:151697253:T:C
NM_001164508.2(NEB):c.23421_23422del (p.Arg7807fs)	RIF1|NEB	R6106fs, R7807fs, R7842fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 2, 2018)	criteria provided, single submitter	VCV000557005	2	152364548 - 152364549	2	151508034 - 151508035	557005	541567	rs1553603400	NC_000002.12:151508033:CTCTCT:CTCT
NM_001164508.2(NEB):c.21093_21094del (p.Val7032fs)	NEB	V7032fs, V5331fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000556980	2	152394394 - 152394395	2	151537880 - 151537881	556980	541477	rs1553688242	NC_000002.12:151537879:CT:
NM_001164508.2(NEB):c.1470+1G>A	NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000556868	2	152553661	2	151697147	556868	541749	rs1220787593	NC_000002.12:151697146:C:T
NM_001164508.2(NEB):c.3880-2A>G	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000556861	2	152531100	2	151674586	556861	541664	rs1342507012	NC_000002.12:151674585:T:C
NM_001164508.2(NEB):c.11602-2A>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000556841	2	152468905	2	151612391	556841	541495	rs1553891733	NC_000002.12:151612390:T:G
NM_001164508.2(NEB):c.23835+1G>A	RIF1|NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000556809	2	152359862	2	151503348	556809	541561	rs781120931	NC_000002.12:151503347:C:T
NM_001164508.2(NEB):c.6808-2A>T	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, single submitter	VCV000556796	2	152510615	2	151654101	556796	541635	rs1553457607	NC_000002.12:151654100:T:A
NM_001164508.2(NEB):c.2416-1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000556741	2	152544248	2	151687734	556741	541696	rs1553565278	NC_000002.12:151687733:C:G
NM_001164508.2(NEB):c.8860del (p.Ala2954fs)	NEB	A2954fs	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000556662	2	152496400	2	151639886	556662	541683	rs1553964158	NC_000002.12:151639885:CC:C
NM_001164508.2(NEB):c.22489C>T (p.Arg7497Ter)	RIF1|NEB	R7532*, R7497*, R5796*	Nemaline myopathy 2|Nemaline myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000556650	2	152376273	2	151519759	556650	541562	rs760935667	NC_000002.12:151519758:G:A
NM_001164508.2(NEB):c.22087C>T (p.Gln7363Ter)	RIF1|NEB	Q7398*, Q7363*, Q5662*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000556628	2	152382546	2	151526032	556628	541463	rs1553646540	NC_000002.12:151526031:G:A
NM_001164508.2(NEB):c.3255+1del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000556478	2	152536234	2	151679720	556478	541605	rs1553538835	NC_000002.12:151679719:C:
NM_001164508.2(NEB):c.23415dup (p.Gln7806fs)	NEB|RIF1	Q6105fs, Q7806fs, Q7841fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000556284	2	152364554 - 152364555	2	151508040 - 151508041	556284	541569	rs1553603438	NC_000002.12:151508040:T:TT
NM_001164508.2(NEB):c.7728_7729delinsA (p.Trp2576_Ser2577delinsTer)	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000556125	2	152500559 - 152500560	2	151644045 - 151644046	556125	541580	rs1553983416	NC_000002.12:151644044:AC:T
NM_001164508.2(NEB):c.8889+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000556035	2	152496370	2	151639856	556035	541621	rs1553963960	NC_000002.12:151639855:C:T
NM_001164508.2(NEB):c.24580-2A>G	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000555932	2	152350383	2	151493869	555932	541525	rs113290650	NC_000002.12:151493868:T:C
NM_001164508.2(NEB):c.9414+1G>T	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000555780	2	152490167	2	151633653	555780	541529	rs1255445731	NC_000002.12:151633652:C:A
NM_001164508.2(NEB):c.9485del (p.Val3162fs)	NEB	V3162fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000555704	2	152487790	2	151631276	555704	541523	rs1553939284	NC_000002.12:151631275:A:
NM_001164508.2(NEB):c.22162-5_22162-2del	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	VCV000555626	2	152381789 - 152381792	2	151525275 - 151525278	555626	541579	rs1553644243	NC_000002.12:151525274:TAAATA:TA
NM_001164508.2(NEB):c.24024_24028dup (p.Tyr8010fs)	NEB|RIF1	Y8010fs, Y8045fs	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000555293	2	152355897 - 152355898	2	151499383 - 151499384	555293	541526	rs772009599	NC_000002.12:151499383:ACAACAC:ACAACACAACAC
NM_001164508.2(NEB):c.3389_3390del (p.Asp1129_Tyr1130insTer)	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 26, 2017)	criteria provided, single submitter	VCV000555244	2	152534567 - 152534568	2	151678053 - 151678054	555244	541719	rs1159756073	NC_000002.12:151678052:ATA:A
NM_001164508.2(NEB):c.24639_24640del (p.Arg8214fs)	NEB|RIF1	R6358fs, R8249fs, R8214fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000554958	2	152350321 - 152350322	2	151493807 - 151493808	554958	541520	rs1357811155	NC_000002.12:151493806:TTT:T
NM_001164508.2(NEB):c.24637G>T (p.Glu8213Ter)	NEB|RIF1	E8248*, E6357*, E8213*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000554956	2	152350324	2	151493810	554956	541522	rs1553536267	NC_000002.12:151493809:C:A
NM_001164508.2(NEB):c.24022-1_24029del	RIF1|NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000554862	2	152355897 - 152355905	2	151499383 - 151499391	554862	541538	rs1423137705	NC_000002.12:151499382:TACAACACCT:T
NM_001164508.2(NEB):c.3879+1G>A	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000554705	2	152531800	2	151675286	554705	541667	rs746999970	NC_000002.12:151675285:C:T
NM_001164508.2(NEB):c.24305T>A (p.Leu8102Ter)	NEB|RIF1	L8137*, L8102*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, single submitter	VCV000554684	2	152353543	2	151497029	554684	541506	rs1553548752	NC_000002.12:151497028:A:T
NM_001164508.2(NEB):c.24096_24099dup (p.Glu8034fs)	NEB|RIF1	E8069fs, E8034fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000554466	2	152355826 - 152355827	2	151499312 - 151499313	554466	541551	rs1553561211	NC_000002.12:151499312:TTGATTG:TTGATTGATTG
NM_001164508.2(NEB):c.24277_24280dup (p.Asn8094fs)	RIF1|NEB	N8129fs, N8094fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000554396	2	152354159 - 152354160	2	151497645 - 151497646	554396	541513	rs1553551650	NC_000002.12:151497645:TGTGT:TGTGTGTGT
NM_001164508.2(NEB):c.20788-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000554333	2	152396963	2	151540449	554333	541604	rs1553695557	NC_000002.12:151540448:C:T
NM_001164508.2(NEB):c.37-1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000554326	2	152586171	2	151729657	554326	541768	rs1428597732	NC_000002.12:151729656:C:G
NM_001164508.2(NEB):c.24127_24130dup (p.Asn8044fs)	RIF1|NEB	N8079fs, N8044fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000554324	2	152354850 - 152354851	2	151498336 - 151498337	554324	541550	rs1553556275	NC_000002.12:151498336:TTTCTTT:TTTCTTTCTTT
NM_001164508.2(NEB):c.21736-13_21743del	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000554313	2	152384092 - 152384112	2	151527578 - 151527598	554313	541465	rs767772838	NC_000002.12:151527577:TAGTCCAGCTGTTTTTAACAG:
NM_001164508.2(NEB):c.9619-1G>A	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000554288	2	152487334	2	151630820	554288	541516	rs1390379576	NC_000002.12:151630819:C:T
NM_001164508.2(NEB):c.20577+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000554275	2	152402400	2	151545886	554275	541611	rs1185654671	NC_000002.12:151545885:A:G
NM_001164508.2(NEB):c.7432-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000554153	2	152502750	2	151646236	554153	541582	rs1553990438	NC_000002.12:151646235:T:C
NM_001164508.2(NEB):c.4300-2A>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, single submitter	VCV000554147	2	152527745	2	151671231	554147	541663	rs1553512813	NC_000002.12:151671230:T:G
NM_001164508.2(NEB):c.1674+1G>T	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000554102	2	152552091	2	151695577	554102	541781	rs750585238	NC_000002.12:151695576:C:A
NM_001164508.2(NEB):c.18694-2del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, single submitter	VCV000553901	2	152419324	2	151562810	553901	541639	rs1553763404	NC_000002.12:151562809:T:
NM_001164508.2(NEB):c.25012delinsTA (p.Glu8338Ter)	NEB|RIF1	E6482*, E8373*, E8338*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000553810	2	152348657	2	151492143	553810	541460	rs1553526619	NC_000002.12:151492142:C:TA
NM_001164508.2(NEB):c.22800+1G>A	NEB|RIF1		not provided|Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553704	2	152374831	2	151518317	553704	541568	rs1302373559	NC_000002.12:151518316:C:T
NM_001164508.2(NEB):c.1570-2_1574del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000553664	2	152552192 - 152552198	2	151695678 - 151695684	553664	541637	rs1553603933	NC_000002.12:151695677:TTTAACT:
NM_001164508.2(NEB):c.9414+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000553647	2	152490167	2	151633653	553647	541614	rs1255445731	NC_000002.12:151633652:C:T
NM_001164508.2(NEB):c.4506+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553581	2	152527536	2	151671022	553581	541660	rs112517981	NC_000002.12:151671021:C:T
NM_001164508.2(NEB):c.9440G>A (p.Trp3147Ter)	NEB	W3147*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000553529	2	152487835	2	151631321	553529	541610	rs1553939774	NC_000002.12:151631320:C:T
NM_001164508.2(NEB):c.24220G>T (p.Glu8074Ter)	NEB|RIF1	E8109*, E8074*	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553511	2	152354220	2	151497706	553511	541503	rs1218073575	NC_000002.12:151497705:C:A
NM_001164508.2(NEB):c.6076-1G>T	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553493	2	152514605	2	151658091	553493	541711	rs1553469502	NC_000002.12:151658090:C:A
NM_001164508.2(NEB):c.24022-1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553437	2	152355905	2	151499391	553437	541541	rs1553561697	NC_000002.12:151499390:C:T
NM_001164508.2(NEB):c.20157+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000553410	2	152404820	2	151548306	553410	541618	rs1553717306	NC_000002.12:151548305:A:G
NM_001164508.2(NEB):c.9108del (p.Lys3036fs)	NEB	K3036fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	VCV000553320	2	152490474	2	151633960	553320	541542	rs1553948395	NC_000002.12:151633959:TTT:TT
NM_001164508.2(NEB):c.18865C>T (p.Arg6289Ter)	NEB	R6289*, R4588*	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553276	2	152419151	2	151562637	553276	541485	rs539819851	NC_000002.12:151562636:G:A
NM_001164508.2(NEB):c.25058-2A>C	RIF1|NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553199	2	152348291	2	151491777	553199	541397	rs866309952	NC_000002.12:151491776:T:G
NM_001164508.2(NEB):c.3255+1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000553174	2	152536234	2	151679720	553174	541754	rs375628303	NC_000002.12:151679719:C:G
NM_001164508.2(NEB):c.24208_24212dup (p.Tyr8072fs)	RIF1|NEB	Y8107fs, Y8072fs	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553170	2	152354227 - 152354228	2	151497713 - 151497714	553170	541548	rs1553552413	NC_000002.12:151497713:AACAC:AACACAACAC
NM_001164508.2(NEB):c.18808C>T (p.Arg6270Ter)	NEB	R6270*, R4569*	Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000553116	2	152419208	2	151562694	553116	541657	rs754369875	NC_000002.12:151562693:G:A
NM_001164508.2(NEB):c.22905+2T>C	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Sep 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553065	2	152372971	2	151516457	553065	541438	rs1553623367	NC_000002.12:151516456:A:G
NM_001164508.2(NEB):c.20514C>A (p.Tyr6838Ter)	NEB	Y6838*, Y5137*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 27, 2017)	criteria provided, single submitter	VCV000553063	2	152402465	2	151545951	553063	541613	rs1242775893	NC_000002.12:151545950:G:T
NM_001164508.2(NEB):c.24735_24736del (p.Arg8245fs)	NEB|RIF1	R6389fs, R8245fs, R8280fs	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552874	2	152349896 - 152349897	2	151493382 - 151493383	552874	541517	rs776059611	NC_000002.12:151493381:CTCTCTC:CTCTC
NM_001164508.2(NEB):c.21312+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000552869	2	152392204	2	151535690	552869	541620	rs1553682994	NC_000002.12:151535689:C:T
NM_001164508.2(NEB):c.10560+1G>A	NEB		Nemaline myopathy 2|not provided	Likely pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000552852	2	152477432	2	151620918	552852	541515	rs1553915731	NC_000002.12:151620917:C:T
NM_001164508.2(NEB):c.2944-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 5, 2017)	criteria provided, single submitter	VCV000552767	2	152537343	2	151680829	552767	541739	rs1553542669	NC_000002.12:151680828:C:T
NM_001164508.2(NEB):c.24377_24383del (p.Gln8126fs)	NEB|RIF1	Q8126fs, Q8161fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	VCV000552683	2	152353465 - 152353471	2	151496951 - 151496957	552683	541540	rs1553548018	NC_000002.12:151496950:TTTTCTT:
NM_001164508.2(NEB):c.37-1G>A	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000552631	2	152586171	2	151729657	552631	541665	rs1428597732	NC_000002.12:151729656:C:T
NM_001164508.2(NEB):c.3988-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552597	2	152529195	2	151672681	552597	541597	rs1553517128	NC_000002.12:151672680:C:T
NM_001164508.2(NEB):c.1802_1803del (p.Asp600_Tyr601insTer)	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000552415	2	152550930 - 152550931	2	151694416 - 151694417	552415	541778	rs1553601066	NC_000002.12:151694415:ATA:A
NM_001164508.2(NEB):c.8392_8395dup (p.Arg2799fs)	NEB	R2799fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	VCV000552414	2	152497158 - 152497159	2	151640644 - 151640645	552414	541564	rs765403861	NC_000002.12:151640644:GATAG:GATAGATAG
NM_001164508.2(NEB):c.25297+1G>A	RIF1|NEB		Nemaline myopathy|Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552340	2	152346885	2	151490371	552340	541456	rs113525641	NC_000002.12:151490370:C:T
NM_001164508.2(NEB):c.1897-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000552281	2	152548877	2	151692363	552281	541706	rs1553593177	NC_000002.12:151692362:C:T
NM_001164508.2(NEB):c.24267_24270del (p.Arg8090fs)	NEB|RIF1	R8090fs, R8125fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552268	2	152354170 - 152354173	2	151497656 - 151497659	552268	541514	rs747564597	NC_000002.12:151497655:TCTTTC:TC
NM_001164508.2(NEB):c.9576del (p.Glu3193fs)	NEB	E3193fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000552221	2	152487699	2	151631185	552221	541680	rs1553938571	NC_000002.12:151631184:T:
NM_001164508.2(NEB):c.25404+1_25404+2insATGGA	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000552180	2	152346483 - 152346484	2	151489969 - 151489970	552180	541500	rs1357452519	NC_000002.12:151489969::TCCAT
NM_001164508.2(NEB):c.9459G>A (p.Trp3153Ter)	NEB	W3153*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000552176	2	152487816	2	151631302	552176	541655	rs1553939648	NC_000002.12:151631301:C:T
NM_001164508.2(NEB):c.24549_24550del (p.Arg8183fs)	NEB|RIF1	R6327fs, R8218fs, R8183fs	Nemaline myopathy|Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 12, 2022)	criteria provided, multiple submitters, no conflicts	VCV000552108	2	152350704 - 152350705	2	151494190 - 151494191	552108	541466	rs755863625	NC_000002.12:151494189:CTCTCT:CTCT
NM_001164508.2(NEB):c.24309C>A (p.Tyr8103Ter)	NEB|RIF1	Y8138*, Y8103*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000552107	2	152353539	2	151497025	552107	541480	rs1332061304	NC_000002.12:151497024:G:T
NM_001164508.2(NEB):c.403-6_405del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552105	2	152581473 - 152581481	2	151724959 - 151724967	552105	541790	rs1553689774	NC_000002.12:151724958:AACCTGCCCAA:AA
NM_001164508.2(NEB):c.25340C>A (p.Ser8447Ter)	RIF1|NEB	S8482*, S6591*, S8447*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552074	2	152346549	2	151490035	552074	541491	rs1553519124	NC_000002.12:151490034:G:T
NM_001164508.2(NEB):c.22479+1del	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552071	2	152380824	2	151524310	552071	541448	rs1488066635	NC_000002.12:151524309:CC:C
NM_001164508.2(NEB):c.22273-1G>A	RIF1|NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552070	2	152381131	2	151524617	552070	541461	rs1553642332	NC_000002.12:151524616:C:T
NM_001164508.2(NEB):c.21630+1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552069	2	152387507	2	151530993	552069	541612	rs1446706909	NC_000002.12:151530992:C:T
NM_001164508.2(NEB):c.11909_11910+4del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552068	2	152467272 - 152467277	2	151610758 - 151610763	552068	541661	rs1553886582	NC_000002.12:151610757:TTACTT:
NM_001164508.2(NEB):c.20158-1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552066	2	152404253	2	151547739	552066	541482	rs1553715579	NC_000002.12:151547738:C:G
NM_001164508.2(NEB):c.19836+1G>T	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552065	2	152409185	2	151552671	552065	541583	rs1446930968	NC_000002.12:151552670:C:A
NM_001164508.2(NEB):c.19207-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552063	2	152417214	2	151560700	552063	541584	rs1553755829	NC_000002.12:151560699:C:T
NM_001164508.2(NEB):c.18891+1G>A	NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552061	2	152419124	2	151562610	552061	541593	rs1443738549	NC_000002.12:151562609:C:T
NM_001164508.2(NEB):c.11910+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552059	2	152467275	2	151610761	552059	541662	rs774495973	NC_000002.12:151610760:C:T
NM_001164508.2(NEB):c.9943del (p.Asp3315fs)	NEB	D3072fs, D3315fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552057	2	152484237	2	151627723	552057	541654	rs1553930053	NC_000002.12:151627722:C:
NM_001164508.2(NEB):c.11076+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552055	2	152474788	2	151618274	552055	541512	rs1460365350	NC_000002.12:151618273:C:T
NM_001164508.2(NEB):c.9724-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552053	2	152486161	2	151629647	552053	541596	rs1553934586	NC_000002.12:151629646:C:T
NM_001164508.2(NEB):c.25404+2T>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000552048	2	152346483	2	151489969	552048	541489	rs1553518813	NC_000002.12:151489968:A:T
NM_001164508.2(NEB):c.9831+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552047	2	152486052	2	151629538	552047	541673	rs1553933986	NC_000002.12:151629537:C:T
NM_001164508.2(NEB):c.7227+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552043	2	152507086	2	151650572	552043	541628	rs1553448527	NC_000002.12:151650571:A:G
NM_001164508.2(NEB):c.6937C>T (p.Arg2313Ter)	NEB	R2313*	Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552042	2	152507378	2	151650864	552042	541697	rs756363951	NC_000002.12:151650863:G:A
NM_001164508.2(NEB):c.6813_6814del (p.Leu2271_Tyr2272insTer)	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552041	2	152510607 - 152510608	2	151654093 - 151654094	552041	541586	rs1180339426	NC_000002.12:151654092:AGAG:AG
NM_001164508.2(NEB):c.6075+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552040	2	152515578	2	151659064	552040	541689	rs1553472127	NC_000002.12:151659063:C:T
NM_001164508.2(NEB):c.4719+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552039	2	152524316	2	151667802	552039	541726	rs1553501889	NC_000002.12:151667801:A:G
NM_001164508.2(NEB):c.3255+1G>T	NEB		not provided|Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Jul 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552035	2	152536234	2	151679720	552035	541733	rs375628303	NC_000002.12:151679719:C:A
NM_001164508.2(NEB):c.3147+1del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552034	2	152536431	2	151679917	552034	541607	rs1553539777	NC_000002.12:151679916:CC:C
NM_001164508.2(NEB):c.2310+2T>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552032	2	152547239	2	151690725	552032	541703	rs1553579092	NC_000002.12:151690724:A:T
NM_001164508.2(NEB):c.2212-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552031	2	152547341	2	151690827	552031	541774	rs1553580540	NC_000002.12:151690826:T:C
NM_001164508.2(NEB):c.2211+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552030	2	152548377	2	151691863	552030	541777	rs1553586486	NC_000002.12:151691862:C:T
NM_001164508.2(NEB):c.1365+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552028	2	152553862	2	151697348	552028	541714	rs770797137	NC_000002.12:151697347:A:G
NM_001164508.2(NEB):c.1258-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000552027	2	152553973	2	151697459	552027	541718	rs1553608621	NC_000002.12:151697458:T:C
NM_001164508.2(NEB):c.1153-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552019	2	152554164	2	151697650	552019	541786	rs1553609515	NC_000002.12:151697649:T:C
NM_001164508.2(NEB):c.78+1G>A	NEB		not provided|Nemaline myopathy|Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000552018	2	152586128	2	151729614	552018	541761	rs778593702	NC_000002.12:151729613:C:T
NM_001164508.2(NEB):c.20889dup (p.Asp6964Ter)	NEB	D5263*, D6964*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552014	2	152396860 - 152396861	2	151540346 - 151540347	552014	541631	rs1553694860	NC_000002.12:151540346:A:AA
NM_001164508.2(NEB):c.24023_24026dup (p.Leu8009fs)	NEB|RIF1	L8009fs, L8044fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000552005	2	152355899 - 152355900	2	151499385 - 151499386	552005	541539	rs1553561665	NC_000002.12:151499385:AACA:AACAAACA
NM_001164508.2(NEB):c.823-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000552001	2	152567054	2	151710540	552001	541722	rs1553642811	NC_000002.12:151710539:T:C
NM_001164508.2(NEB):c.25057+1G>A	RIF1|NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000551995	2	152348611	2	151492097	551995	541496	rs1191429915	NC_000002.12:151492096:C:T
NM_001164508.2(NEB):c.22800+2T>G	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551953	2	152374830	2	151518316	551953	541447	rs1553627466	NC_000002.12:151518315:A:C
NM_001164508.2(NEB):c.21313-728del	RIF1|NEB	L5419fs, L7120fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000551936	2	152390788	2	151534274	551936	541598	rs1553678967	NC_000002.12:151534273:GG:G
NM_001164508.2(NEB):c.9346G>T (p.Glu3116Ter)	NEB	E3116*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000551922	2	152490236	2	151633722	551922	541537	rs193042896	NC_000002.12:151633721:C:A
NM_001164508.2(NEB):c.9102+1G>A	NEB		not provided|Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000551908	2	152492740	2	151636226	551908	541617	rs143644938	NC_000002.12:151636225:C:T
NM_001164508.2(NEB):c.9428C>G (p.Ser3143Ter)	NEB	S3143*	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551907	2	152487847	2	151631333	551907	541666	rs1553939806	NC_000002.12:151631332:G:C
NM_001164508.2(NEB):c.927+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000551905	2	152566947	2	151710433	551905	541750	rs374562457	NC_000002.12:151710432:C:T
NM_001164508.2(NEB):c.21313-765C>G	RIF1|NEB	Y7107*, Y5406*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000551902	2	152390825	2	151534311	551902	541472	rs1553679273	NC_000002.12:151534310:G:C
NM_001164508.2(NEB):c.2943+1G>A	NEB		Nemaline myopathy|Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000551899	2	152539175	2	151682661	551899	541687	rs113091511	NC_000002.12:151682660:C:T
NM_001164508.2(NEB):c.24212T>A (p.Leu8071Ter)	RIF1|NEB	L8106*, L8071*	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000551889	2	152354228	2	151497714	551889	541519	rs756726488	NC_000002.12:151497713:A:T
NM_001164508.2(NEB):c.20467-1G>T	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 19, 2017)	criteria provided, single submitter	VCV000551884	2	152402513	2	151545999	551884	541649	rs760082702	NC_000002.12:151545998:C:A
NM_001164508.2(NEB):c.24353_24356dup (p.Met8119fs)	NEB|RIF1	M8119fs, M8154fs	Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000551882	2	152353491 - 152353492	2	151496977 - 151496978	551882	541416	rs1257495033	NC_000002.12:151496977:ATCT:ATCTATCT
NM_001164508.2(NEB):c.18367-1_18367delinsAA	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 10, 2017)	criteria provided, single submitter	VCV000551869	2	152421662 - 152421663	2	151565148 - 151565149	551869	541658	rs1553770178	NC_000002.12:151565147:CC:TT
NM_001164508.2(NEB):c.23378del (p.Met7793fs)	RIF1|NEB	M7793fs, M7828fs, M6092fs	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: May 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000551865	2	152364592	2	151508078	551865	541436	rs1553603690	NC_000002.12:151508077:A:
NM_001164508.2(NEB):c.24300+1G>A	RIF1|NEB		not provided|Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000551812	2	152354139	2	151497625	551812	541499	rs1366853918	NC_000002.12:151497624:C:T
NM_001164508.2(NEB):c.9724-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 9, 2017)	criteria provided, single submitter	VCV000551807	2	152486162	2	151629648	551807	541606	rs1553934597	NC_000002.12:151629647:T:C
NM_001164508.2(NEB):c.20845dup (p.Thr6949fs)	NEB	T6949fs, T5248fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000551753	2	152396904 - 152396905	2	151540390 - 151540391	551753	541602	rs1553695209	NC_000002.12:151540390:T:TT
NM_001164508.2(NEB):c.7647C>G (p.Tyr2549Ter)	NEB	Y2549*	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000551746	2	152500641	2	151644127	551746	541625	rs1373493309	NC_000002.12:151644126:G:C
NM_001164508.2(NEB):c.613-1G>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Feb 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000551742	2	152580001	2	151723487	551742	541650	rs767693366	NC_000002.12:151723486:C:G
NM_001164508.2(NEB):c.24022-1G>C	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000551556	2	152355905	2	151499391	551556	541553	rs1553561697	NC_000002.12:151499390:C:G
NM_001164508.2(NEB):c.24368_24371dup (p.His8124fs)	RIF1|NEB	H8124fs, H8159fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000551551	2	152353476 - 152353477	2	151496962 - 151496963	551551	541412	rs1553548207	NC_000002.12:151496962:TGTTTG:TGTTTGTTTG
NM_001164508.2(NEB):c.24673-2A>C	RIF1|NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000551371	2	152349961	2	151493447	551371	541402	rs112687345	NC_000002.12:151493446:T:G
NM_001164508.2(NEB):c.25297+2del	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 24, 2017)	criteria provided, single submitter	VCV000551219	2	152346884	2	151490370	551219	541455	rs1553519860	NC_000002.12:151490369:A:
NM_001164508.2(NEB):c.8374-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000551157	2	152497181	2	151640667	551157	541576	rs1180407562	NC_000002.12:151640666:C:T
NM_001164508.2(NEB):c.9457dup (p.Trp3153fs)	NEB	W3153fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000551051	2	152487817 - 152487818	2	151631303 - 151631304	551051	541608	rs1553939660	NC_000002.12:151631303:A:AA
NM_001164508.2(NEB):c.2751del (p.Asp916_Tyr917insTer)	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000551027	2	152541376	2	151684862	551027	541609	rs1553557405	NC_000002.12:151684861:A:
NM_001164508.2(NEB):c.9246G>A (p.Trp3082Ter)	NEB	W3082*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	VCV000550982	2	152490336	2	151633822	550982	541677	rs1553947423	NC_000002.12:151633821:C:T
NM_001164508.2(NEB):c.5344-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000550957	2	152521123	2	151664609	550957	541646	rs1197561990	NC_000002.12:151664608:C:T
NM_001164508.2(NEB):c.23241+2T>A	RIF1|NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, single submitter	VCV000550909	2	152370092	2	151513578	550909	541554	rs1553615846	NC_000002.12:151513577:A:T
NM_001164508.2(NEB):c.24177_24178del (p.Arg8059fs)	NEB|RIF1	R8094fs, R8059fs	Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000550775	2	152354803 - 152354804	2	151498289 - 151498290	550775	541532	rs1266535163	NC_000002.12:151498288:CTCTCT:CTCT
NM_001164508.2(NEB):c.22591-1G>C	NEB|RIF1		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000550749	2	152375584	2	151519070	550749	541575	rs757157808	NC_000002.12:151519069:C:G
NM_001164508.2(NEB):c.24211_24212dup (p.Leu8071fs)	NEB|RIF1	L8071fs, L8106fs	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000550672	2	152354227 - 152354228	2	151497713 - 151497714	550672	541507	rs1553552384	NC_000002.12:151497713:AA:AAAA
NM_001164508.2(NEB):c.6183+2T>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000550371	2	152514495	2	151657981	550371	541708	rs1553468939	NC_000002.12:151657980:A:T
NM_001164508.2(NEB):c.507+1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000550344	2	152581370	2	151724856	550344	541753	rs1553689057	NC_000002.12:151724855:C:T
NM_001164508.2(NEB):c.2385del (p.Gln795fs)	NEB	Q795fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jan 10, 2017)	criteria provided, single submitter	VCV000550324	2	152544836	2	151688322	550324	541771	rs1553568167	NC_000002.12:151688321:TT:T
NM_001164508.2(NEB):c.9465del (p.Ile3156fs)	NEB	I3156fs	Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Mar 11, 2022)	criteria provided, multiple submitters, no conflicts	VCV000550322	2	152487810	2	151631296	550322	541524	rs1553939600	NC_000002.12:151631295:GGGG:GGG
NM_001164508.2(NEB):c.25057+1G>C	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Dec 29, 2016)	criteria provided, single submitter	VCV000550116	2	152348611	2	151492097	550116	541400	rs1191429915	NC_000002.12:151492096:C:G
NM_001164508.2(NEB):c.21736-2A>G	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000550060	2	152384101	2	151527587	550060	541572	rs1389892619	NC_000002.12:151527586:T:C
NM_001164508.2(NEB):c.1674+2T>C	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000550050	2	152552090	2	151695576	550050	541632	rs1553603437	NC_000002.12:151695575:A:G
NM_001164508.2(NEB):c.8887A>T (p.Lys2963Ter)	NEB	K2963*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000550002	2	152496373	2	151639859	550002	541545	rs1553963973	NC_000002.12:151639858:T:A
NM_001164508.2(NEB):c.3043-1G>A	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000534028	2	152536537	2	151680023	534028	516526	rs113326313	NC_000002.12:151680022:C:T
NM_001164508.2(NEB):c.13704T>A (p.Tyr4568Ter)	NEB	Y4568*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, single submitter	VCV000534017	2	152457040	2	151600526	534017	516517	rs1553862274	NC_000002.12:151600525:A:T
NM_001164508.2(NEB):c.17845-1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV000534004	2	152423994	2	151567480	534004	516435	rs1371849916	NC_000002.12:151567479:C:T
NM_001164508.2(NEB):c.24996_24999delinsATTCAA (p.Gln8333fs)	NEB|RIF1	Q8333fs, Q8368fs, Q6477fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000533995	2	152348670 - 152348673	2	151492156 - 151492159	533995	516364	rs1553526832	NC_000002.12:151492155:CTGA:TTGAAT
NM_001164508.2(NEB):c.24189_24192dup (p.Glu8065fs)	NEB|RIF1	E8100fs, E8065fs	Nemaline myopathy 2|Nemaline myopathy	Pathogenic(Last reviewed: May 4, 2022)	criteria provided, multiple submitters, no conflicts	VCV000533994	2	152354788 - 152354789	2	151498274 - 151498275	533994	516394	rs1553555882	NC_000002.12:151498274:TTGATTG:TTGATTGATTG
NM_001164508.2(NEB):c.4652del (p.Gly1551fs)	NEB	G1551fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, single submitter	VCV000533982	2	152524385	2	151667871	533982	516564	rs1553502168	NC_000002.12:151667870:CCC:CC
NM_001164508.2(NEB):c.24395_24398dup (p.Leu8133fs)	NEB|RIF1	L8133fs, L6277fs, L8168fs	Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000533980	2	152352877 - 152352878	2	151496363 - 151496364	533980	516390	rs762133567	NC_000002.12:151496363:AACA:AACAAACA
NM_001164508.2(NEB):c.24339_24342del (p.Pro8114fs)	NEB|RIF1	P8114fs, P8149fs	Nemaline myopathy 2|Nemaline myopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000533968	2	152353506 - 152353509	2	151496992 - 151496995	533968	516477	rs934111355	NC_000002.12:151496991:AGGTAG:AG
NM_001164508.2(NEB):c.21504del (p.Asn7169fs)	NEB|RIF1	N5468fs, N7204fs, N7169fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 14, 2017)	criteria provided, single submitter	VCV000533964	2	152388324	2	151531810	533964	516496	rs934955715	NC_000002.12:151531809:G:
NM_001164508.2(NEB):c.12405_12406del (p.Arg4135fs)	NEB	R4135fs	not provided	Likely pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000524005	2	152465115 - 152465116	2	151608601 - 151608602	524005	514436	rs1553877885	NC_000002.12:151608600:CTCT:CT
NM_001164508.2(NEB):c.5344-1G>C	NEB		Nemaline myopathy 2|Inborn genetic diseases	Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000521692	2	152521123	2	151664609	521692	511330	rs1197561990	NC_000002.12:151664608:C:G
NM_001164508.2(NEB):c.24579G>A (p.Ser8193=)	NEB|RIF1		Nemaline myopathy 2|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2022)	criteria provided, multiple submitters, no conflicts	VCV000521691	2	152350675	2	151494161	521691	511326	rs202048855	NC_000002.12:151494160:C:T
NM_001164508.2(NEB):c.1849del (p.Asp617fs)	NEB	D617fs	Nemaline myopathy|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520693	2	152550884	2	151694370	520693	511331	rs755531536	NC_000002.12:151694369:C:
NM_001164508.2(NEB):c.10872+1G>T	NEB		Arthrogryposis multiplex congenita 6	Pathogenic(Last reviewed: May 27, 2021)	no assertion criteria provided	VCV000506287	2	152475964	2	151619450	506287	497912	rs1336053002	NC_000002.12:151619449:C:A
NM_001164508.2(NEB):c.22144A>C (p.Thr7382Pro)	NEB|RIF1	T5681P, T7417P, T7382P	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 14, 2021)	criteria provided, single submitter	VCV000506284	2	152382489	2	151525975	506284	497909	rs761232641	NC_000002.12:151525974:T:G
NM_001164508.2(NEB):c.25141_25142del (p.Met8381fs)	NEB|RIF1	M6525fs, M8381fs, M8416fs	not provided	Pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000502672	2	152348205 - 152348206	2	151491691 - 151491692	502672	494095	rs1472403020	NC_000002.12:151491690:AT:
NM_001164508.2(NEB):c.12221dup (p.Thr4075fs)	NEB	T3832fs, T4075fs	not provided	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000499820	2	152466431 - 152466432	2	151609917 - 151609918	499820	491244	rs1553883480	NC_000002.12:151609917:T:TT
NM_001164508.2(NEB):c.11184del (p.Lys3728fs)	NEB	K3728fs, K3485fs	not provided	Pathogenic(Last reviewed: Nov 22, 2016)	criteria provided, single submitter	VCV000498809	2	152472621	2	151616107	498809	490233	rs1553901624	NC_000002.12:151616106:TTT:TT
NM_001164508.2(NEB):c.24454C>T (p.Arg8152Ter)	NEB|RIF1	R8187*, R6296*, R8152*	Nemaline myopathy|not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000496135	2	152352822	2	151496308	496135	486887	rs763364977	NC_000002.12:151496307:G:A
NM_001164508.2(NEB):c.24113C>A (p.Ser8038Ter)	NEB|RIF1	S8073*, S8038*	Nemaline myopathy|not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000496134	2	152355813	2	151499299	496134	486889	rs1458048713	NC_000002.12:151499298:G:T
NM_001164508.2(NEB):c.19097G>T (p.Ser6366Ile)	NEB	S6366I, S4665I	Nemaline myopathy|Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000496132	2	152417726	2	151561212	496132	486940	rs191579691	NC_000002.12:151561211:C:A
NM_001164508.2(NEB):c.11164C>T (p.Arg3722Ter)	NEB	R3722*, R3479*	Nemaline myopathy|Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000496131	2	152473895	2	151617381	496131	486874	rs928945364	NC_000002.12:151617380:G:A
NM_001164508.2(NEB):c.11825G>A (p.Trp3942Ter)	NEB	W3942*, W3699*	not provided	Likely pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, single submitter	VCV000489119	2	152467361	2	151610847	489119	481609	rs1553887191	NC_000002.12:151610846:C:T
NM_001164508.2(NEB):c.9726_9727insAT (p.Leu3243fs)	NEB	L3000fs, L3243fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000465655	2	152486157 - 152486158	2	151629643 - 151629644	465655	448711	rs1553934562	NC_000002.12:151629643:A:ATA
NM_001164508.2(NEB):c.6076-2A>C	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 27, 2021)	criteria provided, single submitter	VCV000465621	2	152514606	2	151658092	465621	448983	rs1553469514	NC_000002.12:151658091:T:G
NM_001164508.2(NEB):c.5722del (p.Ser1908fs)	NEB	S1908fs	Nemaline myopathy 2|Nemaline myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000465618	2	152520103	2	151663589	465618	448722	rs1553484601	NC_000002.12:151663588:T:
NM_001164508.2(NEB):c.2920C>T (p.Arg974Ter)	NEB	R974*	Nemaline myopathy 2|Arthrogryposis multiplex congenita 6	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, single submitter	VCV000465594	2	152539199	2	151682685	465594	449009	rs1553548666	NC_000002.12:151682684:G:A
NM_001164508.2(NEB):c.24393+1G>A	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000465581	2	152353454	2	151496940	465581	448760	rs775631800	NC_000002.12:151496939:C:T
NM_001164508.2(NEB):c.24209_24212dup (p.Leu8071fs)	NEB|RIF1	L8106fs, L8071fs	Nemaline myopathy 2|Nemaline myopathy	Pathogenic(Last reviewed: Oct 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000465579	2	152354227 - 152354228	2	151497713 - 151497714	465579	448783	rs781667543	NC_000002.12:151497713:AACA:AACAAACA
NM_001164508.2(NEB):c.24143del (p.Gly8048fs)	RIF1|NEB	G8048fs, G8083fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 12, 2017)	criteria provided, single submitter	VCV000465578	2	152354838	2	151498324	465578	448784	rs1553556154	NC_000002.12:151498323:CC:C
NM_001164508.2(NEB):c.18367-1_18370del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	VCV000465517	2	152421659 - 152421663	2	151565145 - 151565149	465517	448840	rs1553770146	NC_000002.12:151565144:TTACCT:T
NM_001164508.2(NEB):c.13788+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, single submitter	VCV000465492	2	152456955	2	151600441	465492	448648	rs1553862061	NC_000002.12:151600440:C:T
NM_001164508.2(NEB):c.12684T>G (p.Tyr4228Ter)	NEB	Y4228*	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, single submitter	VCV000465462	2	152463183	2	151606669	465462	448912	rs1553875421	NC_000002.12:151606668:A:C
NM_001164508.2(NEB):c.11585_11586delinsC (p.Tyr3862fs)	NEB	Y3619fs, Y3862fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 9, 2016)	criteria provided, single submitter	VCV000465439	2	152470805 - 152470806	2	151614291 - 151614292	465439	448931	rs1553896522	NC_000002.12:151614290:AT:G
NM_001164508.2(NEB):c.24521dup (p.Thr8175fs)	RIF1|NEB	T8210fs, T8175fs, T6319fs	not provided	Pathogenic(Last reviewed: Sep 29, 2017)	criteria provided, single submitter	VCV000452489	2	152350732 - 152350733	2	151494218 - 151494219	452489	442937	rs1330332139	NC_000002.12:151494218:G:GG
NM_001164508.2(NEB):c.19405C>T (p.Arg6469Ter)	NEB	R6469*, R4768*	not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Oct 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000451764	2	152411468	2	151554954	451764	442947	rs1553740233	NC_000002.12:151554953:G:A
NM_001164508.2(NEB):c.36+1G>T	NEB		not provided	Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	VCV000451718	2	152589634	2	151733120	451718	442971	rs1553711195	NC_000002.12:151733119:C:A
NM_001164508.2(NEB):c.25183C>T (p.Arg8395Ter)	NEB|RIF1	R8430*, R6539*, R8395*	Nemaline myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000451684	2	152347000	2	151490486	451684	442936	rs747179265	NC_000002.12:151490485:G:A
NM_001164508.2(NEB):c.3988-2_3988-1delinsTATA	NEB		not provided	Likely pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000450126	2	152529195 - 152529196	2	151672681 - 151672682	450126	442967	rs1553517142	NC_000002.12:151672680:CT:TATA
NM_001164508.2(NEB):c.11627G>A (p.Trp3876Ter)	NEB	W3876*, W3633*	Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: Nov 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000450119	2	152468878	2	151612364	450119	442955	rs776569219	NC_000002.12:151612363:C:T
NM_001164508.2(NEB):c.3255+1G>A	NEB		Nemaline myopathy|not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449502	2	152536234	2	151679720	449502	442968	rs375628303	NC_000002.12:151679719:C:T
NM_001164508.2(NEB):c.5574C>G (p.Tyr1858Ter)	NEB	Y1858*	Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449501	2	152520251	2	151663737	449501	442966	rs781185019	NC_000002.12:151663736:G:C
NM_001164508.2(NEB):c.25336C>T (p.Arg8446Ter)	NEB|RIF1	R8481*, R6590*, R8446*	Nemaline myopathy|not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000449500	2	152346553	2	151490039	449500	442935	rs200731870	NC_000002.12:151490038:G:A
NM_001164508.2(NEB):c.3858C>A (p.Cys1286Ter)	NEB	C1286*	Nemaline myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000444521	2	152531822	2	151675308	444521	438161	rs1386238241	NC_000002.12:151675307:G:T
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)	ZC3H8|ZDBF2|ZEB2|ZFAND2B|ZFP36L2|ZNF142|ZNF2|ZNF385B|ZNF512|ZNF513|ZNF514|ZNF638|ZNF804A|ZNF806|ZRANB3|ZSWIM2|C2orf76|C2orf78|C2orf80|C2orf81|C2orf83|C2orf88|CAB39|CACNB4|CAD|CALCRL|CALM2|CAMKMT|CAPG|CAPN10|CAPN13|CAPN14|CARF|CASP10|CASP8|CATIP|CAVIN2|CBWD2|CCDC115|CCDC121|CCDC138|CCDC140|CCDC141|CCDC142|CCDC148|CCDC150|CCDC74A|CCDC74B|CCDC85A|CCDC88A|CCDC93|CCL20|CCNT2|CCNYL1|CCT4|CCT7|CD207|CD28|CD302|CD8A|CD8B|CDC42EP3|CDCA7|CDK15|CDK5R2|CDKL4|CDRT15P3|CEBPZ|CENPA|CENPO|CEP68|CERKL|CERS6|CFAP210|CFAP36|CFAP65|CFC1|CFC1B|CFLAR|CGREF1|CHAC2|CHCHD5|CHMP3|CHN1|CHPF|CHRNA1|CHRND|CHRNG|CHST10|CIAO1|CIB4|CIR1|CKAP2L|CLASP1|CLEC4F|CLHC1|CLIP4|CLK1|CMKLR2|CMPK2|CNGA3|CNNM3|CNNM4|CNOT11|CNOT9|CNPPD1|CNRIP1|CNTNAP5|COA5|COBLL1|COL3A1|COL4A3|COL4A4|COL5A2|COL6A3|COLEC11|COMMD1|COPS7B|COPS8|COPS9|COQ10B|COX5B|COX7A2L|CPO|CPS1|CPSF3|CRACDL|CREB1|CREG2|CRIM1|CRIPT|CRYBA2|CRYGA|CRYGB|CRYGC|CRYGD|CSRNP3|CTDSP1|CTLA4|CTNNA2|CUL3|CWC22|CXCR1|CXCR2|CXCR4|CYBRD1|CYP1B1|CYP20A1|CYP26B1|CYP27A1|CYP27C1|CYRIA|CYS1|CYTIP|D2HGDH|DAPL1|DARS1|DAW1|DBI|DCAF17|DCDC2C|DCTN1|DDX1|DDX18|DES|DGKD|DGUOK|DHRS9|DHX57|DIRC1|DIRC3|DIS3L2|DLX1|DLX2|DNAAF10|DNAH6|DNAH7|DNAJB2|DNAJB3|DNAJC10|DNAJC27|DNAJC5G|DNER|DNMT3A|DNPEP|DOCK10|DOK1|DPP10|DPP4|DPY30|DPYSL5|DQX1|DRC1|DTNB|DTYMK|DUSP11|DUSP19|DUSP2|DUSP28|DYNC1I2|DYNC2LI1|DYSF|DYTN|E2F6|ECEL1|ECRG4|EDAR|EEF1B2|EFEMP1|EFHD1|EFR3B|EGR4|EHBP1|EHD3|EIF2AK2|EIF2AK3|EIF2B4|EIF4E2|EIF5B|EIPR1|ELMOD3|EMILIN1|EML4|EML6|EMX1|EN1|EPAS1|EPB41L5|EPC2|EPCAM|EPHA4|ERBB4|ERCC3|ERFE|ERICH2|ERLEC1|ERMN|ESPNL|ETAA1|EVA1A|EVX2|EXOC6B|FABP1|FAHD2A|FAHD2B|FAM110C|FAM117B|FAM124B|FAM126B|FAM136A|FAM161A|FAM166C|FAM168B|FAM171B|FAM178B|FAM228A|FAM228B|FAM98A|FANCL|FAP|FARP2|FARSB|FASTKD1|FASTKD2|FBLN7|FBXO11|FBXO36|FBXO41|FBXO48|FER1L5|FEV|FEZ2|FHL2|FIGLA|FIGN|FKBP1B|FKBP7|FLACC1|FMNL2|FN1|FNDC4|FOSL2|FOXD4L1|FOXI3|FOXN2|FRZB|FSHR|FSIP2|FTCDNL1|FZD5|FZD7|G6PC2|GAD1|GAL3ST2|GALM|GALNT13|GALNT14|GALNT3|GALNT5|GAREM2|GBX2|GCA|GCC2|GCFC2|GCG|GCKR|GDF7|GEMIN6|GEN1|GFPT1|GGCX|GIGYF2|GKN1|GKN2|GLB1L|GLI2|GLS|GMCL1|GMPPA|GNLY|GORASP2|GPAT2|GPATCH11|GPBAR1|GPC1|GPD2|GPN1|GPR148|GPR155|GPR17|GPR35|GPR39|GPR45|GPR55|GPR75|GPR75-ASB3|GRB14|GREB1|GRHL1|GTDC1|GTF2A1L|GTF3C2|GTF3C3|GULP1|GYPC|HAAO|HADHA|HADHB|HAT1|HDAC4|HDLBP|HEATR5B|HECW2|HES6|HIBCH|HJURP|HK2|HNMT|HNRNPA3|HNRNPLL|HOXD1|HOXD10|HOXD11|HOXD12|HOXD13|HOXD3|HOXD4|HOXD8|HOXD9|HPCAL1|HS1BP3|HS6ST1|HSPD1|HSPE1|HTR2B|HTRA2|IAH1|ICA1L|ICOS|ID2|IDH1|IFIH1|IFT172|IGFBP2|IGFBP5|IGKC|IHH|IKZF2|IL18R1|IL18RAP|IL1A|IL1B|IL1F10|IL1R1|IL1R2|IL1RL1|IL1RL2|IL1RN|IL36A|IL36B|IL36G|IL36RN|IL37|ILKAP|IMMT|IMP4|ING5|INHA|INHBB|INO80B|INO80D|INPP1|INPP4A|INSIG2|IQCA1|IRS1|ITGA4|ITGA6|ITGAV|ITGB1BP1|ITGB6|ITM2C|ITPRID2|ITPRIPL1|ITSN2|IWS1|KANSL1L|KANSL3|KCMF1|KCNE4|KCNF1|KCNG3|KCNH7|KCNIP3|KCNJ13|KCNJ3|KCNK12|KCNK3|KCNS3|KCTD18|KDM3A|KHK|KIDINS220|KIF1A|KIF3C|KLF11|KLF7|KLHL23|KLHL29|KLHL30|KLHL41|KRCC1|KRTCAP3|KYNU|LANCL1|LAPTM4A|LBH|LBX2|LCLAT1|LCT|LDAH|LGALSL|LHCGR|LIMS1|LIMS2|LIMS3|LIMS4|LINC00570|LINC01873|LINC02898|LIPT1|LMAN2L|LNPK|LOC100128563|LONRF2|LOXL3|LPIN1|LRATD1|LRP1B|LRP2|LRPPRC|LRRFIP1|LRRTM1|LRRTM4|LTBP1|LY75|LY75-CD302|LYG1|LYG2|LYPD1|LYPD6|LYPD6B|M1AP|MAB21L4|MAIP1|MAL|MALL|MAP2|MAP3K19|MAP3K2|MAP3K20|MAP4K3|MAP4K4|MAPRE3|MARCHF4|MARCHF7|MARCO|MARS2|MAT2A|MATN3|MBD5|MBOAT2|MCEE|MCFD2|MCM6|MDH1|MDH1B|MEIS1|MEMO1|MERTK|METAP1D|METTL21A|METTL5|METTL8|MFF|MFSD2B|MFSD6|MFSD9|MGAT4A|MGAT5|MIR10B|MIR1258|MIR128-1|MIR149|MIR216A|MIR217|MIR26B|MIR375|MITD1|MLPH|MMADHC|MOB1A|MOB4|MOGAT1|MOGS|MORN2|MPHOSPH10|MPP4|AAK1|AAMP|ABCA12|ABCB11|ABCB6|ABCG5|ABCG8|ABHD1|ABI2|ACADL|ACKR3|ACMSD|ACOXL|ACP1|ACSL3|ACTG2|ACTR1B|ACTR2|ACTR3|ACVR1|ACVR1C|ACVR2A|ACYP2|ADAM17|ADAM23|ADCY3|ADD2|ADGRF3|ADI1|ADRA2B|AFF3|AFTPH|AGAP1|AGBL5|AGFG1|AGPS|AGXT|ALK|ALKAL2|ALLC|ALMS1|ALPG|ALPI|ALPP|ALS2|AMER3|AMMECR1L|ANAPC1|ANKAR|ANKMY1|ANKRD23|ANKRD36|ANKRD36B|ANKRD36C|ANKRD39|ANKRD44|ANKRD53|ANKZF1|ANO7|ANTXR1|ANXA4|AOX1|AP1S3|APLF|APOB|AQP12A|AQP12B|ARHGAP15|ARHGAP25|ARHGEF33|ARHGEF4|ARID5A|ARL4C|ARL5A|ARL6IP6|ARMC9|ARPC2|ASAP2|ASB1|ASB18|ASB3|ASIC4|ASNSD1|ASPRV1|ASTL|ASXL2|ATAD2B|ATF2|ATG16L1|ATG4B|ATG9A|ATIC|ATL2|ATOH8|ATP5MC3|ATP6V1B1|ATP6V1C2|ATP6V1E2|ATRAID|AUP1|B3GALT1|B3GNT2|B3GNT7|BABAM2|BARD1|BAZ2B|BBS5|BCL11A|BCL2L11|BCS1L|BCYRN1|BIN1|BIRC6|BMP10|BMPR2|BOK|BOLA3|BOLL|BUB1|BZW1|C1D|C1QL2|C2CD6|C2orf15|C2orf16|C2orf27A|C2orf42|C2orf48|C2orf49|C2orf50|C2orf66|C2orf68|C2orf69|C2orf72|C2orf73|C2orf74|MPV17|MREG|MROH2A|MRPL19|MRPL30|MRPL33|MRPL35|MRPL44|MRPL53|MRPS5|MRPS9|MSGN1|MSH2|MSH2-OT1|MSH6|MSTN|MTA3|MTERF4|MTHFD2|MTIF2|MTX2|MXD1|MYCN|MYCNOS|MYL1|MYO1B|MYO3B|MYO7B|MYT1L|MZT2A|MZT2B|NAB1|NABP1|NAGK|NAT8|NAT8B|NBAS|NBEAL1|NCAPH|NCK2|NCKAP1|NCKAP5|NCL|NCOA1|NDUFA10|NDUFAF7|NDUFB3|NDUFS1|NEB|NEMP2|NEU2|NEU4|NEUROD1|NFE2L2|NFU1|NGEF|NHEJ1|NIF3L1|NIFK|NLRC4|NMI|NMS|NMUR1|NOL10|NOP58|NOSTRIN|NOTO|NPAS2|NPHP1|NPPC|NR4A2|NRBP1|NRP2|NRXN1|NT5C1B|NT5C1B-RDH14|NT5DC4|NTSR2|NUP35|NXPH2|NYAP2|OBSL1|ODC1|OLA1|OR6B2|OR6B3|ORC2|ORC4|ORMDL1|OSBPL6|OSGEPL1|OSR1|OST4|OTOF|OTOS|OTX1|OXER1|PAIP2B|PAPOLG|PARD3B|PASK|PAX3|PAX8|PCARE|PCBP1|PCGEM1|PCGF1|PCYOX1|PDCL3|PDE11A|PDE1A|PDE6D|PDIA6|PDK1|PECR|PELI1|PER2|PEX13|PFN4|PGAP1|PHOSPHO2|PID1|PIGF|PIKFYVE|PJVK|PKDCC|PKP4|PLA2R1|PLB1|PLCD4|PLCL1|PLEK|PLEKHA3|PLEKHB2|PLEKHH2|PLEKHM3|PLGLB1|PMS1|PNKD|PNO1|PNPT1|POLE4|POLR1A|POLR1B|POLR2D|POMC|POTEE|POTEF|POTEI|POTEJ|POU3F3|PPIG|PPIL3|PPM1B|PPM1G|PPP1CB|PPP1R1C|PPP1R21|PPP1R7|PPP3R1|PPP4R3B|PRADC1|PREB|PREPL|PRKAG3|PRKCE|PRKD3|PRKRA|PRLH|PROC|PROKR1|PROM2|PRPF40A|PRR21|PRR30|PRSS56|PSD4|PSMD1|PSMD14|PSME4|PTCD3|PTH2R|PTMA|PTPN18|PTPN4|PTPRN|PTRHD1|PUM2|PUS10|PXDN|QPCT|R3HDM1|RAB10|RAB11FIP5|RAB17|RAB1A|RAB3GAP1|RAB6C|RABL2A|RAD51AP2|RALB|RAMP1|RANBP2|RAPGEF4|RAPH1|RASGRP3|RBKS|RBM43|RBM44|RBM45|RBMS1|RDH14|REEP1|REG1A|REG1B|REG3A|REG3G|REL|RESP18|RETREG2|RETSAT|REV1|RFTN2|RFX8|RGPD1|RGPD2|RGPD3|RGPD4|RGPD5|RGPD6|RGPD8|RHBDD1|RHOB|RHOQ|RIF1|RMDN2|RMND5A|RNASEH1|RND3|RNF103|RNF103-CHMP3|RNF144A|RNF149|RNF181|RNF25|RNPEPL1|RNU4ATAC|ROCK2|RPE|RPIA|RPL31|RPL37A|RPRM|RPS27A|RPS7|RRM2|RSAD2|RTKN|RTN4|RUFY4|SAG|SANBR|SAP130|SATB2|SCG2|SCLY|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SCRN3|SCTR|SDC1|SELENOI|SEMA4C|SEMA4F|SEPTIN10|SEPTIN2|SERPINE2|SERTAD2|SESTD1|SF3B1|SF3B6|SFT2D3|SFTPB|SFXN5|SGO2|SGPP2|SH2D6|SH3BP4|SH3YL1|SIX2|SIX3|SLC11A1|SLC16A14|SLC19A3|SLC1A4|SLC20A1|SLC23A3|SLC25A12|SLC30A3|SLC30A6|SLC35F5|SLC35F6|SLC38A11|SLC39A10|SLC3A1|SLC40A1|SLC4A10|SLC4A1AP|SLC4A3|SLC4A5|SLC5A6|SLC5A7|SLC66A3|SLC8A1|SLC9A2|SLC9A4|SMARCAL1|SMC6|SMPD4|SMYD1|SMYD5|SNED1|SNORC|SNORD20|SNORD82|SNRNP200|SNRNP27|SNRPG|SNTG2|SNX17|SOCS5|SOS1|SOS1-IT1|SOWAHC|SOX11|SP100|SP110|SP140|SP140L|SP3|SP5|SP9|SPAG16|SPAST|SPATA3|SPATS2L|SPC25|SPDYA|SPEG|SPHKAP|SPOPL|SPP2|SPR|SPRED2|SPTBN1|SRBD1|SRD5A2|SRSF7|SSB|ST3GAL5|ST6GAL2|STAM2|STAMBP|STARD7|STAT1|STAT4|STEAP3|STK11IP|STK16|STK17B|STK25|STK36|STK39|STON1|STON1-GTF2A1L|STPG4|STRADB|STRN|SUCLG1|SULT1C2|SULT1C3|SULT1C4|SULT6B1|SUMO1|SUPT7L|TACR1|TAF1B|TANC1|TANK|TBC1D8|TBR1|TCF23|TCF7L1|TDRD15|TEKT4|TET3|TEX261|TEX37|TEX44|TFCP2L1|TFPI|TGFA|TGFBRAP1|TGOLN2|THADA|THAP4|THNSL2|THSD7B|THUMPD2|TIA1|TIGD1|TLK1|TLX2|TM4SF20|TMBIM1|TMEFF2|TMEM127|TMEM131|TMEM150A|TMEM163|TMEM169|TMEM17|TMEM177|TMEM178A|TMEM18|TMEM182|TMEM185B|TMEM198|TMEM214|TMEM237|TMEM247|TMEM37|TMEM87B|TMSB10|TNFAIP6|TNP1|TNS1|TOGARAM2|TP53I3|TPO|TPRKB|TRABD2A|TRAF3IP1|TRAK2|TRAPPC12|TRIB2|TRIM43|TRIM43B|TRIM54|TRIP12|TRMT61B|TRPM8|TSGA10|TSN|TSPYL6|TTC21B|TTC27|TTC30A|TTC30B|TTC31|TTC32|TTC7A|TTL|TTLL4|TTN|TUBA3D|TUBA3E|TUBA4A|TWIST2|TXNDC9|TYW5|UBE2E3|UBE2F|UBR3|UBXN2A|UBXN4|UCN|UGGT1|UGP2|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9|UNC50|UNC80|UPP2|USP34|USP37|USP39|USP40|UXS1|VAMP5|VAMP8|VAX2|VIL1|VIT|VPS54|VRK2|VSNL1|VWA3B|VWC2L|WBP1|WDCP|WDFY1|WDPCP|WDR12|WDR33|WDR35|WDR43|WDR54|WDR75|WDSUB1|WIPF1|WNT10A|WNT6|XDH|XIRP2|XPO1|XRCC5|YIPF4|YPEL5|YWHAQ|ZAP70|ZC3H15|ZC3H6		See cases	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000442998	2	12771 - 242783384			442998	436660		
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)x3	DHRS9|DHX57|DIRC1|DIRC3|DIS3L2|DLX1|DLX2|DNAAF10|DNAH6|DNAH7|DNAJB2|DNAJB3|DNAJC10|DNAJC27|DNAJC5G|DNER|DNMT3A|DNPEP|DOCK10|DOK1|DPP10|DPP4|DPY30|DPYSL5|DQX1|DRC1|DTNB|DTYMK|DUSP11|DUSP19|DUSP2|DUSP28|DYNC1I2|DYNC2LI1|DYSF|DYTN|E2F6|ECEL1|ECRG4|EDAR|EEF1B2|EFEMP1|EFHD1|EFR3B|EGR4|EHBP1|EHD3|EIF2AK2|EIF2AK3|EIF2B4|EIF4E2|EIF5B|EIPR1|ELMOD3|EMILIN1|EML4|EML6|EMX1|EN1|EPAS1|EPB41L5|EPC2|EPCAM|EPHA4|ERBB4|ERCC3|ERFE|ERICH2|ERLEC1|ERMN|ESPNL|ETAA1|EVA1A|EVX2|EXOC6B|FABP1|FAHD2A|FAHD2B|FAM110C|FAM117B|FAM124B|FAM126B|FAM136A|FAM161A|FAM166C|FAM168B|FAM171B|FAM178B|FAM228A|FAM228B|FAM98A|FANCL|FAP|FARP2|FARSB|FASTKD1|FASTKD2|FBLN7|FBXO11|FBXO36|FBXO41|FBXO48|FER1L5|FEV|FEZ2|FHL2|FIGLA|FIGN|FKBP1B|FKBP7|FLACC1|FMNL2|FN1|FNDC4|FOSL2|FOXD4L1|FOXI3|FOXN2|FRZB|FSHR|FSIP2|FTCDNL1|FZD5|FZD7|G6PC2|GAD1|GAL3ST2|GALM|GALNT13|GALNT14|GALNT3|GALNT5|GAREM2|GBX2|GCA|GCC2|GCFC2|GCG|GCKR|GDF7|GEMIN6|GEN1|GFPT1|GGCX|GIGYF2|GKN1|GKN2|GLB1L|GLI2|GLS|GMCL1|GMPPA|GNLY|GORASP2|GPAT2|GPATCH11|GPBAR1|GPC1|GPD2|GPN1|GPR148|GPR155|GPR17|GPR35|GPR39|GPR45|GPR55|GPR75|GPR75-ASB3|GRB14|GREB1|GRHL1|GTDC1|GTF2A1L|GTF3C2|GTF3C3|GULP1|GYPC|HAAO|HADHA|HADHB|HAT1|HDAC4|HDLBP|HEATR5B|HECW2|HES6|HIBCH|HJURP|HK2|HNMT|HNRNPA3|HNRNPLL|HOXD1|HOXD10|HOXD11|HOXD12|HOXD13|HOXD3|HOXD4|HOXD8|HOXD9|HPCAL1|HS1BP3|HS6ST1|HSPD1|HSPE1|HTR2B|HTRA2|IAH1|ICA1L|ICOS|ID2|IDH1|IFIH1|IFT172|IGFBP2|IGFBP5|IGKC|IHH|IKZF2|IL18R1|IL18RAP|IL1A|IL1B|IL1F10|IL1R1|IL1R2|IL1RL1|IL1RL2|IL1RN|IL36A|IL36B|IL36G|IL36RN|IL37|ILKAP|IMMT|IMP4|ING5|INHA|INHBB|INO80B|INO80D|INPP1|INPP4A|INSIG2|IQCA1|IRS1|ITGA4|ITGA6|ITGAV|ITGB1BP1|ITGB6|ITM2C|ITPRID2|ITPRIPL1|ITSN2|IWS1|KANSL1L|KANSL3|KCMF1|KCNE4|KCNF1|KCNG3|KCNH7|KCNIP3|KCNJ13|KCNJ3|KCNK12|KCNK3|KCNS3|KCTD18|KDM3A|KHK|KIDINS220|KIF1A|KIF3C|KLF11|KLF7|KLHL23|KLHL29|KLHL30|KLHL41|KRCC1|KRTCAP3|KYNU|LANCL1|LAPTM4A|LBH|LBX2|LCLAT1|LCT|LDAH|LGALSL|LHCGR|LIMS1|LIMS2|LIMS3|LIMS4|LINC00570|LINC01873|LINC02898|LIPT1|LMAN2L|LNPK|LOC100128563|LONRF2|LOXL3|LPIN1|LRATD1|LRP1B|LRP2|LRPPRC|LRRFIP1|LRRTM1|LRRTM4|LTBP1|LY75|LY75-CD302|LYG1|LYG2|LYPD1|LYPD6|LYPD6B|M1AP|MAB21L4|MAIP1|MAL|MALL|MAP2|MAP3K19|MAP3K2|MAP3K20|MAP4K3|MAP4K4|MAPRE3|MARCHF4|MARCHF7|MARCO|MARS2|MAT2A|MATN3|MBD5|MBOAT2|MCEE|MCFD2|MCM6|MDH1|MDH1B|MEIS1|MEMO1|MERTK|METAP1D|METTL21A|METTL5|METTL8|MFF|MFSD2B|MFSD6|MFSD9|MGAT4A|MGAT5|MIR10B|MIR1258|MIR128-1|MIR149|MIR216A|MIR217|MIR26B|MIR375|MITD1|MLPH|MMADHC|MOB1A|MOB4|MOGAT1|MOGS|MORN2|MPHOSPH10|MPP4|MPV17|MREG|MROH2A|MRPL19|MRPL30|MRPL33|MRPL35|MRPL44|MRPL53|MRPS5|MRPS9|MSGN1|MSH2|MSH2-OT1|MSH6|MSTN|MTA3|MTERF4|MTHFD2|MTIF2|MTX2|MXD1|MYCN|MYCNOS|MYL1|MYO1B|MYO3B|MYO7B|MYT1L|MZT2A|MZT2B|NAB1|NABP1|NAGK|NAT8|NAT8B|NBAS|NBEAL1|NCAPH|NCK2|NCKAP1|NCKAP5|NCL|NCOA1|NDUFA10|NDUFAF7|NDUFB3|NDUFS1|NEB|NEMP2|NEU2|NEU4|NEUROD1|NFE2L2|NFU1|NGEF|NHEJ1|NIF3L1|NIFK|NLRC4|NMI|NMS|NMUR1|NOL10|NOP58|NOSTRIN|NOTO|NPAS2|NPHP1|NPPC|NR4A2|NRBP1|NRP2|NRXN1|NT5C1B|NT5C1B-RDH14|NT5DC4|NTSR2|NUP35|NXPH2|NYAP2|OBSL1|ODC1|OLA1|OR6B2|OR6B3|ORC2|ORC4|ORMDL1|OSBPL6|OSGEPL1|OSR1|OST4|OTOF|OTOS|OTX1|OXER1|PAIP2B|PAPOLG|PARD3B|PASK|PAX3|PAX8|PCARE|PCBP1|PCGEM1|PCGF1|PCYOX1|PDCL3|PDE11A|PDE1A|PDE6D|PDIA6|PDK1|PECR|PELI1|PER2|PEX13|PFN4|PGAP1|PHOSPHO2|PID1|PIGF|PIKFYVE|PJVK|PKDCC|PKP4|PLA2R1|PLB1|PLCD4|PLCL1|PLEK|PLEKHA3|PLEKHB2|PLEKHH2|PLEKHM3|PLGLB1|PMS1|PNKD|PNO1|PNPT1|POLE4|POLR1A|POLR1B|POLR2D|POMC|POTEE|POTEF|POTEI|POTEJ|POU3F3|PPIG|PPIL3|PPM1B|PPM1G|PPP1CB|PPP1R1C|PPP1R21|PPP1R7|PPP3R1|PPP4R3B|PRADC1|PREB|PREPL|PRKAG3|PRKCE|PRKD3|PRKRA|PRLH|PROC|PROKR1|PROM2|PRPF40A|PRR21|PRR30|PRSS56|PSD4|PSMD1|PSMD14|PSME4|PTCD3|PTH2R|PTMA|PTPN18|PTPN4|PTPRN|PTRHD1|PUM2|PUS10|PXDN|QPCT|R3HDM1|RAB10|RAB11FIP5|RAB17|RAB1A|RAB3GAP1|RAB6C|RABL2A|RAD51AP2|RALB|RAMP1|RANBP2|RAPGEF4|RAPH1|RASGRP3|RBKS|RBM43|RBM44|RBM45|RBMS1|RDH14|REEP1|REG1A|REG1B|REG3A|REG3G|REL|RESP18|RETREG2|RETSAT|REV1|RFTN2|RFX8|RGPD1|RGPD2|RGPD3|RGPD4|RGPD5|RGPD6|RGPD8|RHBDD1|RHOB|RHOQ|RIF1|RMDN2|RMND5A|RNASEH1|RND3|RNF103|RNF103-CHMP3|RNF144A|RNF149|RNF181|RNF25|RNPEPL1|RNU4ATAC|ROCK2|RPE|RPIA|RPL31|RPL37A|RPRM|RPS27A|RPS7|RRM2|RSAD2|RTKN|RTN4|RUFY4|SAG|SANBR|SAP130|SATB2|SCG2|SCLY|SCN1A|SCN2A|SCN3A|SCN7A|SCN9A|SCRN3|SCTR|SDC1|SELENOI|SEMA4C|SEMA4F|SEPTIN10|SEPTIN2|SERPINE2|SERTAD2|SESTD1|SF3B1|SF3B6|SFT2D3|SFTPB|SFXN5|SGO2|SGPP2|SH2D6|SH3BP4|SH3YL1|SIX2|SIX3|SLC11A1|SLC16A14|SLC19A3|SLC1A4|SLC20A1|SLC23A3|SLC25A12|SLC30A3|SLC30A6|SLC35F5|SLC35F6|SLC38A11|SLC39A10|SLC3A1|SLC40A1|SLC4A10|SLC4A1AP|SLC4A3|SLC4A5|SLC5A6|SLC5A7|SLC66A3|SLC8A1|SLC9A2|SLC9A4|SMARCAL1|SMC6|SMPD4|SMYD1|SMYD5|SNED1|SNORC|SNORD20|SNORD82|SNRNP200|SNRNP27|SNRPG|SNTG2|SNX17|SOCS5|SOS1|SOS1-IT1|SOWAHC|SOX11|SP100|SP110|SP140|SP140L|SP3|SP5|SP9|SPAG16|SPAST|SPATA3|SPATS2L|SPC25|SPDYA|SPEG|SPHKAP|SPOPL|SPP2|SPR|SPRED2|SPTBN1|SRBD1|SRD5A2|SRSF7|SSB|ST3GAL5|ST6GAL2|STAM2|STAMBP|STARD7|STAT1|STAT4|STEAP3|STK11IP|STK16|STK17B|STK25|STK36|STK39|STON1|STON1-GTF2A1L|STPG4|STRADB|STRN|SUCLG1|SULT1C2|SULT1C3|SULT1C4|SULT6B1|SUMO1|SUPT7L|TACR1|TAF1B|TANC1|TANK|TBC1D8|TBR1|TCF23|TCF7L1|TDRD15|TEKT4|TET3|TEX261|TEX37|TEX44|TFCP2L1|TFPI|TGFA|TGFBRAP1|TGOLN2|THADA|THAP4|THNSL2|THSD7B|THUMPD2|TIA1|TIGD1|TLK1|TLX2|TM4SF20|TMBIM1|TMEFF2|TMEM127|TMEM131|TMEM150A|TMEM163|TMEM169|TMEM17|TMEM177|TMEM178A|TMEM18|TMEM182|TMEM185B|TMEM198|TMEM214|TMEM237|TMEM247|TMEM37|TMEM87B|TMSB10|TNFAIP6|TNP1|TNS1|TOGARAM2|TP53I3|TPO|TPRKB|TRABD2A|TRAF3IP1|TRAK2|TRAPPC12|TRIB2|TRIM43|TRIM43B|TRIM54|TRIP12|TRMT61B|TRPM8|TSGA10|TSN|TSPYL6|TTC21B|TTC27|TTC30A|TTC30B|TTC31|TTC32|TTC7A|TTL|TTLL4|TTN|TUBA3D|TUBA3E|TUBA4A|TWIST2|TXNDC9|TYW5|UBE2E3|UBE2F|UBR3|UBXN2A|UBXN4|UCN|UGGT1|UGP2|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9|UNC50|UNC80|UPP2|USP34|USP37|USP39|USP40|UXS1|VAMP5|VAMP8|VAX2|VIL1|VIT|VPS54|VRK2|VSNL1|VWA3B|VWC2L|WBP1|WDCP|WDFY1|WDPCP|WDR12|WDR33|WDR35|WDR43|WDR54|WDR75|WDSUB1|WIPF1|WNT10A|WNT6|XDH|XIRP2|XPO1|XRCC5|YIPF4|YPEL5|YWHAQ|ZAP70|ZC3H15|ZC3H6|ZC3H8|ZDBF2|ZEB2|ZFAND2B|ZFP36L2|ZNF142|ZNF2|ZNF385B|ZNF512|ZNF513|ZNF514|ZNF638|ZNF804A|ZNF806|ZRANB3|ZSWIM2|AAK1|AAMP|ABCA12|ABCB11|ABCB6|ABCG5|ABCG8|ABHD1|ABI2|ACADL|ACKR3|ACMSD|ACOXL|ACP1|ACSL3|ACTG2|ACTR1B|ACTR2|ACTR3|ACVR1|ACVR1C|ACVR2A|ACYP2|ADAM17|ADAM23|ADCY3|ADD2|ADGRF3|ADI1|ADRA2B|AFF3|AFTPH|AGAP1|AGBL5|AGFG1|AGPS|AGXT|ALK|ALKAL2|ALLC|ALMS1|ALPG|ALPI|ALPP|ALS2|AMER3|AMMECR1L|ANAPC1|ANKAR|ANKMY1|ANKRD23|ANKRD36|ANKRD36B|ANKRD36C|ANKRD39|ANKRD44|ANKRD53|ANKZF1|ANO7|ANTXR1|ANXA4|AOX1|AP1S3|APLF|APOB|AQP12A|AQP12B|ARHGAP15|ARHGAP25|ARHGEF33|ARHGEF4|ARID5A|ARL4C|ARL5A|ARL6IP6|ARMC9|ARPC2|ASAP2|ASB1|ASB18|ASB3|ASIC4|ASNSD1|ASPRV1|ASTL|ASXL2|ATAD2B|ATF2|ATG16L1|ATG4B|ATG9A|ATIC|ATL2|ATOH8|ATP5MC3|ATP6V1B1|ATP6V1C2|ATP6V1E2|ATRAID|AUP1|B3GALT1|B3GNT2|B3GNT7|BABAM2|BARD1|BAZ2B|BBS5|BCL11A|BCL2L11|BCS1L|BCYRN1|BIN1|BIRC6|BMP10|BMPR2|BOK|BOLA3|BOLL|BUB1|BZW1|C1D|C1QL2|C2CD6|C2orf15|C2orf16|C2orf27A|C2orf42|C2orf48|C2orf49|C2orf50|C2orf66|C2orf68|C2orf69|C2orf72|C2orf73|C2orf74|C2orf76|C2orf78|C2orf80|C2orf81|C2orf83|C2orf88|CAB39|CACNB4|CAD|CALCRL|CALM2|CAMKMT|CAPG|CAPN10|CAPN13|CAPN14|CARF|CASP10|CASP8|CATIP|CAVIN2|CBWD2|CCDC115|CCDC121|CCDC138|CCDC140|CCDC141|CCDC142|CCDC148|CCDC150|CCDC74A|CCDC74B|CCDC85A|CCDC88A|CCDC93|CCL20|CCNT2|CCNYL1|CCT4|CCT7|CD207|CD28|CD302|CD8A|CD8B|CDC42EP3|CDCA7|CDK15|CDK5R2|CDKL4|CDRT15P3|CEBPZ|CENPA|CENPO|CEP68|CERKL|CERS6|CFAP210|CFAP36|CFAP65|CFC1|CFC1B|CFLAR|CGREF1|CHAC2|CHCHD5|CHMP3|CHN1|CHPF|CHRNA1|CHRND|CHRNG|CHST10|CIAO1|CIB4|CIR1|CKAP2L|CLASP1|CLEC4F|CLHC1|CLIP4|CLK1|CMKLR2|CMPK2|CNGA3|CNNM3|CNNM4|CNOT11|CNOT9|CNPPD1|CNRIP1|CNTNAP5|COA5|COBLL1|COL3A1|COL4A3|COL4A4|COL5A2|COL6A3|COLEC11|COMMD1|COPS7B|COPS8|COPS9|COQ10B|COX5B|COX7A2L|CPO|CPS1|CPSF3|CRACDL|CREB1|CREG2|CRIM1|CRIPT|CRYBA2|CRYGA|CRYGB|CRYGC|CRYGD|CSRNP3|CTDSP1|CTLA4|CTNNA2|CUL3|CWC22|CXCR1|CXCR2|CXCR4|CYBRD1|CYP1B1|CYP20A1|CYP26B1|CYP27A1|CYP27C1|CYRIA|CYS1|CYTIP|D2HGDH|DAPL1|DARS1|DAW1|DBI|DCAF17|DCDC2C|DCTN1|DDX1|DDX18|DES|DGKD|DGUOK		See cases	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000442997	2	12771 - 242783384			442997	436659		
NM_001164508.2(NEB):c.1471-1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	VCV000435970	2	152553250	2	151696736	435970	427917	rs1553605995	NC_000002.12:151696735:C:T
NM_001164508.2(NEB):c.24996del (p.Gln8333fs)	NEB|RIF1	Q6477fs, Q8333fs, Q8368fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 22, 2015)	criteria provided, single submitter	VCV000435969	2	152348673	2	151492159	435969	427910	rs1553526884	NC_000002.12:151492158:AA:A
NM_001164508.2(NEB):c.2499del (p.Ala834fs)	NEB	A834fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 11, 2016)	criteria provided, single submitter	VCV000435967	2	152544164	2	151687650	435967	427916	rs1553564693	NC_000002.12:151687649:TTT:TT
NM_001164508.2(NEB):c.18830_18831del (p.Thr6277fs)	NEB	T6277fs, T4576fs	not provided	Pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000432818	2	152419185 - 152419186	2	151562671 - 151562672	432818	425405	rs1553762626	NC_000002.12:151562670:CG:
NM_001164508.2(NEB):c.24588C>G (p.Tyr8196Ter)	NEB|RIF1	Y8231*, Y6340*, Y8196*	not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000432817	2	152350373	2	151493859	432817	425402	rs754272530	NC_000002.12:151493858:G:C
NM_001164508.2(NEB):c.25057+1G>T	NEB|RIF1		not provided|Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jul 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000432070	2	152348611	2	151492097	432070	425401	rs1191429915	NC_000002.12:151492096:C:A
NM_001164508.2(NEB):c.14323G>T (p.Glu4775Ter)	NEB	E4775*	not provided	Likely pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	VCV000430109	2	152450715	2	151594201	430109	421282	rs1131691787	NC_000002.12:151594200:C:A
NM_001164508.2(NEB):c.8265+1G>A	NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000429723	2	152499278	2	151642764	429723	421284	rs1131691547	NC_000002.12:151642763:C:T
NM_001271208.1(NEB):c.[7291G>A];[7523_7526delTCAA]			Nemaline myopathy 2	Likely pathogenic(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	VCV000424830					424830			
NM_001164508.2(NEB):c.16273C>T (p.Gln5425Ter)	NEB	Q5425*	not provided	Likely pathogenic(Last reviewed: Feb 13, 2017)	criteria provided, single submitter	VCV000423231	2	152438008	2	151581494	423231	405317	rs1064796311	NC_000002.12:151581493:G:A
NM_001164508.2(NEB):c.24213_24214insAA (p.Tyr8072fs)	NEB|RIF1	Y8072fs, Y8107fs	not provided	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000422612	2	152354226 - 152354227	2	151497712 - 151497713	422612	405307	rs1064795894	NC_000002.12:151497712:T:TTT
NM_001164508.2(NEB):c.20858del (p.Ile6953fs)	NEB	I6953fs, I5252fs	not provided	Likely pathogenic(Last reviewed: Feb 20, 2016)	criteria provided, single submitter	VCV000420412	2	152396892	2	151540378	420412	405315	rs1064794461	NC_000002.12:151540377:A:
NM_001164508.2(NEB):c.2415+1G>A	NEB		Nemaline myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000420125	2	152544805	2	151688291	420125	405326	rs1057524581	NC_000002.12:151688290:C:T
NM_001164508.2(NEB):c.24289_24292dup (p.Ile8098fs)	NEB|RIF1	I8098fs, I8133fs	not provided	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	VCV000419830	2	152354147 - 152354148	2	151497633 - 151497634	419830	405306	rs1553551595	NC_000002.12:151497633:TATTT:TATTTATTT
GRCh37/hg19 2q23.1-23.3(chr2:148842506-152370040)x1	EPC2|LYPD6|LYPD6B|MBD5|MMADHC|NEB|NMI|RBM43|RIF1|RND3|TNFAIP6		See cases	Pathogenic	no assertion criteria provided	VCV000395440	2	148842506 - 152370040			395440	382333		
NM_001164508.2(NEB):c.2415+1G>T	NEB		not provided	Likely pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000392654	2	152544805	2	151688291	392654	366009	rs1057524581	NC_000002.12:151688290:C:A
NM_001164508.2(NEB):c.9619-2A>G	NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000379231	2	152487335	2	151630821	379231	365720	rs375145370	NC_000002.12:151630820:T:C
NM_001164508.2(NEB):c.23989C>T (p.Arg7997Ter)	NEB|RIF1	R8032*, R7997*	Nemaline myopathy 2|not provided|Limb pain|Muscular dystrophy|Progressive proximal muscle weakness	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000373977	2	152357937	2	151501423	373977	360820	rs549794342	NC_000002.12:151501422:G:A
NM_001164508.2(NEB):c.4720-2A>G	NEB		not provided	Likely pathogenic(Last reviewed: Nov 11, 2016)	criteria provided, single submitter	VCV000373328	2	152522917	2	151666403	373328	359295	rs1057518353	NC_000002.12:151666402:T:C
NM_001164508.2(NEB):c.17262G>A (p.Trp5754Ter)	NEB	W5754*, W4053*	not provided	Pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000373081	2	152426763	2	151570249	373081	359277	rs1057518200	NC_000002.12:151570248:C:T
NM_001164508.2(NEB):c.9046C>T (p.Arg3016Ter)	NEB	R3016*	not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000372773	2	152492797	2	151636283	372773	359394	rs1057517977	NC_000002.12:151636282:G:A
NM_001164508.2(NEB):c.2415+2T>C	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000371599	2	152544804	2	151688290	371599	357232	rs1057517399	NC_000002.12:151688289:A:G
NM_001164508.2(NEB):c.412C>T (p.Arg138Ter)	NEB	R138*	not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000371551	2	152581466	2	151724952	371551	357235	rs1057517360	NC_000002.12:151724951:G:A
NM_001164508.2(NEB):c.5452-2A>G	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Oct 5, 2016)	criteria provided, single submitter	VCV000371493	2	152520375	2	151663861	371493	357229	rs1057517317	NC_000002.12:151663860:T:C
NM_001164508.2(NEB):c.3987+1G>A	NEB		Nemaline myopathy|not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000371210	2	152530990	2	151674476	371210	357230	rs780022652	NC_000002.12:151674475:C:T
NM_001164508.2(NEB):c.7228-1G>A	NEB		Nemaline myopathy|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000371087	2	152506894	2	151650380	371087	357227	rs1057516996	NC_000002.12:151650379:C:T
NM_001164508.2(NEB):c.2391_2392del (p.Arg797fs)	NEB	R797fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000371010	2	152544829 - 152544830	2	151688315 - 151688316	371010	357233	rs1057516938	NC_000002.12:151688314:CTCT:CT
NM_001164508.2(NEB):c.6078del (p.Lys2026fs)	NEB	K2026fs	Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000370777	2	152514602	2	151658088	370777	357228	rs1057516758	NC_000002.12:151658087:TTT:TT
NM_001164508.2(NEB):c.1672_1674+2del	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Apr 6, 2016)	criteria provided, single submitter	VCV000370748	2	152552090 - 152552094	2	151695576 - 151695580	370748	357234	rs1057516739	NC_000002.12:151695575:ACATCAC:AC
NM_001164508.2(NEB):c.8038C>T (p.Arg2680Ter)	NEB	R2680*	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, single submitter	VCV000370674	2	152499786	2	151643272	370674	357225	rs1057516676	NC_000002.12:151643271:G:A
NM_001164508.2(NEB):c.3880-1G>T	NEB		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Jan 4, 2016)	criteria provided, single submitter	VCV000370296	2	152531099	2	151674585	370296	357231	rs1057516381	NC_000002.12:151674584:C:A
NM_001164508.2(NEB):c.7266_7268delinsTC (p.Gly2423fs)	NEB	G2423fs	Nemaline myopathy 2	Likely pathogenic(Last reviewed: Dec 27, 2015)	criteria provided, single submitter	VCV000370249	2	152506853 - 152506855	2	151650339 - 151650341	370249	357226	rs1057516348	NC_000002.12:151650338:CCT:GA
NM_001164508.2(NEB):c.17557_17558del (p.Glu5853fs)	NEB	E4152fs, E5853fs	not provided	Pathogenic(Last reviewed: Jul 12, 2016)	criteria provided, single submitter	VCV000288778	2	152425208 - 152425209	2	151568694 - 151568695	288778	273015	rs886044005	NC_000002.12:151568693:TCT:T
NM_001164508.2(NEB):c.294+2T>C	NEB		not provided|Nemaline myopathy 2|Nemaline myopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000287422	2	152584203	2	151727689	287422	271659	rs773952935	NC_000002.12:151727688:A:G
NM_001164508.2(NEB):c.17541dup (p.Tyr5848fs)	NEB	Y4147fs, Y5848fs	Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: Oct 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000287419	2	152425224 - 152425225	2	151568710 - 151568711	287419	271656	rs886043631	NC_000002.12:151568710:TTTTTT:TTTTTTT
NM_001164508.2(NEB):c.6385C>T (p.Gln2129Ter)	NEB	Q2129*	not provided|Nemaline myopathy 2	Pathogenic(Last reviewed: Nov 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000282373	2	152512777	2	151656263	282373	266610	rs80344795	NC_000002.12:151656262:G:A
NM_001164508.2(NEB):c.18862_18872del (p.Val6288fs)	NEB	V6288fs, V4587fs	not provided	Pathogenic(Last reviewed: Jun 11, 2015)	criteria provided, single submitter	VCV000281369	2	152419144 - 152419154	2	151562630 - 151562640	281369	265606	rs886042141	NC_000002.12:151562629:GCGTTTCGGACGCGT:GCGT
NM_001164508.2(NEB):c.16620T>A (p.Tyr5540Ter)	NEB	Y5540*	not provided	Pathogenic(Last reviewed: Sep 29, 2016)	criteria provided, single submitter	VCV000280871	2	152435936	2	151579422	280871	264053	rs886041998	NC_000002.12:151579421:A:T
NM_001164508.2(NEB):c.11806-1G>A	NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280692	2	152467381	2	151610867	280692	264035	rs886041851	NC_000002.12:151610866:C:T
NM_001164508.2(NEB):c.24051del (p.Ile8018fs)	RIF1|NEB	I8018fs, I8053fs	not provided	Pathogenic(Last reviewed: Mar 3, 2016)	criteria provided, single submitter	VCV000280373	2	152355875	2	151499361	280373	264014	rs758105619	NC_000002.12:151499360:CCC:CC
NM_001164508.2(NEB):c.24666del (p.Phe8222fs)	NEB|RIF1	F6366fs, F8222fs, F8257fs	not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2022)	criteria provided, multiple submitters, no conflicts	VCV000279999	2	152350295	2	151493781	279999	264046	rs794727136	NC_000002.12:151493780:AAA:AA
NM_001164508.2(NEB):c.24114+1G>A	NEB|RIF1		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2022)	criteria provided, multiple submitters, no conflicts	VCV000279977	2	152355811	2	151499297	279977	264067	rs755239192	NC_000002.12:151499296:C:T
NM_001164508.2(NEB):c.12018+1G>A	NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265494	2	152467029	2	151610515	265494	259697	rs762278237	NC_000002.12:151610514:C:T
NM_001164508.2(NEB):c.24527_24528del (p.Pro8176fs)	NEB|RIF1	P6320fs, P8176fs, P8211fs	not provided|Nemaline myopathy 2|Abnormality of the neck|Low-set ears|Dysphagia|Nemaline myopathy	Pathogenic(Last reviewed: Nov 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000265493	2	152350726 - 152350727	2	151494212 - 151494213	265493	259696	rs555445835	NC_000002.12:151494211:AG:
NM_001271208.1(NEB):c.7523_7526del	NEB	I2508fs	Nemaline myopathy 2|not provided	Pathogenic(Last reviewed: Aug 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000242434	2	152502654 - 152502657	2	151646140 - 151646143	242434	226443	rs878854368	NC_000002.12:151646139:TTGATT:TT
NM_001164508.2(NEB):c.24477_24480dup (p.Ser8161delinsTyrTer)	RIF1|NEB		not provided|Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2019)	no assertion criteria provided	VCV000212737	2	152352795 - 152352796	2	151496281 - 151496282	212737	209343	rs797044606	NC_000002.12:151496281:AATA:AATAAATA
NM_001164508.2(NEB):c.3774+1G>A	NEB		Nemaline myopathy 2	Pathogenic(Last reviewed: Dec 1, 2014)	criteria provided, single submitter	VCV000211588	2	152534078	2	151677564	211588	206868	rs111293259	NC_000002.12:151677563:C:T
NM_001164508.2(NEB):c.18597del (p.Tyr6200fs)	NEB	Y6200fs, Y4499fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Jan 20, 2015)	criteria provided, single submitter	VCV000211583	2	152420216	2	151563702	211583	206865	rs797045735	NC_000002.12:151563701:T:
NM_001164508.2(NEB):c.23743-1G>C	NEB|RIF1		Nemaline myopathy 2	Likely pathogenic(Last reviewed: Dec 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000208599	2	152359956	2	151503442	208599	205133	rs797045098	NC_000002.12:151503441:C:G
NM_001164508.2(NEB):c.24665_24666del (p.Asn8221_Phe8222insTer)	NEB|RIF1		Inborn genetic diseases|Nemaline myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000194452	2	152350295 - 152350296	2	151493781 - 151493782	194452	191615	rs794727136	NC_000002.12:151493780:AAA:A
NM_001164508.2(NEB):c.21076C>T (p.Arg7026Ter)	NEB	R7026*, R5325*	Non-immune hydrops fetalis|Nemaline myopathy 2|Nemaline myopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000190457	2	152394412	2	151537898	190457	188272	rs769345284	NC_000002.12:151537897:G:A
NM_001164508.2(NEB):c.3987+1_3987+2delinsTG	NEB		Nemaline myopathy|Nemaline myopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188944	2	152530989 - 152530990	2	151674475 - 151674476	188944	186648	rs786204576	NC_000002.12:151674474:AC:CA
NM_001164508.2(NEB):c.2784del (p.Asp929fs)	NEB	D929fs	Nemaline myopathy 2|Nemaline myopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000188731	2	152541343	2	151684829	188731	186649	rs786204430	NC_000002.12:151684828:A:
GRCh38/hg38 2q22.3-24.1(chr2:146324191-156219125)x3	ACVR2A|ARL5A|ARL6IP6|CACNB4|EPC2|FMNL2|GALNT13|KCNJ3|KIF5C|LINC01817|LINC01818|LINC01876|LINC01911|LINC01920|LINC01931|LINC02612|LOC100144595|LOC101929319|LOC108348024|LOC110120673|LOC110120710|LOC110120715|LOC110121086|LOC111556122|LOC112806054|LOC112806055|LOC115945200|LOC120961787|LOC120977009|LOC122819164|LOC122819165|LOC122819166|LOC122819167|LOC122847293|LOC122847294|LOC122847295|LOC122847296|LOC122847297|LOC122847298|LYPD6|LYPD6B|MBD5|MIR4773-1|MIR4773-2|MIR9899|MMADHC|MMADHC-DT|NEB|NMI|ORC4|PRPF40A|RBM43|RIF1|RND3|RPRM|STAM2|TNFAIP6		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000154515	2	147081759 - 157075637	2	146324191 - 156219125	154515	164269		
GRCh38/hg38 2q22.3-24.1(chr2:143900149-158321624)x3	ACVR1|ACVR1C|ACVR2A|ARL5A|ARL6IP6|CACNB4|CCDC148|CCDC148-AS1|CYTIP|EPC2|ERMN|FLJ46875|FMNL2|GALNT13|GALNT5|GPD2|GTDC1|KCNJ3|KIF5C|LINC01412|LINC01817|LINC01818|LINC01876|LINC01911|LINC01920|LINC01931|LINC01966|LINC02612|LINC02993|LOC100144595|LOC101928386|LOC101929319|LOC107228318|LOC108348024|LOC110120671|LOC110120673|LOC110120674|LOC110120675|LOC110120706|LOC110120708|LOC110120710|LOC110120715|LOC110120731|LOC110120736|LOC110121086|LOC110121209|LOC111556122|LOC111721705|LOC112806051|LOC112806054|LOC112806055|LOC115945200|LOC120961787|LOC120977009|LOC121725105|LOC122819163|LOC122819164|LOC122819165|LOC122819166|LOC122819167|LOC122847293|LOC122847294|LOC122847295|LOC122847296|LOC122847297|LOC122847298|LYPD6|LYPD6B|MBD5|MIR4773-1|MIR4773-2|MIR9899|MMADHC|MMADHC-DT|NEB|NMI|NR4A2|ORC4|PRPF40A|RBM43|RIF1|RND3|RPRM|STAM2|TEX41|TNFAIP6|TRA-CGC3-1|TRG-GCC2-2|UPP2|ZEB2|ZEB2-AS1		See cases	Pathogenic(Last reviewed: Jul 30, 2009)	no assertion criteria provided	VCV000146076	2	144657717 - 159178136	2	143900149 - 158321624	146076	155827		
NM_001164508.2(NEB):c.3567+1G>A	NEB		Nemaline myopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000129741	2	152534389	2	151677875	129741	135187	rs587780399	NC_000002.12:151677874:C:T
NM_001164508.2(NEB):c.19712_19716delinsGAG (p.Ala6571fs)	NEB	A6571fs, A4870fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Feb 7, 2014)	criteria provided, single submitter	VCV000129704	2	152409927 - 152409931	2	151553413 - 151553417	129704	135150	rs587780397	NC_000002.12:151553412:ATAAG:CTC
NM_001164508.2(NEB):c.8031_8041del (p.Lys2677fs)	NEB	K2677fs	not provided|Nemaline myopathy 2|Nemaline myopathy	Pathogenic/Likely pathogenic(Last reviewed: Apr 29, 2022)	criteria provided, multiple submitters, no conflicts	VCV000095138	2	152499783 - 152499793	2	151643269 - 151643279	95138	101038	rs398124172	NC_000002.12:151643268:CTCGTTTATTT:
NM_001164508.2(NEB):c.1152+1G>A	NEB		not provided|Arthrogryposis multiplex congenita 6|Nemaline myopathy 2|Nemaline myopathy	Pathogenic(Last reviewed: Sep 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000095104	2	152563394	2	151706880	95104	101004	rs398124167	NC_000002.12:151706879:C:T
GRCh38/hg38 2q23.1-24.3(chr2:148917286-163204623)x1	LINC01920|LINC01931|LINC02478|LINC02612|LOC100144595|LOC101929319|LOC101929532|LOC108175345|LOC108281133|LOC108348024|LOC110120673|LOC110120674|LOC110120675|LOC110120676|LOC110120708|LOC110120710|LOC110120736|LOC110121086|LOC110121120|LOC110121242|LOC111556122|LOC112806054|LOC112806055|LOC112806056|LOC114827830|LOC115945200|LOC117152610|LOC117152611|LOC120961787|LOC120977009|LOC120977010|LOC120977011|LOC120977012|LOC121725105|LOC122819166|LOC122819167|LOC122847293|LOC122847294|LOC122847295|LOC122847296|LOC122847297|LOC122847298|LOC122847299|LOC122847300|LOC122847301|LOC122847302|LOC122847303|LOC122847304|LOC122847305|LOC122847306|LOC122847307|LY75|LY75-CD302|LYPD6|LYPD6B|MARCHF7|MIR4773-1|MIR4773-2|MIR4785|MIR6888|MIR9899|MMADHC|MMADHC-DT|NEB|NMI|NR4A2|PKP4|PKP4-AS1|PLA2R1|PRPF40A|PSMD14|PSMD14-DT|RBM43|RBMS1|RIF1|RND3|RPRM|SLC4A10|STAM2|TANC1|TANK|TANK-AS1|TBR1|TNFAIP6|TRA-CGC3-1|TRG-GCC2-2|UPP2|WDSUB1|ACVR1|ACVR1C|ARL5A|ARL6IP6|BAZ2B|BAZ2B-AS1|CACNB4|CCDC148|CCDC148-AS1|CD302|CYTIP|DAPL1|DPP4|DPP4-DT|ERMN|FAP|FLJ46875|FMNL2|GALNT13|GALNT5|GCA|GCG|GPD2|IFIH1|ITGB6|KCNH7|KCNH7-AS1|KCNJ3|KIF5C|LINC01806|LINC01817|LINC01818|LINC01876		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000060219	2	149674855 - 164061133	2	148917286 - 163204623	60219	74814		
GRCh38/hg38 2q22.3-23.3(chr2:147590324-153496674)x1	ACVR2A|ARL5A|ARL6IP6|CACNB4|EPC2|FMNL2|KIF5C|LINC01817|LINC01818|LINC01920|LINC01931|LINC02612|LOC101929319|LOC108348024|LOC110121086|LOC112806054|LOC112806055|LOC115945200|LOC120961787|LOC120977009|LOC122819165|LOC122819166|LOC122819167|LOC122847293|LOC122847294|LOC122847295|LOC122847296|LOC122847297|LYPD6|LYPD6B|MBD5|MIR4773-1|MIR4773-2|MIR9899|MMADHC|MMADHC-DT|NEB|NMI|ORC4|PRPF40A|RBM43|RIF1|RND3|RPRM|STAM2|TNFAIP6		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000060217	2	148347892 - 154353187	2	147590324 - 153496674	60217	74812		
GRCh38/hg38 2q22.3-24.1(chr2:147251948-157856378)x1	ACVR1|ACVR1C|ACVR2A|ARL5A|ARL6IP6|CACNB4|CYTIP|EPC2|ERMN|FLJ46875|FMNL2|GALNT13|GALNT5|GPD2|KCNJ3|KIF5C|LINC01817|LINC01818|LINC01876|LINC01920|LINC01931|LINC02612|LOC100144595|LOC101929319|LOC108348024|LOC110120673|LOC110120674|LOC110120675|LOC110120708|LOC110120710|LOC110120736|LOC110121086|LOC111556122|LOC112806054|LOC112806055|LOC115945200|LOC120961787|LOC120977009|LOC122819165|LOC122819166|LOC122819167|LOC122847293|LOC122847294|LOC122847295|LOC122847296|LOC122847297|LOC122847298|LYPD6|LYPD6B|MBD5|MIR4773-1|MIR4773-2|MIR9899|MMADHC|MMADHC-DT|NEB|NMI|NR4A2|ORC4|PRPF40A|RBM43|RIF1|RND3|RPRM|STAM2|TNFAIP6|TRA-CGC3-1|TRG-GCC2-2		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000060216	2	148009516 - 158712890	2	147251948 - 157856378	60216	74811		
NM_001164508.2(NEB):c.7431+1919_7536+374del	NEB		Arthrogryposis multiplex congenita 6|Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 15, 2012)	no assertion criteria provided	VCV000014052	2	152502270 - 152504771	2	151645756 - 151648257	14052	29091		
NM_001164508.2(NEB):c.22479+1G>C	NEB|RIF1		Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 2, 1999)	no assertion criteria provided	VCV000014051	2	152380824	2	151524310	14051	29090	rs1057515575	NC_000002.12:151524309:C:G
NM_001164508.2(NEB):c.25174G>T (p.Glu8392Ter)	NEB|RIF1	E6536*, E8392*, E8427*	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 2, 1999)	no assertion criteria provided	VCV000014050	2	152347009	2	151490495	14050	29089	rs121913662	NC_000002.12:151490494:C:A
NEB, 2-BP DEL, GA, EX181	NEB		Arthrogryposis multiplex congenita 6	Pathogenic(Last reviewed: Mar 2, 1999)	no assertion criteria provided	VCV000014049					14049	29088	rs1559154278	
NEB, 2-BP DEL, AG, EX172	NEB		Arthrogryposis multiplex congenita 6	Pathogenic(Last reviewed: Oct 1, 2002)	no assertion criteria provided	VCV000014048					14048	29087		
NM_001164508.2(NEB):c.23395_23398dup (p.Leu7800fs)	NEB|RIF1	L6099fs, L7835fs, L7800fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Mar 2, 1999)	no assertion criteria provided	VCV000014047	2	152364571 - 152364572	2	151508057 - 151508058	14047	29086	rs1057515574	NC_000002.12:151508057:AAACA:AAACAAACA
NM_001164508.2(NEB):c.22641del (p.Met7547fs)	NEB|RIF1	M5846fs, M7547fs, M7582fs	Nemaline myopathy 2	Pathogenic(Last reviewed: Aug 24, 2021)	criteria provided, single submitter	VCV000014046	2	152375533	2	151519019	14046	29085	rs1057515573	NC_000002.12:151519018:C:
